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ABSTRACT 
 
As South Africa moves into an era of National Health Insurance (NHI), the idea of 
primary health care (PHC) re-engineering is placed at the forefront; however, the role 
of the pharmacist in this process remains vague. Task-shifting of the dispensing 
process to pharmacist’s assistants and nurses in PHC clinics is a common 
phenomenon, but the implications of this on the provision of pharmaceutical services 
and care to patients is largely unstudied. Thus, this study aims to explore these 
pharmacist-based, pharmacist’s assistant-based and nurse-based dispensing models 
present in PHC clinics. A two-phase, mixed methods approach was utilised, 
comprising of a pharmaceutical services audit and semi-structured interviews. The 
interviews provided insight into the lived experiences of personnel and patients of 
pharmaceutical care provision. Results revealed that although basic pharmaceutical 
services may be available at clinics with each of the three dispensing models, the 
quality is of a varying standard due to challenges in infrastructure and maintenance 
and poor personnel support. Furthermore, the provision of quality pharmaceutical care 
is minimal with all three dispensing models, resulting in a missed opportunity to 
optimise patient health outcomes in patient-centred PHC. 
KEY WORDS 
 
National Health Insurance, Primary health care re-engineering, Pharmaceutical 
services, Pharmaceutical care, Dispensing models, Task-shifting, Human resources 
for health. 
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CHAPTER ONE 
INTRODUCTION 
 
Background 
 
As part of the global post-2015 development agenda, Universal Health Coverage 
(UHC) is a key goal to improving health care delivery, most importantly in 
strengthening health system delivery in low- and middle income countries (LMICs) 
(Norheim, 2015; Sengupta, 2013; Vega, 2013). Since 2000, many governments have 
committed to adopting policies aligned with the principles of UHC; including healthcare 
systems based on social solidarity and redistribution of health and human resources 
(particularly to vulnerable populations and marginalised groups (Reich et al., 2016; 
Virk & Surender, 2016). Poor health status in developing countries, often due to the 
large inequalities in access to quality healthcare, perpetuates other interlinked forms 
of inequality. This has substantial effects on human capital, economic status and the 
inter-generational socio-economic status of families (Wilkinson & Pickett, 2009; 
Yazbeck, 2009) 
Since 1994, attempts have been made to transform South Africa’s pluralistic 
healthcare system into one united socialised system with UHC implementation. These 
attempts largely focus on the National Health Insurance (NHI) which is derived from 
the Reconstruction and Development Programme (RDP), the 1997 White Paper for 
the Transformation of the Health System and the constitutional mandate based on 
Section 27 of the Constitution and Vision 2030 of National Development Plan (NDP) 
of South Africa (Department of Health: South Africa, 2017a; Fusheini & Eyles, 2016; 
Rowe & Moodley, 2013). The NHI, a 14-year implementation plan (from 2012 to 2025), 
is a policy response aimed at poverty alleviation, progressive universalism, and 
addressing historical inequalities still present in South Africa, and, in particular, the 
systemic inequities relating to quality, access, efficiency and effectiveness of 
healthcare service provision (Department of Health: South Africa, 2017a; Fusheini & 
Eyles, 2016; Gray, Riddin, & Jugathpal, 2016). The NHI aims to target other pertinent 
aspects of South Africa’s health care system; including growing disparities between 
public and private sector and a generalised human resources for health (HRH) deficit 
(Amollo, 2009). 
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As South Africa begins to implement the NHI, primary health care (PHC) re- 
engineering is a major emphasis in health system restructuring. The development of 
sustainable PHC is widely considered a major pillar of healthcare system alignment 
with the principles of UHC (Bheekie & Bradley, 2016; Department of Health: South 
Africa, 2017a). Since the Declaration of Alma Ata (1978), PHC has been the 
cornerstone of strengthening and expanding health systems in LMICs, with the ability 
to improve health system objectives in line with the Millennium Development Goals 
(MDGs) and the Sustainable Development Goals (SDGs) (Kruk, Porignon, Rockers, & 
Van Lerberghe, 2010). In an attempt to improve equity of healthcare access and to 
address the increasing need for chronic therapy with long-term patient support, there 
has been a transition in service provision from hospi-centric healthcare to the 
strengthening of previously-underdeveloped PHC and associated preventative and 
promotive services. Considering South Africa’s quadruple burden of disease 
(communicable diseases, non-communicable diseases, injuries and HIV/AIDS), NHI 
reform needs to emphasise the strengthening of preventative and promotive PHC in 
conjunction with curative services (Bheekie & Bradley, 2016; Department of Health: 
South Africa, 2017a). 
Since 2010, the revitalisation of PHC through the implementation of Operation Phakisa 
and the development of the Ideal Clinic (IC) concept saw the growth in capacity and 
quality of health facilities with outreach and community-based services (Department 
of Health: South Africa, 2015). However, despite an increase in utilisation, disparities 
still exist with inequalities still prevalent; thus, the NHI has prioritised PHC and District 
Health Systems (DHS) during the first phase of implementation of the NHI (Department 
of Health: South Africa, 2017a; Department of Health: South Africa, 2015). 
Due to the transformation of the health care system in South Africa with prioritised 
PHC, the role of the pharmacist involved is required to undergo some adjustment to 
further prioritise patient care (one of the goals of PHC). Patients require the services 
of a pharmacist when they receive medicinal treatment, as individual medicine 
decisions are required with adequate patient monitoring. Despite the knowledge of the 
importance of the pharmacist’s role in patient care, the pharmacists’ role within the 
PHC setting under the NHI is vague; with the PHC staff envisaged to include a doctor, 
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PHC nurse, nurse, pharmacist’s assistant and a counsellor (Department of Health: 
South Africa, 2017a). 
Due to the shortage of pharmacists, as part of a greater HRH crisis in the public sector, 
task-shifting to pharmacist’s assistants and nurses has become common practice 
(Gilbert, 2013). The inclusion of a pharmacist’s assistant into this PHC staff team 
involves the task-shifting of dispensing and medicine supply management to the 
pharmacist’s assistant, a pharmacy support workforce cadre (PSWC), to ensure the 
adequate supply and dispensing of medicines in many PHC clinics (Department of 
Health: South Africa, 2017a). Where a pharmacist’s assistant is not available, the 
dispensing and supply management of medicines is managed by registered nurses. 
This process of task-shifting has resulted in pharmacist’s assistant-based and nurse- 
based dispensing models being largely utilised in South Africa’s PHC clinic context. 
Task-shifting of the dispensing process to midlevel workers and registered nurses 
remains largely unstudied and the effects on patient care remain largely unknown 
(Monteith, Grimwood, & Pillay, 2010; Sanne et al., 2010). 
1.1 Problem statement 
 
The NHI aims to deconstruct South Africa’s fragmented healthcare system into a 
united, more equitable health care system. However, the shortage of HRH in South 
Africa is a major challenge that requires the need for the empowerment of support 
personnel to compensate for the shortage of highly-skilled health care professionals. 
Task-shifting of the dispensing process to pharmacist’s assistants and registered 
nurses is a cost-effective solution to aid in increasing access to pharmaceutical 
services; although the effects of this process in pharmacy remain largely unstudied. 
There is little known about the difference in pharmaceutical service delivery and 
pharmaceutical care provision by pharmacist-based, pharmacist  assistant-based and 
nurse-based dispensing models at public PHC clinics in South Africa. This study aims 
to contribute to the understanding of these models in the context of pharmaceutical 
services and care provision; hence providing more clarity on the current role of the 
pharmacist within South Africa’s PHC clinic setting. 
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Research question 
 
How do the experiences of pharmaceutical services and care provision differ between 
pharmacist-based, pharmacist’s assistant-based and nurse-based dispensing models 
at PHC clinics in the Nelson Mandela Bay Health District? 
 
Study aims and objectives 
 
The primary aim of this study is to explore pharmacist-based, pharmacist’s assistant- 
based and nurse-based dispensing models through experiences of quality and 
availability of pharmaceutical services and care provided at three public PHC clinics in 
the Nelson Mandela Bay Health District. 
1.3.1 Study objectives 
 
In support of this aim the objectives of this study are to: 
 
(i)  Establish the quality and availability of pharmaceutical service delivery in a PHC 
clinic with a pharmacist-based, pharmacist’s assistant-based and nurse-based 
dispensing model. 
 
(ii)  Establish the perceived quality of pharmaceutical care provision in a PHC clinic 
with a pharmacist-based, pharmacist’s assistant-based and the nurse-based 
dispensing model. 
 
Dissertation overview 
 
This research dissertation will be presented in the following manner: 
Chapter 1: Introduction 
Chapter 2: Literature review - Task-shifting in pharmaceutical services and care in the 
context of South Africa’s National Health Insurance. 
 The National Health Insurance in South Africa 
o The structure of the South African National Health Insurance 
o The need for the National Health Insurance in South Africa 
o The global need for primary health care 
o Primary health care in South Africa 
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 The provision of pharmaceutical services and care 
o Pharmaceutical services provision in the South African primary 
health care 
o Pharmaceutical care in South African primary health care 
o The pharmacist’s role in the multidisciplinary health care team 
 Task-shifting in the delivery of pharmaceutical services and care 
o The human resources for health deficit in South Africa 
o Task-shifting as a response to the human resources for health 
deficit 
o Task-shifting in the South African pharmaceutical sector 
Chapter 3: Methodology 
 Research design 
 Research process 
o Phase 1 
o Phase 2 
 Research site and population 
o Research site 
o Research population 
 Research sample 
 Pilot study 
o Pilot study changes 
 Data collection 
o Phase 1 
o Phase 2 
 Data analysis 
 Validity and trustworthiness of the data 
o Validity of the data 
o Trustworthiness of the data 
 Ethical considerations 
o Avoidance of harm 
o Voluntary participation 
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o Informed consent 
o Confidentiality and anonymity 
Chapter 4: Results and discussion 
 Phase 1: Results obtained from dispensaries and medicine rooms 
o General standards relating to the premises 
o Standards dependent on the type of personnel present on 
premises 
 Phase 2: Results obtained from semi-structured interviews 
 Summary 
o Phase 1 
o Phase 2 
 
Chapter 5: Conclusion, recommendations and limitations 
 
 Conclusion 
o Pharmaceutical services 
o Pharmaceutical care 
 Limitations 
 Recommendations 
o Future research 
o Policy 
o Practice 
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CHAPTER TWO 
LITERATURE REVIEW 
Task-shifting in pharmaceutical services and care in the 
context of South Africa’s National Health Insurance. 
This review aims to contextualise the research study within the NHI implementation 
and in relation to the current South African public healthcare system. PHC re- 
engineering, a key pillar of NHI implementation, is discussed with emphasis placed on 
Operation Phakisa and the IC programme; a programme that frames the study 
focussed on PHC clinics. Speaking to the aims of the study, pharmaceutical services  
and care at PHC level will be explored in the review, with an emphasis on the role and 
contribution of the pharmacist in the provision thereof. Thereafter, task- shifting will be 
discussed in relation to the HRH deficit. Task-shifting models involved in South African 
PHC clinics will then be explored including; pharmacist-based, pharmacist’s assistant-
based and nurse-based dispensing models, focusing on their influence on pharmacy 
practice within PHC clinics. 
 
The National Health Insurance in South Africa 
 
After the turn of democracy in 1994, policy proposals regarding a NHI were made, with 
the resolution to implement an NHI for South Africa being adopted in 2007. A 
Ministerial Advisory Committee (MAC) was set up to outline health system reform 
proposals to further shape a broad South African NHI policy (McIntyre, 2010). In 2000, 
healthcare provision formed part of an inquiry into a comprehensive system of social 
security for South Africa, in an attempt to enhance a broader sense of social protection 
for all South Africans. As part of this Inquiry, the MAC also recommended the 
development of the NHI, with the integration of the public sector and the medical 
schemes in South Africa underpinned by multiple funding sources to support extended, 
broader health services coverage of the population (Amollo, 2009, 2012). 
The NHI, a not-for-profit public entity, is a policy reform that aims to provide 
accessibility to affordable and quality health care services for all South Africans based 
on healthcare need. It is a reformed financing system that pools funds to ensure 
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financial risk protection of South Africans against financial hardships from the use of 
health care services. The NHI is based on the idea that health is a social investment 
and not a commodity of trade; thus justice, fairness and solidarity need to underpin the 
reorganisation of the current fragmented health care system (Department of Health: 
South Africa, 2017a). 
The NHI, aiming to ensure the equity, effectiveness, efficiency and quality of 
healthcare provision, is fundamental to South Africa’s overall development and is 
aligned with crucial aims of the NDP and Vision 2030 of South Africa. Furthermore, it 
is aligned with the Bill of Rights and Section 27 of the Constitution of South Africa, 
which encompass the commitment of the state to take reasonable measures (including 
legislative means) to achieve the progressive realisation of the right to access of health 
care services for all. The World Health Organisation (WHO) supports a ‘universal 
health system that provides all citizens with adequate care at an affordable cost’, 
hence the WHO has advocated for the movements of governments to be focused on 
the attainment of UHC (World Health Organisation, 2009). Goal 3.8 of the global 
SDGs, adopted by the United Nations (UN), also states that governments should take 
active steps to ‘achieve universal health coverage including financial risk protection, 
access to quality essential health care services and access to safe, effective, quality 
and affordable essential medicines and vaccines for all’ (Department of Health: South 
Africa, 2017a; United Nations, 2017; World Health Organisation, 2017). 
The NHI is seen as an important step in the progressive realisation of the right to 
health, together with influencing poverty alleviation and historical inequalities 
(Department of Health: South Africa, 2017a). The NHI proposes universal coverage to 
ensure more equitable access to health services, thus promoting the solidarity of South 
Africans and the sharing of available health resources, with access to such not limited 
by the ability-to-pay (Amollo, 2009, 2012; Department of Health: South Africa, 2017a). 
The introduction of an NHI policy, aligned with international trends, would be an 
integral step to equitable UHC realisation in South Africa; with all South African citizens 
and permanent foreign nationals being able to access available health services. The 
government has attempted to consider South Africa’s context into the 
conceptualisation, design and implementation of the NHI for South Africa and aims to 
treat health as a social investment that is affordable and sustainable in light of the 
South African context. Furthermore, the NHI aims to use resources more efficiently, to 
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optimise value for money while ensuring acceptable standards of quality are delivered 
through appropriate service delivery models to achieve positive health outcomes at all 
levels of care for all in the population (Department of Health: South Africa, 2017a). 
 
The structure of the South African National Health Insurance 
 
The implementation of the NHI was planned over three phases, the first of which (five 
years) was focussed on the strengthening of service delivery and overall quality of the 
public sector; in order to improve structure, financial management, accountability and 
governance within public sector PHC and hospital levels. The Green Paper on the NHI 
was published in 2011, with key stakeholders and consultations over a four-year period 
culminating in the release of the White Paper (volume 40) in 2015, with an updated 
version (volume 41) in 2017 (Department of Health: South Africa, 2017a). 
2.1.2.1 Phase 1: 2012/2013-2016/2017 
 
Phase 1 of the NHI roll-out, implemented from 2012/2013 to 2016/2017, aimed to 
strengthen the health system with the implementation of the four streams of PHC re- 
engineering (involving the contracting of private health professionals into public health 
facilities); the improvement of quality and governance structures of public clinics 
(through the IC Model) and hospitals; the implementation of the Centralised Chronic 
Medication Dispensing and Distribution (CCMDD) programme; strengthening financial 
management and procurement of health services and implementation of HRH and 
appropriate eHealth Strategies. The public health system is to be the ‘backbone’ of the 
health system, thus the reorganisation and quality improvement thereof is crucial to 
the success of the NHI roll-out (Department of Health: South Africa, 2017a). 
 
The PHC clinics and Community Health Centres (CHCs), that conform to the IC model, 
have been established as the point of entry into the health system; with gate-keeping 
and a strict referral system to specialist or hospital-based care. This system aims to 
promote financial sustainability, with fees being charged to those who bypass referral 
pathways, and with incentives provided to health professionals who successfully 
ensure the correct referral of patients upon full NHI implementation. In addition, a 
comprehensive set of health services will be provided; including PHC (involving health 
promotion and preventative healthcare), curative, rehabilitative and palliative care with 
access to pharmaceutical services and appropriate emergency medical services 
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(EMS). An NHI Benefits Advisory Committee has begun to advise in a range of 
services at primary, secondary, tertiary and quaternary levels that promotes the best 
population health outcomes, with treatment guidelines that are based on cost- 
effectiveness, health technology assessments and efficacy. Any changes to the 
comprehensive range of services will be informed by local burden of disease, 
demographic profiles, and technological advancements locally and internationally and 
updated efficacy and cost-effectiveness of treatments. The Essential Medicines List 
(EML) complements the treatment guidelines with a current inventory of 
pharmaceuticals, medical supplies and devices linked to treatment guidelines by the 
NHI Benefits Advisory Committee (Department of Health: South Africa, 2017a). 
 
The DHS, involving PHC services (both public and private) and district hospitals 
encompass bi-directional referral across the entire health system via a feedback 
referral system and planned patient transportation. District Health Management 
Offices (DHMOs) aim to ensure adequate planning of purchasing, provision, co- 
ordination and monitoring of both personal and non-personal health services against 
policy guidelines and health priorities and needs in the district (Department of Health: 
South Africa, 2017a). 
 
The NDP has called for an increased level of autonomy for public hospitals to promote 
stronger management at facility level. Rather than being managed by provincial health 
department head offices, which has led to poor remuneration, poor retention and 
support of skilled managers due to over-centralisation, the reorganisation of public 
hospitals has begun to establish legitimised Hospital Boards (Department of Health: 
South Africa, 2017a). Provincial Tertiary Services (T1) involve higher specialised care, 
receiving referrals from a national referral plan not limited to provincial boundaries. 
Some regional hospitals render some health services under T1 if distance constraints 
or burden of disease dictate the need thereof. Central Referral Services (T2) provided 
by central hospitals involve highly specialised services (delivered in sub-specialities) 
that require sophisticated and expensive technologies to support care. Lastly, National 
Referral Services (T3) provide super-specialist services in national referral sites linked 
to Central Hospitals according to the national referral plan. Extremely specialised 
personnel and technologies are utilised and form the final level of care in the referral 
system (Department of Health: South Africa, 2017a). 
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To promote adequate quality, effectiveness and accountability of performance of 
health service provision, management and governance structures have been modified 
to allow more effective decision-making capabilities. The management of facilities and 
equipment, human resources, finances, procurement and supply chain should improve 
with the establishment of strict minimum competency requirements, assured by the 
Office of Health Standards Compliance (OHSC) and NHI Benefits Advisory 
Committee. The accreditation of facilities for service provision in the NHI is to continue 
into Phase 2 and 3 (Department of Health: South Africa, 2017a). These standards 
encompass National Quality Standards for Health and include: 
i.  patient safety 
ii.  clinical support services 
iii.  clinical governance and care 
iv. leadership and corporate governance 
v. public health 
vi. operational management 
vii.  facilities and infrastructure 
viii.  human resources management. 
 
Furthermore, National Core Standards have been created to guide quality 
improvement at PHC clinic level, including: 
i.  attitudes of staff 
ii.  cleanliness 
iii.  infection control 
iv. safety and security 
v. waiting times 
vi. availability of medicines. 
Health facilities are inspected by the OHSC Inspectorate according to these 
established norms and standards to be successfully accredited for health service 
provision under the NHI Fund, while an ombud function ensures the investigating of 
patient complaints at facilities. The National Core Standards justly inform Operation 
Phakisa’s Ideal Clinic Realisation and Maintenance (ICRM) to promote quality 
improvement in PHC re-engineering with a sustainable plan for compliance with norms 
and standards will be developed to ensure that health infrastructure is of an 
acceptable, quality standard (Department of Health: South Africa, 2017a). 
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2.1.2.2 Phase 2: 2017/2018-2019/2021 
 
From 2017/2018 – 2019/2021, health system strengthening continues to be a major 
emphasis. PHC services (non-specialist level) will be purchased from accredited and 
certified public and private providers by a Transitional Fund, with all ICs being 
contracted and accredited. Thereafter, public hospitals (including district, regional, 
tertiary, central and specialised) certified with the OHSC, National Laboratory Health 
service (NHLS) and the Emergency Medical Services (EMS) will be contracted. The 
NHI Fund, managed by the NHI Board, will be a pool of funds set up to contract and 
purchase health services for the population with the Board reporting to Parliament and 
the Minister of Health (Department of Health: South Africa, 2017a). Contracting and 
re-imbursement of these accredited health services providers will be done based on 
population need, cost-effectiveness, accountability and equity. The procurement of 
goods and services, including medicines, medical equipment and technology for all 
contracted facilities, will be facilitated via the NHI Fund through the purchasing power 
of the fund. Contracts with service providers will be reviewed regularly by the 
Performance Monitoring Unit, taking into account epidemiology transitions and 
adherence to clinical guidelines and protocols (Department of Health: South Africa, 
2017a). 
During this phase, the NHI Fund, an autonomous public entity, will be established as 
a single-payer and single-purchaser (purchaser-provider split). The details regarding 
the establishment of the Fund have been released in terms of the National Health 
Insurance Bill as of June 2018 (South Africa, 2018b). The Fund is envisaged to pool 
funds to strategically purchase personal health services for the whole population. To 
ensure sustainability of the Fund, means of cost-containment will incentivise improved 
quality of care in the public sector, while encouraging a price decrease in the private 
sector. The Fee-for-Service Model as a provider reimbursement model has been noted 
to promote over servicing and unnecessary referrals and the lack of accountability of 
quality of service provision, thus comprising cost-effectiveness. Hence, the NHI Fund 
will aim to improve efficiency of quality service provision by linking provider payment 
to performance and accreditation. At PHC level, this would mean a risk-adjusted 
capitation system, based on principles of performance-based payment that would be 
guided by reliable patient data involving diagnosis groups and service need. Hospitals 
will employ a case-based reimbursement system (involving Diagnosis Related Groups 
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(DRGs)), guided by reliable patient data (Department of Health: South Africa, 2017a; 
Department of Health: South Africa, 2018b). 
The population will be provided with NHI cards linked to the Smart Identification 
System with encrypted patient information. During the registration, provision of NHI 
cards will be required by the Health Provider Registration System (HPRS) at all 52 
districts and in 400 public sector hospitals, vulnerable populations, including the 
elderly, children, women and those in rural communities, will be prioritised 
(Department of Health: South Africa, 2017a). A National Health Information Repository 
and Data System will comprise of an interlinked eHealth national patient-based 
information system or NHI Fund membership database and accredited providers. This 
will be key to the NHI for effective management and service delivery, aiding monitoring 
the coverage of the population and the demographic and disease profile data (for 
capitation allocations). It will also be useful to monitor quality assurance, facility 
performance reports and research that are crucial to the efficiency of health service 
provision (Department of Health: South Africa, 2017a). 
The NHI links to the broader social protection framework and it is an integral part of 
South Africa’s developmental future, i.e. to the broader social security and 
development structures, including the Compensation Fund for Occupational Diseases 
and Injury Act, Compensation Commissioner for Occupational Diseases in Mines and 
Works Act, Unemployment Insurance Fund and Road Accident Fund. Funds will be 
mobilised from the compensation funds and a review of state subsidies to medical 
schemes will be made, with these subsidies being contributed to the NHI Fund. During 
this phase, the NHI Fund should become fully functional with purchasing health 
services from accredited public and private PHC providers (Department of Health: 
South Africa, 2017a). 
Toward the end of phase two, the Medical Schemes Act No, 131 of 1998 will be 
amended to provide complementary cover when the NHI becomes fully implemented 
(Department of Health: South Africa, 2017a). The Medical Schemes Amendment Bill 
was released in June 2018 outlining key changes to the Act, involving; availability of 
information concerning services rendered to beneficiaries from health care providers; 
creation of a Central Beneficiary Register to assist with risk measurement; cancellation 
of membership and re-assessment of admission of beneficiaries; 
14  
determination of beneficiary contributions; new governance mechanisms for medical 
schemes; implications of broker fees and determination thereof and the regulation and 
registration of medical schemes in South Africa (South Africa, 2018a). 
2.1.2.3 Phase 3: 2021/2022 – 2024/2025 
 
The final phase of the NHI roll-out, from 2021/2022 to 2024/2025, will ensure that the 
NHI is fully functional, with all health facilities and institutions accredited with the NHI 
Fund only if norms and standards of the OHSC are met. The accreditation of the 
private sector providers (including private hospitals and specialists) with the OHSC will 
also occur during this phase according to the need of the population. A mandatory pre- 
payment for those eligible will be implemented to provide additional revenue for the 
NHI Fund (Department of Health: South Africa, 2017a). 
To ensure the firm management and governance of NHI structures, a National Health 
Commission is to be established to target an increasing burden of disease and 
correlated health care costs. This is to be done by promoting health and wellness in 
collaboration with government and non-governmental stakeholders to reduce lifestyle 
diseases, also known as Non-Communicable Diseases (NCDs). The NDP 2030 is in 
support of the aims of this Commission, as it envisages that NCDs will pose a major 
threat to overall social development in the next thirty years (Department of Health: 
South Africa, 2017a). The NHI Fund will be governed by the NHI Commission that 
involves expertise regarding health economics, financing and taxation, epidemiology 
and public health, health policy and planning, monitoring and evaluation, with civil 
society representatives. The NHI Fund will provide quarterly reports to the 
Commission, annually to Parliament and to the public and will provide financial 
performance as audited by the Auditor General annually (Department of Health: South 
Africa, 2017a). 
Private medical schemes in South Africa, following the amendment of the Medical 
Schemes Act, will begin to provide complementary cover at this phase onward. 
Mechanisms will be put in place to ensure medical schemes work concurrently with 
the NHI Fund aligned to prevent duplicative cover. Medical schemes will intend to play 
a supplementary role and once fully implemented fill the gaps in the universal 
comprehensive range of services provided (Department of Health: South Africa, 
2017a). 
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The need for the National Health Insurance in South Africa 
 
South Africa has a heavily burdened health care system with a high prevalence of 
communicable diseases such as HIV and AIDs, tuberculosis, maternal, infant and child 
mortality. There has been a rise in NCDs and violence-related injuries (particularly 
violence against women and children). The National Department of Health of South 
Africa (NDoH) warns that the health improvements noted over the past 50 years could 
be in danger if the health care system persists as it is; thus advocates for the NHI as 
an appropriate solution (Department of Health: South Africa, 2017a). 
2.1.3.1 A fragmented health care system: public and private sector 
 
Currently, South Africa has an underperforming health system characterised by 
‘systemic failures in both public and private systems’ (Van den Heever, 2012). A fixed 
two-tiered system relying on private and public funding has emerged, with 
socioeconomic status defining the level and quality of care a South African can access 
(Department of Health: South Africa, 2017a). The need for a NHI in South Africa was 
discussed prior to 1994, although the discussion around funding models and re- 
organisation of the public and private sector were highly disputed (Botha & Hendriks, 
2008; Shisana et al., 2006). Despite an increase in the population life expectancy, the 
effectiveness and efficiency of the health care system falls below projected targets and 
population need. Challenges are potentiated for the marginalised due to inequitable 
healthcare financing and the risk of occurring devastating health expenditure for poor 
households (Department of Health: South Africa, 2017a). Despite some reform, funding 
disparities between public and private sector remain. The South African government 
spends an estimated 8.3% Gross Domestic Product (GDP) on health higher than the 
minimum (5%) standard of the WHO; however, a mere 4% is spent within the public 
sector that provides services for an estimated 87% of the South African population 
(Gray et al., 2016; World Health Organisation, 2016). The public sector is funded by 
general taxes and has spending equivalent to 3.8% of the GDP, while the private 
sector has spending equivalent to 3.45% of GDP (Council of Medical Schemes, 2014; 
National Treasury of South Africa, 2011). Evidently, South Africa has a disproportion 
between resources and need that prevents adequate access to health services for the 
majority of the population (Department of Health: South Africa, 2017a; World Health 
Organisation, 2012). 
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A history of poor development of health-related policy, together with weak 
implementation thereof post-1994, are reported to have exacerbated historical 
institutional weaknesses of the health care system, with government arguing that there 
has been inadequate response to the institutional mechanisms in place to allow the 
public and private sectors to realise their highest potential concurrently (Development 
Bank of South Africa, 2008; Van den Heever, 2012). Currently, higher income earners 
often utilise private services over government-subsidised services. These private 
services complement public services in health service provision and rely on financial 
contribution of these higher earners, often through a private medical aid scheme (Van 
den Heever, 2012). 
In addition, the two-tier healthcare system currently has a skewed distribution of health 
care professionals between public and private sector, among different health districts 
and urban and rural geographical areas. Many health care professionals are attracted 
to the better resourced private health care system, resulting in a neglected public 
health care system. In response, the public sector has attempted to retain health 
professionals by increasing salaries of public sector workers; however this drives 
higher labour costs in the public sector (Department of Health: South Africa, 2017a). 
2.1.3.2 The cost of healthcare service provision 
 
The costly private sector in South Africa is currently largely under-regulated by means 
of legislation to ensure affordability of costly private sector services. Private sector 
hospitals are expensive in relation to the wealth of South Africa and continuously 
increase rates charged to patients above the accepted rate of inflation, making South 
African private hospitals least affordable when compared to other Organization for 
Economic Cooperation and Development countries (BRICS countries). Furthermore, 
the fee-for-service model currently employed by the private sector is costly with tariff 
imbalances often resulting between purchasers and providers of health care services 
(Department of Health: South Africa, 2017a). 
To ensure some access to the private health system, South Africa has 87 medical 
schemes regulated by the independent body, the Council of Medical Schemes (CMS) 
that is responsible for reporting to the Minister of Health and in upholding and assuring 
the general acceptable conduct of medical schemes in South Africa (Council of 
Medical Schemes, 2014). The private health care system funds only 8.8 million of the 
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population, however health funding is six times higher than other BRICS countries 
globally. Those in medical schemes incur high out-of-pocket (OOP) payment often 
from specialists, medicine costs and private hospital fees. Between 2013 – 2014, an 
estimated R6000 per beneficiary (around R20.7 billion) was paid out as OOPs for 
private health services, however this estimate is reported to be understated by the 
CMS (Council of Medical Schemes, 2014; Department of Health: South Africa, 2017a). 
Medical scheme members are becoming increasingly uninsured for healthcare costs 
by having to more frequently pay OOP payments for health services outside the 
covered minimum benefits package or when scheme benefits have run out 
(Department of Health: South Africa, 2017a). 
According to Regulation 8 of the Medical Schemes Act No.131 of 1998, all medical 
schemes have to pay for all prescribed minimum benefits (PMBs) (the diagnosis, 
treatment and care for a limited set of 270 medical conditions and 25 chronic 
conditions that medical schemes need to cover costs for). The fee-for-service 
reimbursement model used to service the provision and cost coverage of these PMBs 
has resulted in major cost escalation, resulting in more OOPs. The cost of PMBs is 
further increased by the absence of a price regulation mechanism between the 
contracting of providers by schemes, the unregulated introduction and use of new 
healthcare technologies that have not undergone adequate healthcare technology 
assessment and the low-level cross-subsidisation between beneficiaries within 
particular schemes (Department of Health: South Africa, 2017a). The NHI is 
responding to medical schemes by amending the Medical Schemes Act to offer 
complementary cover once the NHI is fully implemented after 14 years (Department 
of Health: South Africa, 2017a). 
In attempts to protect vulnerable populations within the public health system, the South 
African Human Rights Commission states PHC is currently free of charge and that 
children under six years, pregnant women, the poor and disabled do not pay user fees. 
However, only half of those who visited public facilities had free access although all 
were eligible for the user fee exemption (Department of Health: South Africa, 2017a). 
The National Health Act aims to ensure the free health care at higher levels, such as 
hospital care, is extended to more categories of users. The NHI will reduce OOP 
payments made by patients in return for health services and decreasing mandatory 
prepayments for services, thus increasing access to health care services and allowing 
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for more disposable income for households. The introduction of the NHI Fund is 
expected to create a 5% Keynesian macroeconomic multiplier effect; thus increasing 
economic activity, strengthened human development, poverty alleviation and quality 
of life (Department of Health: South Africa, 2017a). 
 
2.1.3.3 Poor quality of available healthcare 
 
The quality of available health care services in the public and private sector need to 
be adequately addressed, taking into account apparent quality short-falls in infection 
control, medicine stock-outs, patient waiting times, staff attitudes, levels of cleanliness 
and security and safety of patients and staff. The increased use of the health care 
system has increased patient loads and compromised the quality of care. In addition, 
the access of patients to the health care system often occurs at an inappropriate level 
of care (not at the primary level), thus extra costs are incurred with the inefficiency of 
the system. This is further implicated by the historic emphasis of our health system on 
curative means of treatment, with a historical absence of strong primary health care 
and preventative services (Department of Health: South Africa, 2017a). 
A key aspect of the NHI is the strengthening of leadership and governance structures 
through reforms in the management and accountability of management of quality of 
services delivered by clinics and hospitals, and health districts. For this, adequate 
policy consistency is required across all spheres of government to ensure successful 
implementation of new laws and amendments to existing legislation (Department of 
Health: South Africa, 2017b). The strengthening and implementation of clinical 
guidelines aims to ensure better quality of available health services. Furthermore, the 
reimbursement of health services will be adapted to incentivise quality service 
provision, such as capitation for PHC services and DRGs for hospital-based services 
(Department of Health: South Africa, 2017a). 
 
The global need for primary health care 
 
The concept of PHC was defined in the Declaration of Alma Ata (1978) as “essential 
health care based on practical, scientifically sound and socially acceptable methods 
and technology made universally accessible to individuals and families in the 
community through their full participation and at a cost that the community and country 
can afford to maintain at every stage of their development in the spirit of self-reliance 
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and self-determination”. It provided a paradigm shift in the thinking around health 
system reform, with a multi-sectoral approach to tackling of health inequalities globally, 
particularly in LMICs. It forms an integral part of the country's health system, of which 
it is the central function and main focus, and of the overall social and economic 
development of the community. It is the first level of contact of individuals, the family 
and community with the national health system bringing health care as close as 
possible to where people live and work. It constitutes the first element of a continuing 
health care process and has been identified as a strong health reform tool by the WHO 
(Hsieh, Wu, Wu, & Chiang, 2015). Underpinning PHC by person-centred and 
population-based public health policies and combined with contextual social, 
macroeconomic, cultural, political and geographic attributes of country contexts, 
contributes to PHC coverage expansion and consequential sustainable all-round 
development of populations (Hsieh et al., 2015). 
 
Promotive and preventative health care provision, a key underpinning of PHC, has had 
stronger effects on patient health outcomes than curative services in a multi- country 
analysis, resulting in less need for hospitalisation and speciality-oriented services 
(Lagomarsino, Garabrant, Adyas, Muga, & Otoo, 2012). Marginalised populations, 
including the poor, often benefit from the fairer distribution of health services based on 
better governance and supportive health infrastructure in PHC coverage. There has 
been much criticism in health expenditure in LMICs in the past 15 years, with public 
spending not improving equity in service provision enough, with pro-rich spending 
resulting in tangible changes to overall health outcomes. To provide meaningful 
progress toward UHC, PHC should be prioritised within national health financing to 
ensure more equity of health system provision on the population (Moreno- Serra & 
Smith, 2012). 
 
Primary health care in South Africa 
 
Primary health care is based on principles of equity, affordability, effectiveness and 
efficiency, thus is a key approach in South Africa’s NHI and in the overall development 
of the South African population. The DHS is currently based on these principles of 
PHC, being organised according to geographic areas (districts and sub-districts) and 
managed through a decentralised structure based on a ‘bottom up approach’. The 
DHS approach aims to work between government departments, with non-government
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organisations, clinic health committees and the district management structure to 
promote a localised, holistic approach to health care with firm community participation. 
However, understaffing, lack of capacity, service short-falls, low service utilisation and 
financing constraints have weakened delivery of PHC services to communities across 
districts (Harrison, 2009; Phaswana-Mafuya et al., 2008). 
 
The usage of PHC clinics and services are on the rise, with over 127 million PHC 
consultations occurring in the 2015/16 financial year in PHC clinics and community 
healthcare centres (Department of Health: South Africa, 2017c). However, negative 
perceptions of PHC exist, due to long waiting times and insufficient space to consult 
(Harrison, 2009). In order to improve quality of PHC health facilities, numerous 
concurrent interventions are being made to ensure quality standards are in line with 
norms and standards relevant under the NHI, with the IC Model, public sector 
infrastructure improvement, and the implementation of the WHO’s Workload Indicators 
for Staffing need (WISn) tool to the South African PHC context (Department of Health: 
South Africa, 2017a). 
2.1.5.1 Operation Phakisa: Ideal Clinic Concept 
 
Operation Phakisa is South Africa’s ‘socio-economic development blueprint’ launched 
in mid-2014, to engage stakeholders, such as government, citizens, labour and private 
business to address inequality, poverty and unemployment in an accountable and 
transparent manner (Department of Planning, Monitoring and Evaluation: South Africa, 
n.d.). The three phase ICRM programme, as part of Operation Phakisa, was 
established in 2013 by the NDoH to target deficiencies in the public PHC sector. Phase 
1 and Phase 2 of the IC programme were based on deficiencies identified as part of the 
baseline audit commissioned in 2001 by the NDoH. PHC clinics showed more deficit 
in the audit than any other level of health system in all priority areas, particularly in 
medicine availability, adequate staffing, poor infrastructure and patient satisfaction, 
with only one clinic facility in the public sector meeting the desired minimum standards 
of a health facility (Department of Health: South Africa, 2013). 
 
Operation Phakisa aimed to target eight work streams identified as priorities including; 
service delivery, waiting times, infrastructure, human resources for health, financial 
management, supply chain management, institutional arrangements and agreements 
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and scale-up and sustainability (Department of Planning, Monitoring and Evaluation: 
South Africa, n.d.). The ICRM, a crucial component of the IC Model was established 
to deliver integrated health services that are patient-centric offering a full continuum of 
care for patients with chronic and acute diseases (Department of Health: South Africa, 
2017a; Department of Health: South Africa, 2014). In attempts for clinics to begin work 
toward IC standards, an IC manual, outlining aspects of ICRM, has been developed 
as a reference guide to assist the management of clinics and for the facility managers 
and for managers at sub-district, district, provincial and national level to target 
apparent weaknesses in service provision at facilities, and to ensure the progressive 
accountability and realisation of the IC programme goals. Each element is weighted, 
determining if IC status has been achieved or not, with 15 vital elements, 87 essential 
elements and 81 important elements reflecting the eight priority work streams 
(Department of Health: South Africa, 2017b). 
 
The IC Programme includes pharmaceutical aspects such as adequate medicine and 
supplies, adequate staffing, administrative process and applicable clinical policies; 
although the pharmacists’ role within this scale-up programme remains elusive 
(Bheekie & Bradley, 2016; Department of Health: South Africa, 2017b). Some 
important features of ICs involve pharmaceutical and laboratory services; including 
medicine supplies and storage, the assurance of the quality of medicine by process of 
storage control, availability of essential PHC medicines (including tracer medicines) 
and the safe disposal of expired medicines. Other elements involve pharmacy and the 
PSWC indirectly; involving adequate human resources mix for optimal service 
delivery, the access to a full range of health care professionals, including the 
pharmacist on-site or through referral, and the collection of pre-dispensed medication 
for patients enrolled on the Central Chronic Medicine Dispensing and Distribution 
(CCMDD) programme (Department of Health: South Africa, 2017a; Department of 
Health: South Africa, 2017b). 
2.1.5.2 Primary health care re-engineering 
 
As shown in Figure 2.1, the re-engineering of South Africa’s PHC was planned for 
Phase 1 of the NHI roll-out, as guided by the MAC, standards of the OHSC and the 
DHMO as governance structures. The re-engineering process involved the 
development of four active streams; namely Ward-based Primary Health Care 
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Outreach Teams (WBPHCOTs), Integrated School Health Programme, District Clinical 
Specialist Teams (within Phase 1), and the contracting-in of private health practitioners 
at non-specialist level (within Phase 3) (Department of Health: South Africa, 2017a). 
 
 
Figure 2.1: The four streams of PHC re-engineering within the context of       
Phase 1 and 3 of the NHI (adapted from Department of Health: South Africa, 
2017a) 
 
The first stream, WBPHCOTs, are intended to involve the collaboration of community 
health workers (CHWs) with a professional nurse, health promotors and environmental 
health practitioners with the collective aim of promoting health and to providing 
preventative health care monitored by appropriate service delivery targets. CHWs 
would ensure that individuals in households within designated communities are 
assessed in terms of health need and refer those who require services to a relevant 
PHC facility (Department of Health: South Africa, 2017a). A partnership between all 
stakeholders, government representatives and civil society organisations would ideally 
ensure that each of the 4277 electoral wards in South Africa have a WBPHCOT to 
support the provision of community-based healthcare provision (Department of Health: 
South Africa, 2011). 
The second stream of PHC re-engineering involves the Integrated School Health 
Programme (ISHP) that is linked with the Department of Health, the Department of 
Basic Education, and the Department of Social Development. A revised School Health 
Policy is to be launched to provide quintile 1 and 2 schools with promotive, 
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preventative and curative services with prioritised screening for developmental 
impairment of children and developmental barriers to adequate learning. In addition, 
routine vaccination and immunisations will be prioritised, including vaccination of 
grade 4 female learners against the human papilloma virus (HPV), and missed 
Extended Programme on Immunisation (EPI) vaccines. De-worming and nutritional 
services, together with substance abuse, sexual and reproductive health and family 
planning services will be introduced to age-appropriate children, to ensure crucial 
health promotion (Department of Health: South Africa, 2017a). 
The third stream of PHC involves the District Clinical Specialist Teams (DCST), with 
districts being equipped with a multidisciplinary team comprised of a primary 
healthcare nurse, advanced midwife, family physician, gynaecologist and 
paediatrician, collectively aligned to strengthening clinical governance at PHC and 
district level. In addition, the DCST will aid in monitoring and reaching adequate health 
outcomes by ensuring guidelines and protocols are developed and utilised, providing 
mentorship and capacity building to support adequate clinical care in facilities. The 
three streams will not operate in silos, as the ISHP will link with the WBPHCOTs to 
ensure adequate living environments for healthy child development. Furthermore, the 
work of these teams will be monitored and assessed based on public health outcomes 
(Department of Health: South Africa, 2011, 2017a). 
Fourthly, during phase 3 of the NHI, private PHC services will be contracted to 
supplement public PHC services, to improve access to healthcare and to respond to 
the growing health burden within South African communities. The Contracting Unit for 
PHC (CUP) will be integral in this regard with providers being reimbursed through a 
capitation funding model (Department of Health: South Africa, 2017a). 
An established performance monitoring framework will be used to ensure acceptable 
performance standards of PHC, including the IC model specifications being used to 
accredit PHC facilities (Department of Health: South Africa, 2017a). The Patients’ 
Right Charter will be implemented to ensure well-being of patients, with the right to: 
i.  access timely emergency care regardless of ability-to-pay; 
ii.  participate in health decision-making regarding the development of health 
policies; 
24  
iii.  choose health providers and facilities based on information provided relating 
to health coverage; 
iv. receive treatment from named health professionals, aligned to ethical 
standards and guidelines; 
v. have informed consent, confidentiality and privacy, except when information is 
required by a court of law; 
vi.  access a continuum of quality care, with the option of referral; 
vii.  adequately complain about health services provision through appropriate 
channels (Department of Health: South Africa, n.d.). 
In addition, patient satisfaction will be a prime concern throughout the process, being 
measured by the OSHC and other stakeholders, with assistance, if required, from 
relevant statutory bodies (Department of Health: South Africa, 2017a). 
In terms of management and governance, DHMOs will be responsible for the 
management of these PHC streams as well as coordination of the integrated services 
provided through a range of contracted providers both private and public and fixed and 
mobile. Thus, district level management together with CUP will be able to successfully 
coordinate and monitor the provision of services. At facility level, clinic committees will 
ensure community participation of those in catchment areas for each facility, bringing 
into focus public health issues and needs of each area (Department of Health: South 
Africa, 2017a). 
 
The provision of pharmaceutical services and care 
 
Within the last 40 years, there has been a shift in focus of the pharmacy profession 
from medicine supply to patient care. The pharmacist is considered the ‘custodian of 
medicine’, providing responsible services that promotes the highest attainable 
standard of patient care in limited financial constraints (South African Pharmacy 
Council, 2018; Wiedenmayer et al., 2006). The pharmacist’s role includes assuming 
the responsibility for the medicine-related needs of the patient and thereby making a 
meaningful contribution to ensuring adequate patient medicine therapy and proper 
indication. Moreover, the role ensures that the medicine provided is the safest, most 
effective, affordable medication available for the patient to ensure the highest quality 
of life (Wiedenmayer et al., 2006). 
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Pharmacists find themselves in a time when access to medicines remains a major 
concern in LMICs, with one third of the world not having sustainable access to 
essential lifesaving medicines (World Health Organisation, 2004). Additionally, the 
rational use of medicines remains low with increasing antimicrobial resistance and 
failing therapy globally. The irrational prescribing of medicines remains high, with 
incorrectly prescribed medications being rife in settings deficient of pharmacists. 
Global health sector reform is thus needed to address challenges and overcome 
barriers to high quality care of patients. This reform, together with the paradigm shift 
in pharmacy practice from a product-centred to a patient-centred approach, means 
that the pharmacist providing pharmaceutical services and care may pose a potential 
solution to these problems (Wiedenmayer et al., 2006). 
 
Pharmaceutical services provision in South African primary health care 
 
At all levels of healthcare, medicinal therapy is the most frequently used intervention, 
with the appropriate medicine regimen underpinning quality health outcomes for most 
patients. The need for a health professional with knowledge of patient needs, medicine 
supply and a way of integrating both into safe, effective and appropriate medicine 
therapy for patients is required. Thus, the pharmacist could play a key role in assuring 
rational medicine use and adequate medicine supply that is underpinned by a health 
care system that is equitable, affordable and sustainable (Wiedenmayer et al., 2006). 
According to Good Pharmacy Practice (GPP), obligatory in terms of Section 35A of 
the Pharmacy Act 53 of 1974, as amended, Regulation 20(1) of the Regulations 
Relating to the Practice of Pharmacy and Regulation 7(a) of the Regulations Relating 
to the Ownership and Licensing of Pharmacies, pharmaceutical services consist of 13 
core objectives that are relevant to the practice of pharmacy in South Africa (South 
Africa, 1974). The fundamental objectives of pharmaceutical services should include: 
i.  drug supply management; 
ii.  availability of medicine information and health information materials; 
iii.  a prescription monitoring system to ensure the monitoring of effective 
prescribing and administration of medicines; 
iv. managerial capabilities for various patient groups ensuring that services fit 
organisational needs and that; 
v. an adverse drug reaction reporting system to ensure the safe use of medicines; 
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vi.  quality assurance of dispensing services; 
vii.  assurance of safe systems of work; 
viii.  support of research and clinical trials for the progression and relevance of 
available services (South African Pharmacy Council, 2018). 
It is important to note that pharmaceutical services, other than basic counselling on 
medicine use during part three of the dispensing process, offers no tangible patient- 
specific pharmaceutical care required for positive health outcomes of patients. Thus, 
pharmaceutical services can be seen as the technical processes that comprise and 
support the three phases of dispensing process (South African Pharmacy Council, 
2018). Pharmaceutical care however, involves the relationship between the health 
professional and patient focussed on more cognitive and patient-centred activities 
(Walkowiak & Keene, 2004). 
The practice of pharmacy, and the education and training of pharmacists and 
pharmacy personnel, is governed by unit standards of practice developed by the South 
African Pharmacy Council (SAPC). The practice standards are aimed at ensuring the 
commitment to the pharmacy profession and fulfilment of the statutory obligation to 
ensure pharmaceutical services are at an acceptable standard to meet the needs of 
patients. Pharmacists are required to ensure pharmaceutical services comply with 
GPP. Pharmaceutical services, involving the supply and management of medicines, 
should also comply with the terms of the Medicines and Related Substances Act 101 
of 1965, to ensure the safe and legal control of medicines in South Africa (South 
African Pharmacy Council, 2018). 
The scope of practice of a pharmacist, as prescribed by section 35A of the Pharmacy 
Act involves aspects of pharmaceutical services, including: 
i. compounding, preparation, manipulation and packaging of any medicine or 
the supervision thereof; 
ii.  the import, possession, purchase, manufacture, use, release, storage, supply, 
distribution and selling of any medicine or supervision thereof; 
iii.  formulation of any medicine for the registration and application for registration 
thereof; 
iv. conducting of research and development involving the medicine for means of 
pharmaceutical research (South African Pharmacy Council, 2018). 
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The provision of a reliable range of pharmaceutical services needs to be supported by 
adequate secure facilities that comply with statutory requirements. The GPP 
guidelines are formulated to successfully guide the profession of pharmacy, with the 
main elements including the professional standards for premises, services, pharmacy 
human resources, and pharmacy management; all of which promote optimal 
pharmaceutical service and care provision in the South African context (South African 
Pharmacy Council, 2018). A safe system of work is required that protects staff from 
hazardous chemicals or processes, including the safe disposal of waste. A sound 
management structure needs to underpin processes that successfully cater for 
organisational and patient needs and the level of pharmaceutical service provided. 
Lines of accountability need to be in place to ensure proper professional and 
managerial accountability among pharmacy personnel. Effective systems to facilitate 
drug supply management should be available at each facility, with personnel receiving 
support to make certain of an adequate supply of medicine at each facility. Means of 
quality assurance should be part of the process of pharmaceutical services provision, 
with services being available and appropriate for the level of care provided (South 
African Pharmacy Council, 2018). 
An important aspect of pharmaceutical services involves the promotion of rational 
prescribing and use of medicines. To ensure GPP, all pharmaceutical services 
provided should be underpinned by available medical and pharmaceutical information 
about the patient. For this to succeed, a ‘therapeutic alliance’ with other health care 
professionals is required to ensure a common goal of successful 
pharmacotherapeutics for all patients (South African Pharmacy Council, 2018). 
Furthermore, an adverse drug reaction reporting system should be used and managed 
by the responsible pharmacist involved to record adverse effects at facilities to make 
certain these are recorded for statistical purposes by pharmacovigilance authorities 
(South African Pharmacy Council, 2018). 
In addition to this, ideally pharmaceutical care should be provided to ensure 
responsibility of meeting the patients’ medicine-related needs. This is to ensure that 
the indication, effectiveness and safety of the prescribed medicine is prioritised when 
dispensing according to a prescription from someone appropriately authorised to 
prescribe. In relation, the GPP requires that the welfare of the patient is the priority, 
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with the fundamental services provided by the pharmacist being the supply, 
distribution and provision of appropriate information to ensure the correct use of the 
medicine (South African Pharmacy Council, 2018). 
Where the pharmaceutical services at a PHC level facility are provided by post-basic 
pharmacist’s assistants, indirect supervision may take place if documented visits are 
made by a pharmacist to the clinic for supervision. This should involve monthly 
monitoring and support, updated written protocols and standard operating procedures 
(SOPs) and patient ready packs or repackaged medicines ideally being supplied to 
the facility for dispensing (South African Pharmacy Council, 2018). Compounding of 
medicines may occur if necessary by both a pharmacist or a pharmacist’s assistant 
under the indirect supervision of a pharmacist if the necessary equipment is available 
according to section 1.2.11.4 of the GPP manual (South African Pharmacy Council, 
2018). 
 
Pharmaceutical care in South African primary health care 
 
Pharmaceutical care is in contrast to pharmaceutical services provision as it is a 
patient-centred philosophy involving the determination of the medicine needs of a 
patient and assurance of the most appropriate medicinal therapy. The Pharmacy Care 
Network Europe (PCNE) provided a consolidated definition of pharmaceutical care as 
‘the pharmacist’s contribution to the care of individuals in order to optimize medicines 
use and improve patient outcomes’ (Allemann et al., 2014). Hepler (1988) first 
described pharmaceutical care as a relationship between both patient and pharmacist 
that makes the patient’s interests a priority when fulfilling medicine supply and control 
functions. Hepler and Strand (1990) further described pharmaceutical care as 
pharmacy practice that allows direct communication between pharmacist and patient 
for the prioritisation of the patients’ medicine-related needs. This involves the 
pharmacist taking the time to determine patients’ needs and treatment preferences, 
and making a commitment to provide responsible services that ensure optimal patient 
health outcomes that better the quality of life of the patient (Hepler & Strand, 1990). 
Since the conceptualisation of pharmaceutical care, a crucial emphasis has been 
placed on patient-orientated care and the development of a patient-pharmacist 
relationship in the bettering of patient quality of life (Cipolle, Strand, & Morley, 2012). 
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Pharmaceutical care needs to be executed in the caring paradigm, one that involves 
understanding and respect for the patient and their individual preferences and needs. 
Individual assessments are required in pharmaceutical care practice, to understand 
patient treatment circumstances and medication history to ensure current and future 
therapy can be optimised (Cipolle et al., 2012). The pharmacist is ideally placed as the 
pharmaceutical care practitioner since the knowledge and training required to provide 
pharmaceutical care requires aspects of pharmacotherapy, pharmacy practice and 
pharmacology in order to accurately identify drug therapy problems through the 
pharmacotherapy work-up process. The steps in patient care involved in the 
pharmaceutical care process include assessing patient need to establish required 
professional contribution, a patient treatment plan and the follow up to ensure 
accountability for decisions made by both health professional and patient (Cipolle et 
al., 2012). 
To ensure a thorough and reliable assessment, patient data, disease data and 
medicine-related data should be available to the pharmacist. Firstly, as indicated in 
Figure 2.2, an assessment should allow for medicine-related problems to be identified. 
Ascertaining if medicine-related needs are being met by current treatment or whether 
there are any unmet or potential medicine-related problems is crucial. A cause for 
these problems should be established if possible, such as a pharmacological or 
pathophysiological cause, as this may inform the development phase of the process. 
Thereafter, a rational decision-making process follows involving identifying a 
prevention strategy about identified problem(s); involving establishing the care plan 
with related interventions that target the problems identified during the assessment 
phase. Finally, evaluation of established interventions needs to occur to evaluate the 
outcomes of the care plan. From the evaluation, the outcomes obtained should be 
considered with regard to goals of the medicine-related intervention formed during the 
development phase. If the outcomes have aligned with these goals, the 
pharmaceutical care process has been successful. If outcomes fall short of intended 
goals, the goals of the therapy and associated interventions outlined during the 
development phase need to be reconsidered in light of possible causative factors 
(Cipolle et al., 2012; South African Pharmacy Council, 2018; Wiedenmayer, 2006). 
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Figure 2.2: A summary of the pharmaceutical care process (Adapted from 
Cipolle et al., 2012; South African Pharmacy Council, 2018) 
 
The pharmacist’s role in the multidisciplinary health care team 
 
Pharmaceutical care can be enhanced through a strong professional interpersonal 
relationship between patient and care provider, with mutual interest in desired patient 
outcomes (Walkowiak & Keene, 2004; Wiedenmayer, 2006). As the care of the patient 
becomes more complex with medical technologies and demographic and 
epidemiologic transitions affecting medical practice, health practitioners from diverse 
health disciplines need to be included to yield high quality standards of care. 
Collaborative care, performed by the multidisciplinary healthcare team (MDHT), has 
shown to improve patient and population health outcomes in acute cases, and 
multidisciplinary models have been established that successfully manage chronic 
disease, particularly relevant to PHC (Archer et al., 2012; Dennis et al., 2008; Holland 
et al., 2005; Lemieux-Charles & McGuire, 2006). 
Although, the pharmacist’s primary role involves medicine supply management and 
dispensing of medicines, their potential as a knowledgeable member of the MDHT on 
a clinical level proves useful to the improvement of treatment of patients. The 
pharmacist can be beneficial through the consideration of possible therapeutic options 
and effects of treatment; often being able to provide information on alternative therapy 
Have the 
goals/outcomes 
been    
achieved? 
Have the 
goals/outcomes 
not been 
achieved? 
Evaluation: 
 
- Establish time frame 
for follow -ups (with 
patient) 
- Evaluate treatment 
goals and outcomes. 
Care Plan Development: 
 
- State appropriate 
interventions for medicine-
related problems 
- Identify goals of therapy  
and intended outcomes. 
Assessment: 
 
- Assess medicine needs 
- Identify any current 
medicine-related 
problems 
- Identify any potential 
(future) medicine-related 
problems. 
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(Wiedenmayer et al., 2006). Not only does the pharmacist have technical and 
pharmacological information on medicines available on the market and on relevant 
prescribing lists, but the pharmacist forms a link between prescribing and dispensing 
of medicines and ensures that there is no conflict or irregularity in the dispensing of 
safe and effective medication. Moving forward, the pharmacist needs to be recognised 
as part of the MDHT, and not as a separate, independent entity (Viktil & Blix, 2008; 
Wiedenmayer et al., 2006). 
Many MDHTs do not see the benefit of an addition of the pharmacist to the team, which 
in turn introduces barriers to the highest attainable standards of care for patients 
(Newton, Halcomb, Davidson, & Denniss, 2007). The peripheral role of the pharmacist 
in the team-based approach could be the cause of the vague inclusion of the 
pharmacist in PHC development frameworks; with the role of the pharmacist within the 
MDHT in the NHI context remaining undefined. This could be due to the isolated nature 
that pharmacy services have traditionally assumed in South Africa, together with the 
lack of understanding of the scope of practice of the pharmacist and associated 
PSWC. Furthermore, the scarcity of pharmacists available in the public sector is a 
prevailing factor as part of a more generalised HRH deficit within the South African 
public sector (Bheekie & Bradley, 2016). 
 
Task-shifting in the delivery of pharmaceutical services and care 
 
The human resources for health deficit in South Africa 
 
South Africa faces a generalised HRH deficit, with pharmacists not being exempt from 
this phenomenon. World Health Organisation (WHO) guidelines recommend a ratio of 
one pharmacist to 2300 people for adequate provision of pharmaceutical care (World 
Health Organisation, 2015). South Africa, however has 1: 3992 with the movement  of 
pharmacists to urban-based facilities, pharmaceutical services in South Africa are 
unevenly distributed with pronounced effects in the rural PHC settings (Sello, 
Dambisya, Serfontein, & Lubbe, 2011; South African Pharmacy Council, 2016). 
Furthermore, South Africa exhibits a strong movement of pharmacists from the public 
health service to private sector facilities. Not only is this ratio and its causative factors 
delaying health services coverage, but it also postpones advancements in availability, 
accessibility and quality objectives within the profession and the healthcare system 
(World Health Organisation, 2015). 
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Task-shifting as a response to the human resources for health deficit 
 
In the 2006 World Health Report, the WHO placed emphasis on task-shifting and 
delegation of tasks to the midlevel worker as a response to the broader HRH crisis at 
primary and secondary care levels (Samb et al., 2007; World Health Organisation, 
2006). Task-shifting involves shifting of tasks from higher-skilled worker to lower- 
skilled worker or shifting of tasks from workers with more general training of 
appropriate skills to those trained more narrowly for a more specific task in mind 
(Dovlo, 2004). Task shifting poses a pragmatic solution to health service inequalities 
and increased needs of patients as the demand for chronic care rises, especially in 
PHC (World Health Organisation, 2007). It has been documented that task-shifting can 
lead to better access to and coverage of quality healthcare services, with costs being 
more affordable for healthcare systems. (Dovlo, 2004; Walker & Jan, 2005). Task-
shifting is already a feature of the restructuring of PHC in resource-constrained 
facilities with nurses often being at the frontline of improving patient access to available 
health services (Crowley & Stellenberg, 2015). 
Increasing productive efficiency is the core aim of task shifting, while increasing the 
quantity of health service provision at a maintained quality and at current or lower cost. 
Increased patient access may result, with overall reduction in costs associated with 
health worker training and employment. Task-shifting is used to scale-up health 
services due to the minimal training being required by the midlevel worker onto which 
the task is shifted (Lehmann, Van Damme, Barten, & Sanders, 2009). 
Together with task-shifting, considering the combination of health workers or ‘skills 
mix’ that constitutes a level of quality health care service provision is important to 
ensuring quality services in resource limited-settings. To ensure that personnel are 
productively efficient is crucial and involves a maximum output being realised with the 
least costly mix of inputs (Palmer & Torgerson, 1999). There has been a need for 
research into the impact of skills mix and task-shifting on productive efficiency and to 
estimate appropriate skills mixes on quality of care, cost of care and patient health 
outcomes. Local epidemiology and burden of disease should guide research and 
identify key areas in the management of additional diseases such as malaria, maternal 
health, children’s health and tuberculosis to complement the task-shifting in HIV/AIDs 
(Fulton et al., 2011). The identification of enabling factors within contexts is necessary 
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to determine if task-shifting will be effective, including patient acceptance (Hermann et 
al., 2009). Furthermore, incentives need to be available for those involved in 
healthcare recruitment and management to ensure the productively efficient skill mix 
in each localised setting (Fulton et al., 2011). Task-shifting in the South African 
pharmaceutical sector 
Task-shifting is not a new practice in South Africa and Sub-Saharan Africa. In 
particular, the nurse-initiated and – managed antiretroviral treatment (NIMART) is a 
common feature in South African PHC facilities where nurses can initiate new patients 
on antiretroviral treatment (ART) and to re-new for the ongoing treatment of stable 
patients. The NIMART process has successfully increased the access to ART in 
existing and new PHC facilities (Georgeu et al., 2012). 
Within the pharmaceutical sector, there are three major dispensing models relevant to 
PHC; the pharmacist-based model, the pharmacist’s assistant-based model and the 
nurse-based model. These latter two models involve the task-shifting of the dispensing 
process from the pharmacist to the pharmacist’s assistant or nurse at respective PHC 
clinics. 
2.3.3.1 The Nurse-based Dispensing Model 
 
In many PHC clinics where pharmacists or pharmacist’s assistants are not available, 
pharmaceutical services are provided by nurses who prescribe, dispense and manage 
drug supply (South African Pharmacy Council, 2018). Lekoubou et al. (2010) 
suggested that nurses in sub-Saharan Africa are a ‘promising cadre’ in the 
management of chronic conditions, in particular diabetes and hypertension; thus 
making it well suited to disease profiles evident within the PHC. 
According to the National Drug Policy of 1996, personnel should be issued with a 
dispensing license by the South African Health Products Regulatory Authority 
(SAHPRA) (Department of Health: South Africa, 1996). These annual licenses are 
provided to health personnel with proven competency to dispense within particular 
geographical limits (Gray et al., 2016). Similarly, according to Section 22A (5) of the 
Medicines and Related Substances Act (Act 101 of 1965), a nurse may compound and 
dispense only if he or she is the holder of a licence provided for in section 22C (1) and 
complies with the dispensing of scheduled substances in terms of the Act. (South 
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Africa, 1965). However, no schedule containing applicable scheduled substances has 
been published in terms of this provision. Concurrent provisions have been made 
within Section 56(6) of the Nursing Act that "if the services of a medical practitioner or 
pharmacist, as the circumstances may require, are not available", such as within the 
PHC setting, the “physical examination", "diagnosis” and "keeping of prescribed 
medicines and their supply, administering or prescribing on the prescribed conditions” 
can be undertaken by a nurse (South Africa, 2005). Currently, the legislation allows 
nurses the ability to prescribe and dispense has limited clarity; thus the revision of 
such legislation and the adequate support of nurses is required to ensure safe 
prescribing and dispensing in the PHC setting (Crowley & Stellenberg, 2015). 
In recent studies involving NIMART in the Eastern Cape, it was noted that many nurses 
may have limited knowledge about managing drug supply and ensuring the safety of 
medicine use (pharmacology and adverse drug reaction management); thus, the 
efficiency and quality of pharmaceutical services while dispensing medicines to 
patients may be of concern (Ruud, Toverud, Radloff, & Srinivas, 2010). It has also 
been suggested that when dispensing pre-packed medicines or patient-ready packs, 
the provision of patient education and the assessment of patient adherence to the 
prescribed regimen is omitted from the dispensing process. This is detrimental to the 
promotion of rational medicine use (Georgeu et al., 2012; Schellack, 2011). 
Furthermore, additional tasks such as medicine supply management and increased 
dispensing practices place an extra burden on nurses over and above traditional 
nursing responsibilities. Nurses’ limited knowledge of contraindications, adverse 
effects and side effects of medicines could also hinder patient safety. In addition, it has 
been noted that the quality control and rational use of medicines has been inadequate 
in cases where the prescriber and personnel are the same person (Crowley & 
Stellenberg, 2015). 
2.3.3.2 Pharmacist’s assistant-based Dispensing Model 
 
In the case where pharmaceutical services are not provided by a pharmacist at the 
PHC clinic, the services could be provided by a post-basic pharmacist’s assistant 
working under the indirect supervision of a pharmacist. Any pharmaceutical services 
provided pertaining to the scope of practice of a pharmacist in a PHC clinic should be 
supervised and monitored by a designated responsible pharmacist of an institutional 
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pharmacy that is accountable to the SAPC (up to five post-basic pharmacist’s assistants 
being supervised by one responsible pharmacist). Where indirect supervision is 
warranted, the pharmacist should be available telephonically during working hours and 
be consulted with when post-basic pharmacist’s assistants dispense for a patient with 
co-morbidities (South Africa, 2011). In some cases, patient-ready packs of medication 
will be dispensed to patients by appropriate personnel when a pharmacist is off-site 
according to stipulated SOPs (Foster & McIntyre, 2012). In the PHC setting, post- 
basic pharmacist’s assistants may dispense medicines from the PHC EML, prescribed 
in accordance with the Standard Treatment Guidelines (STGs) or with Pharmacy and 
Therapeutic Committee (PTC) protocols of the district, province or any other authority 
that the PHC clinic may fall under (South African Pharmacy Council, 2018). 
It has been found that the pharmacist’s assistant-based model is cost-saving and allows 
more time for other healthcare personnel (nurses and pharmacists) to take on clinical 
tasks; thus, it has been recommended in resource-limited settings. In addition, the use 
of a post-basic pharmacist’s assistant to dispense increases access to basic dispensing 
of medicines and basic pharmaceutical services (Callaghan et al., 2010). Although this 
model is helpful in situations of HRH deficit, the fact that post-basic pharmacist’s 
assistants have limited pharmacology training and knowledge of rational prescribing 
raises concerns over the quality and level of pharmaceutical care provided at such 
facilities (Foster & McIntyre, 2012). It has been noted that aspects of quality of care, 
health outcomes and team dynamics require further review as often training and 
support of PSWC varies in different facilities (Callaghan et al., 2010). However, the 
utilisation of PSWC that require constant supervision or that are inadequately trained 
will not save time or money and may put the health of patients at risk (Callaghan et al., 
2010). However, unlike other examples of task-shifting, including NIMART, there is a 
noted deficiency of research into task-shifting with regard to quality and efficiency in 
pharmaceutical services in the pharmacy context (Monteith et al., 2010; Sanne et al., 
2010). 
2.3.3.3 Pharmacist-based Dispensing Model 
 
Having a full-time, on-site pharmacist has been presented as the ideal standard of 
pharmaceutical care provision at PHC facilities (Foster & McIntyre, 2012). The 
presence of an on-site pharmacist may be costlier due to a higher salary requirement, 
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however the benefit to the rational prescribing at facilities may yield an overall cost- 
saving (Munroe, Kunz, Dalmady-Israel, Potter, & Schonfeld, 1997). The responsibility 
of pharmaceutical services is evolving to include more patient-centred care; with 
medicine-related problem monitoring, adherence monitoring and patient follow-ups, all 
roles to which the pharmacist is well-suited. Due to the increase in these patient- 
centred, pharmaceutical care-based activities, PSWC have been identified to take on 
new roles within the pharmacy setting, thus providing more time for pharmacists to 
focus on supportive and more specialised clinical services (Walkowiak & Keene, 
2004). 
Aligned with more patient-centred care, the envisaged role of the pharmacist includes: 
i. an active role in chronic medication therapy and review; 
ii. clinical pharmacy within the MDHT; 
iii. health promotion initiatives, 
iv. pharmacovigilance, 
v. pharmacoepidemiology, 
vi. pharmacoeconomics, 
vii. antimicrobial stewardship, 
viii. health information and technology management; 
ix. informing policy making at a provincial and national level, while guiding 
implementation at a facility level; 
x. engagement in the mass mobilisation for better health outcomes; 
xi. strengthening of research and development and review of current drug policy 
(Bheekie & Bradley, 2016). 
 
Despite the development of these roles, the utilisation of the pharmacist within the 
public PHC sector remains unclear, with a lot unknown regarding where and how the 
pharmacist’s role should be integrated into the PHC re-engineering concept. In 
addition, questions regarding PHC clinics without an on-site pharmacist being able to 
provide adequate pharmaceutical services and pharmaceutical care have been raised 
(Sello et al., 2011). This apparent void leaves the dispensing practices at PHC largely 
misunderstood. To achieve strengthened PHC systems and quality patient-oriented 
care, the optimisation of dispensing processes is crucial to ensuring good patient 
health outcomes, both for acute and chronic patients. Thus, there is a crucial 
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opportunity for the pharmacist to play a key role in patient care and to promote 
population health through successful PHC-orientated care (Bheekie & Bradley, 2016). 
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CHAPTER THREE 
METHODOLOGY 
 
Research design 
 
As the role of the pharmacist within the NHI and PHC re-engineering remains vague, 
the study aims to grow the understanding of the experiences of dispensing personnel 
and patients at three PHC Clinics; thus, a mixed methods study design with a 
phenomenological case-based approach was utilised. 
A two-phase approach to an exploratory mixed methods design was used in the study, 
with the quantitative data informing the qualitative data collection. This approach is 
useful when the phenomenon under study is multifaceted, using the integration of both 
quantitative and qualitative data to provide better insight into the research question. 
This is done by building on the strengths of both quantitative and qualitative data 
collection, while minimising the limitations of each method (Creswell & Clark, 2011; 
Curry & Nunez-Smith, 2015). Mixed methods are frequently used in health sciences 
research, including the study of quality of care within provided service, healthcare 
decision-making processes and facility performance (Curry & Nunez-Smith, 2015). 
Furthermore, qualitative research has become more popular in recent times, by adding 
to a firmer understanding of the lives of people involved in the healthcare sector and 
consequently influencing healthcare service provision (Crabtree & Miller, 1999; Curry 
& Nunez-Smith, 2015; Glaser & Strauss, 1967). 
The mixed method approach is underpinned by a critical realism philosophical 
framework that states that quantitative and qualitative research can work in unison to 
provide better data analysis, particularly when exploring the behaviour of participants 
(Byrne, 2009; Creswell & Clark, 2011). Bhaskar (2008) explains that critical realism 
makes sense of phenomena by considering three layers of reality; the actual, the 
empirical and the real, stating that theories of reality cannot be considered true reality 
as these theories help understand the ‘idiographic’ perception of a phenomenon and 
are not fully capable of representing ‘universal social laws’. 
After the collection of data from the study, most commonly through the process of 
interviews, themes are deduced during the analysis of the data. This relates to critical 
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realism being constructivist in nature, involving the researcher’s frame-of-reference to 
construct a perception of the world (Creswell & Clark, 2011). The constructivist themes 
are considered to give a good indication of the lived experiences of the phenomenon 
by those interviewed in the study (Nieswiadomy & Bailey, 2017). Critical realism allows 
a perspective that accentuates the diversity and reference points of participants; one 
that allows the voices of participants to be empowered, yet understood as only a partial 
representation of the reality of a phenomenon (Tashakkori & Teddlie, 2010). Moreover, 
the understanding from the participant’s perspective of a phenomenon is valued in 
phenomenological studies, rather than the study of laws or theories (Curry & Nunez- 
Smith, 2015). In phenomenological research, participants may be considered ‘co- 
constructors’ of research; thus, trustworthiness criteria is essential to ensure adequate 
interpretation of valuable participant experiences (Curry & Nunez-Smith, 2015; Guba 
& Lincoln, 1989). 
To ensure the collection of rich data within each facility, case studies are employed as 
they provide an all-rounded understanding of a phenomenon with the researcher being 
able to examine data within a context (Yin, 2013). McLeod (2013) suggests case 
studies are important to bring to the fore the understanding of aspects of true 
experiences within each case. These can contribute toward more ‘generalised’ truths 
within a group that can make a heuristic contribution to practice (McLeod, 2013). A 
single-case design, using a single case per dispensing model, was used in this study 
to investigate relevant experiences within each model type from a variety of 
perspectives. 
Lastly, this study was based on a transformative epistemology, ensuring that 
communication with the community was made with cultural awareness and participant 
empowerment in mind, with careful and valued consideration given to each input and 
voice within the research process. The transformative paradigm frames this study, 
promoting ethical behaviour or inclusivity of all participants, cultures, languages and 
contexts of participants to promote trust in the researcher-participant relationship 
(Mertens, Holmes, & Harris, 2013). 
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Research process 
 
A research proposal was submitted to the Faculty of Health Science’s Faculty 
Postgraduate Ethics Committee at Nelson Mandela University (NMU) with the 
completed Human Research Ethics Committee application form. Once ethical 
approval was obtained (H17-HEA-PHA-015), additional ethics approval was requested 
and granted from the Eastern Cape Department of Health: South Africa (DoH) online 
(via the National Health Research Database (EC_2017_08_008); as public facilities, 
staff and patients were involved in the intended study. Additionally, a letter was sent 
by the researcher and supervisor to the local provincial office to request access to 
research sites, and when approval was granted the appropriate information was 
disseminated to the clinics involved (Appendix A). 
As shown in Figure 3.1, a two-phase data collection approach has utilised preceded 
by a pilot study. Phase 1 was implemented first with findings informing Phase 2 of the 
data collection. Thereafter, data analysis occurred through audit analysis and thematic 
review. 
 
Figure 3.1: A summary of the research process 
Phase 1 
To provide insight into the quality and availability of pharmaceutical services at each 
PHC clinic, as outlined in objective 1.3.1(i) of the study, an audit was carried out using 
a purpose-designed checklist (Appendix B). The checklist integrated aspects of the 
GPP and the IC Guidelines. This audit was carried out within the dispensary or 
medicine room, where storage and/or dispensing takes place. According to GPP, in a 
clinic where a pharmacist or pharmacist’s assistant dispenses there must be a suitable 
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dispensary for the dispensing process to take place. If dispensing takes place by a 
nurse (a licensed personnel) there should be a suitable medicine room available for 
use for medicine storage with dispensing taking place in nurses’ consultation rooms 
(South African Pharmacy Council, 2018). From this audit, intrinsically quantitative data 
was collected by the researcher and informed Phase 2 of the study. The checklist 
aimed to provide a ‘results measure’ to identify the relationship between current 
pharmaceutical service provision and how this relates to the ultimate aim of the facility 
in providing acceptable minimum standards of pharmaceutical service delivery that 
promotes optimal patient health outcomes. Although no statistical analysis was done 
involving the audit data, the data gave descriptive insight into the pharmaceutical 
services offered at each PHC clinic. 
Reviewing current service availability through a quantitative lens allowed the 
researcher to review the performance of the facilities, against accepted and applicable 
benchmark standards in pharmaceutical services at PHC level. The GPP guidelines 
form a worthwhile tool in assessing the effectiveness and quality of pharmaceutical 
service provision at a facility level; as wherever these services are provided the GPP 
minimum standards should be upheld in practice. As the pharmaceutical services will 
take place in a PHC clinic context, the IC standards relating to the supply of medicines 
can also be used to determine the effectiveness and quality of pharmaceutical services 
provision from a PHC revitalisation reference point; thus when assessing the provision 
of these services in PHC clinics, it would be advantageous to consider both GPP 
standards and relevant IC standards. 
 
Phase 2 
 
To provide a better understanding of the perceived quality of pharmaceutical care 
provision at each PHC clinic, as mentioned as objective 1.3.1 (ii) of the study, the lived 
experiences of the personnel and patients involved in the dispensing process are 
investigated in two parts; Part A and Part B. 
3.2.2.1 Part A 
 
After approval from the DoH was received, a letter of consent and invitation (Appendix 
C) to participate in the study was given to the personnel of medication at the three 
PHC clinics identified for the study. Once consent was obtained from the personnel, 
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semi-structured interviews followed, according to a predetermined interview schedule 
(Appendix D). 
3.2.2.2 Part B 
 
After completion of Part A, ten patients who received medication from the personnel 
at each clinic were approached and a letter of consent and an invitation to participate 
in the study was provided (Appendix C). After consent was given to part in the study, 
the ten patients also participated in semi-structured recorded interviews guided by a 
predetermined interview schedule (Appendix E). Each semi-structured interview, 
lasting approximately 10 to 15 minutes, took place in a private area of the clinic and 
was recorded. 
Thereafter, all interviews were transcribed, and thematic analysis was conducted to 
identify key issues from experiences of personnel and patients reported during the 
interview process. 
 
Research site and population 
 
Research Site 
 
The study took place at three PHC Clinics in the Nelson Mandela Bay District (Sub- 
District C) in the Eastern Cape Province of South Africa, a province with a quadruple 
burden of disease; communicable, non-communicable, perinatal and maternal and 
injury-related conditions (Department of Health: Province of the Eastern Cape, 2018). 
Nelson Mandela Bay District is comprised of three sub-districts, Nelson Mandela A, 
Nelson Mandela B and Nelson Mandela C and falls into socio-economic quintile 5 with 
20.7% medical aid scheme coverage. Within the district there are 46 PHC clinics with 
an estimated 26.5% considered ICs. The Nelson Mandela Bay District provides PHC 
services for an estimated population of 2 802 965, of which 950 281 are serviced by 
the Nelson Mandela Bay Sub-District C PHC facilities (2016/2017) (Health Systems 
Trust, 2018). 
The Eastern Cape Province is a meaningful setting to conduct research related to 
health service delivery as the Eastern Cape healthcare system has a noted history of 
poor health service delivery, with the Minister of Health announcing emergency 
interventions in the province in late 2013 (Treatment Action Campaign, 2014). More 
43  
recently in 2017, the National and Provincial Department of Health: South Africa set 
aside R151 million for prioritised solutions to human resources for crucial problems 
noted within the functioning of Eastern Cape health facilities, including; healthcare 
shortages, issues of poor service delivery and inadequate medication supply (Dlamini, 
2017). 
 
Research Population 
 
The research population describes the larger set from which a sample is to be 
gathered, limited by location and purpose of the given research aim (Creswell & Clark, 
2011; Vogt & Johnson, 2011). Thus, the research population involves the group that a 
particular study focusses on and to whom the research findings are relevant and may 
be generalised to (Oliver, 2010; Vogt & Johnson, 2011). 
In Phase 1 of the study, all PHC clinics in the Nelson Mandela Bay Health District and 
their respective medicine rooms or dispensaries made up the population of the study. 
These were of particular importance to the study as they are the designated areas 
where dispensing activities, stock control and management of medicines is ordinarily 
carried out at each clinic; thus, can be considered to provide insight into the 
pharmaceutical services and quality of pharmaceutical-related infrastructure available. 
This spoke to objective 1.3.1 (i) of the research, to characterise the quality of 
pharmaceutical services provision. The review of data from Phase 1 informed Phase 
2: Part A and B as it provided an indication of the capacity to provide adequate 
pharmaceutical services which is necessary to ensure the practice of pharmaceutical 
care and promotion of optimal patient health outcomes (Hepler, 1988; Hepler & Strand, 
1990). 
In Phase 2: Part A of the study, the research population consisted of the personnel of 
medication at the three chosen PHC clinics. Patients who had received medication 
from each of the three PHC clinics formed the research population in Phase 2: Part B. 
The patients provided their perspective on the dispensing process and related 
provision of pharmaceutical care, thus giving insight into objective 1.3.1 (ii) of the 
study, through accounts of their lived experiences at the PHC Clinic. These lived 
experiences provided a rich source of qualitative data necessary to the interpretivist 
and phenomenological paradigm of the study. 
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Research Sample 
 
The research sample refers to the selection of a subset from the greater population for 
inclusion in the study. The validity of findings and generalisability to the greater 
population is largely related to the efficiency of a researcher’s sampling technique and 
strategy (Guest, Namey, & Mitchell, 2013; Oliver, 2010). In this study, purposive non- 
probabilistic sampling was utilised as it promotes better explanatory data that is 
context-specific; as opposed to probabilistic sampling that does not allow for much 
insight into individual experiences, knowledge and norms of research participants 
(Bryman, 2015; Guest et al., 2013). The ability to include multiple experiences as part 
of the qualitative component of the research strengthens the validity of data; however 
exclusion and inclusion criteria are pertinent to ensure the study fulfils the aim, scope, 
budget and time constraints of the study reference (Guest et al., 2013). 
For Phase 1 of the study, three PHC clinics were identified as the sample for the study, 
with the three PHC clinics being selected based on whether they have a nurse-based, 
pharmacist’s assistant-based or pharmacist-based dispensing models. Furthermore, 
for Phase 1, the inclusion criteria involved the ability to conduct the audits in areas 
where dispensing, storage and stock management of medicines dispensed at the 
clinics are carried out. This could be in a pharmacy dispensary or a medicine room 
depending on the dispensing model at the PHC clinic investigated. The availability of 
quality pharmaceutical services should be evident in the pharmacy or medicine rooms 
of PHC clinics. 
For Phase 2: Part A of the study, inclusion criteria involved being a pharmacist, nurse 
or post-basic pharmacist’s assistant involved in the dispensing of medicines at the 
respective facilities included in the study. Exclusion criteria included any staff members 
who did not dispense medications to patients, as well as nurses facilitating NIMART 
at each PHC Clinic. Nurses dispensing ART certified as part of NIMART, have 
received specialised training (typically a five day training course with six month 
mentorship, a completed portfolio and workbook, and a competency assessment) to 
dispense for HIV patients (Department of Health: South Africa: Province of Kwazulu- 
Natal, 2016). The focus of this study was not on the role of nurse-initiated dispensing 
of ARVs, since these nurses are trained to provide separate dispensing processes not 
normally applicable to the dispensing of general medicines within the PHC setting. 
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For Phase 2: Part B, patients were required to have received dispensed medication at 
the respective study PHC clinic to be eligible for inclusion in the study. Patients who 
had not been dispensed medications from the clinic were excluded from the sample. 
Patients who had had their medications dispensed through the NIMART process were 
also excluded. 
In Phase 2 Part A, the number of participants interviewed at each clinic was restricted 
by the number of people involved in the dispensing process. In Part B, data collection 
took place until data saturation was reached. Data saturation is the point at which a 
study has produced rich reliable data and no new relevant data is acquired through 
additional interviews being conducted (Burmeister & Aitken, 2012; Guest et al., 2013). 
It is important to note that data saturation is related to the sample size, thus context 
and content under study (Given, 2008). In the case of the semi-structured interviews, 
the number of facilitated interviews required to reach data saturation is variable, 
although as little as six interviews can be used to reach data saturation (Guest et al., 
2013). 
 
Pilot Study 
 
The pilot study preceded the phases of data collection in the study. This was done as 
pilot studies increase the chances of successful fulfilment of the study, providing an 
indication of where the research process could fail or if the instrument for data 
collection is unsuitable. In addition, the subsequent study interviews could be better 
streamlined with improved question-asking that promotes better responses from 
research participants (Van Teijlingen & Hundley, 2010). The pilot study involves the 
pre-testing of a study, including both the process and the instrument of data collection. 
In this study, the audit process and audit used in Phase 1 and the semi-structured 
interviews and interview schedules used in Phase 2 were piloted. The pilot study took 
place at a PHC clinic not identified within the main study and involved the audit of a 
medicine room and pharmacy dispensary, and the semi-structured interviewing of 
patients and personnel involved in the dispensing process. 
The audit intended for the study was used in the pilot study, therefore the suitability 
and reliability of this checklist as a means of collecting valuable data to inform Phase 
2 of the data collection process was ensured. The interview schedules intended for 
the study were used in the pilot interviews. Following the pilot interviews feedback 
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about the questions asked and the interview process were used to improve the 
efficiency of the process (Thabane et al., 2010; Van Teijlingen & Hundley, 2010). The 
pilot study was used to assess if the study was feasible in terms of research resources 
and budget. In addition, the pilot study helped identify any problems relating to 
participant difficulties or data management issues (Thabane et al., 2010). In addition, 
the interview schedules were modified from feedback obtained from the pilot study to 
ensure better constructed interviews suited to the participants. The length of the 
interviews was also adjusted and finalised from feedback obtained from the pilot study, 
ensuring that the length of interviews were suitable for both participant and researcher. 
 
Pilot Study Changes 
 
The audit used in Phase 1 of the study was modified after the pilot study, to ensure 
better clarity regarding the explanation of each standard outcome. For several 
minimum standards, the appropriate documentation was available indicating 
compliance with the standard, however the evidence of actual use of this 
documentation was not always available or the documentation was only partially up- 
to-date. For example, ‘1.4. Thermolabile medicines are kept in accordance with cold 
chain management, including; 1.4.4. refrigerator cleaned and defrosted once a month’ 
was changed to ‘1.4.4. refrigerator cleaned and defrosted once a month (with evidence 
thereof)’. Thus, evidence ensuring the appropriate use of these documents was noted 
rather than just the presence of the documents within the dispensary or medicine 
room. This change helped to ensure the audit more accurately described the 
conditions indicating capacity to provide the pharmaceutical services. Furthermore, 
some ambiguity of the language used in the audit was found during the pilot. This was 
noted and changed, for example, ‘1.4.7. evidence of stock control within the 
refrigerator (vaccines and medicines) changed to ‘1.4.7. evidence of stock control of 
contents of the refrigerator (vaccines and medicines)’. This provided greater clarity 
and application of the audit. 
With regard to the developed interview schedule involved in Phase 2 of the study, no 
participant difficulties or data management issues were found. The interview schedule 
seemed well-suited to the interviewing process, however the original allocation of 15- 
20 minutes per interview was decreased to 10-12 minutes required to conduct the the 
pilot interviews. In addition, patients seemed to be more responsive and willing to 
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participate in interviews of around 10-12 minutes. Many stated that by the time they 
reached the dispensary or medicine room they had already been through a long clinic 
visit and were tired and not willing to undertake a long interview process. 
 
Data Collection 
Once ethical approval from the Faculty of Health Science’s Faculty Postgraduate 
Studies Committee (FPGSC) at NMU and the Eastern Cape Department of Health, 
and permission from local health offices was granted, identified personnel from the 
three PHC Clinics were approached and issued with information and consent forms 
pertaining to the intended study. After informed consent to participate was given, 
audits were conducted by the researcher, with semi-structured interviews with 
dispensing personnel and patients of the PHC clinic being completed thereafter. 
 
Phase 1 
 
As part of Phase 1, the audit (Appendix C) was formulated to give insight into the 
availability of quality pharmaceutical services at PHC level according to relevant 
national guidelines; including the IC and GPP standards as stipulated by the Pharmacy 
Act of 1974 and two checklists provided by the SAPC (Department of Health: South 
Africa, 2017b; South Africa, 1974; South African Pharmacy Council, 2018). The 
checklist was developed to accommodate the presence of either pharmacy 
dispensaries or medicine rooms, as either one or the other was present in the PHC 
clinics to facilitate the dispensing of medications. The audits were done in the medicine 
rooms or dispensaries and involved the checklist being by the researcher. The options 
of ‘Does comply’ and ‘Does not comply’, provided an indication of the state of 
pharmaceutical services offered at the PHC clinic. Each checklist requirement was 
allocated a numerical ‘weighting’ to indicate the importance of each requirement based 
on that indicated by the National Guidelines. These audits were reviewed to identify 
questions for Phase 2: Part A that may relate to the ability of the personnel at the 
facility to provide pharmaceutical care. This speaks to the mixed methods design of 
the study with the complementary nature of these two methods providing synergistic 
insight into the problem question (Creswell & Clark, 2011; Curry & Nunez-Smith, 
2015). 
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Phase 2 
 
As part of Phase 2, the semi-structured interviews of research participants were 
conducted. In Part A (Appendix D), dispensing personnel from each PHC clinic, were 
interviewed in a private area away from other clinic personnel and patients of the clinic. 
Part B (Appendix E), involved semi-structured interviews with patients at each clinic in 
in a private area away from other clinic personnel and patients. Interviews were 
conducted in English, with an interpreter available during the interviews to translate 
questions or responses into IsiXhosa. This was helpful in promoting the clear 
understanding of the questions asked and provided better insight into patients’ 
experiences, as some of the participants could provide more articulate responses 
when speaking IsiXhosa. 
Semi-structured interviews involve a selection of broad, open-ended questions that 
have been set in advance that relate to the research aim guiding the study and are 
related to the phenomenon under investigation (Galletta, 2013; Given, 2008). The 
question schedule consists of a ‘question stem’ with possible intended or unintended 
probes (Merton, Fiske, & Kendall, 1990; Richards & Morse, 2007). Participants are not 
constrained in responses provided to questions asked, which helps participants better 
express and describe their lived experiences as participants express themselves in 
differing forms (Galletta, 2013; Given, 2008). According to Bryman (2006), mixed 
methods design employs semi-structured interviewing as the qualitative component of 
data collection as the semi-structured nature of the qualitative data set often ‘fits’ 
quantitative data sets more favourably to better characterise phenomena (Bryman, 
2015; Morse, 2012). Furthermore, the use of semi-structured interviews provides the 
researcher freedom to pursue emerging themes that may come up during the 
interviewing process, thus aiding the qualitative data analysis and research process 
(Galletta, 2013). 
With the consent of all participants, semi-structured interviews (with translations by the 
interpreter) were digitally recorded and then transcribed. Without a recording and 
transcription into a reliable transcript, the analysis of semi-structured interviews is 
limited and may be restricted to the narrative of the third person. Thus, a reliable 
transcript allows for better understanding of the lived experiences of the phenomenon 
under study, without consistent disruptive note-taking by an interviewer (Olsen, 2012). 
To further minimise disruption and to promote the comfort of the participant, efforts 
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were focused on providing productive interviews in a space with a favourable attitude 
and atmosphere promoting subjective reflection; thus, interviews took place in a private 
area away from the busy clinic atmosphere. 
 
Within the area of the interview the use of positive body language, favourable 
positioning of chairs (perpendicular to participant), approaching topics with an 
empathic and non-judgemental nature and encouragement by the interviewer were 
employed to further create a comfortable interviewing environment. Participants were 
asked less complex questions first, followed by ones that could be answered easier 
than more complex or sensitive questions, also promoting a more relaxed interviewing 
process (Marks & Yardley, 2004). This attempt to ensure participant comfort and 
consideration speaks to the paradigm of transformative epistimology that underpins 
this data collection process. This was done to empower the voice of participants, 
through ensuring their comfort and well-being in voicing concerns with regard to the 
status of their local clinic’s pharmaceutical services and care delivery were enabled 
(Mertens et al., 2013). 
 
Data Analysis 
 
The completed audits were analysed by the researcher. This analysis took place prior 
to Phase 2 data collection, so that the results informed the types of questions that were 
asked during the semi-structured interviews. The audits were analysed, and results  
were characterised according to general standards relating to the premises and 
standards dependent on the type of personnel present on premises. Key categories 
within each of these were identified and noted, with personnel being probed if these 
were unclear from this analysis process. 
After collection and transcription of the recordings in Phase 2: Part A and B, data 
analysis was performed using a coding process that conceptualises data while 
allowing the researcher to successfully differentiate, combine, reflect and interpret the 
data collected. The system of coding used involves the questioning of data and viewing  
the data in terms of properties and characteristics. The coding probes the data and 
investigates the ‘layers of meaning that are embedded in data’ (Corbin & Strauss, 
2014). Pattern coding was then used to assign themes to codes with explanations into 
why and how these patterns exist, resulting in a thematic analysis of collected data. 
Doing this sorts data into more manageable units and helps the researcher form 
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relationships between data to characterise findings of the study (Walliman, 2010). 
Thematic analysis is most often used in phenomenological studies and is particularly 
favourable when using interpretative analysis. Themes are considered inferential, 
often being implicit, ‘backgrounded’ or sometimes evident through other means of 
interpretation such as through signs or indicators open to interpretation evident in 
interviews or within multiple interviews (Morse, 2012). 
Computer-assisted qualitative analysis can be used to aid the thematic analysis of 
qualitative data, often through the use of generalist qualitative data analysis (QDA) 
software available for use on personal computers (Seale, 2014). In this study, Atlas.ti® 
was utilised for Phase 2: Part A and B. To begin this process, transcripts were 
uploaded onto the Atlas.ti® software and grouped as document groups for personnel 
and patients at each clinic (as indicated in Figure 3.2). 
 
Figure 3.2: Atlas.ti® interface indicating personnel and patient document groups 
at each clinic 
Atlas.ti® is based on a ‘code and retrieve’ concept that helps file and retrieve coded 
information to aid the researcher in the coding process (Seale, 2014; Walliman, 2010). 
Inductive codes were allocated to excerpts of the transcripts that conveyed a particular 
analytical meaning, as shown in Figure 3.3. The QDA software is instrumental in this 
regard, being able to retrieve the parts of text that have been coded by a researcher 
indicating a link to a specific analytical meaning or theme (Seale, 2014). 
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Figure 3.3: Atlas.ti® interface showing the process of assigning inductive codes 
to sections of text to convey analyticial meaning 
To assist in theme development, these allocated codes were categorised into groups 
of similar or related meaning, as indicated in Figure 3.4. 
 
 
Figure 3.4: Atlas.ti® interface displaying code groups that have been made from 
the categorisation of individual inductive codes 
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Atlas.ti® is useful in being able to develop findings and can be used to draw up 
‘conceptual maps’ aiding the thematic analysis and theory building capacities. The 
conceptual map or network diagram was constructed using the Atlas.ti® programme, 
as a means to graphically link and relate code groups (Figure 3.5). 
Figure 3.5: Atlas.ti® network diagram assisting in the development of qualitative 
themes from code groups 
The network diagram aided theme development, with themes being discussed in the 
results of Phase 2: Part A and B of the study. Due to this useful feature of Atlas.ti®, the 
use of QDA software has become well established within social research and related 
fields (Seale, 2014). 
 
Validity and trustworthiness of the data 
 
Validity of the data 
 
In the audit review, validity involves the extent to which a concept has been realistically 
represented by given indicators, in comparison to the actual concept; and can be 
considered an indication of quality of the data collection process (Curry & Nunez- 
Smith, 2015; Mills, Durepos, & Wiebe, 2010). Validity encompasses face validity, 
ecological validity, predictive validity, construct validity, and internal and external 
validity. 
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Table 3.1: Parameters of validity and application of these within 
Phase 1 of the study (Mills et al, 2010) 
 
Validity 
parameter 
Definition Application to methodology (Phase 1) of the 
study 
Face The extent that the All criteria (questions and weightings) used in the 
validity data collection tool audit are based on accredited checklists and 
 represents a credible institutional and departmental standards of the 
 understanding of the SAPC and the NDoH. Only aspects integral to the 
 phenomenon under provision of pharmaceutical services in South 
 study. Africa were represented, making the assessment 
  contextually appropriate according to applicable 
  
standards stipulated by each institution. In 
Internal The extent that 
validity relations between 
addition, the audit was checked by the supervisor 
 
variables within the 
and co-supervisor, who critiqued the checklist in 
 
study have been 
relation to the aim of the study and its validity 
 
identified. 
against the SAPC-approved checklists. 
Ecological The correlation Personnel dispensing within the pharmacy or 
validity between the lived medicine rooms under study were asked to check 
 experiences of the the audit after the researcher had completed the 
 participants and the audit. This was to confirm that audit results 
 findings of the study. adequately represented the situation at facilities. 
  
Furthermore, modifications from feedback   
Construct The level of success provided by the pilot study were made to the 
validity that the researcher audits such as to better characterise the 
 has at accurately contextual lived experiences of personnel and 
 measuring the patients at each clinic. 
 phenomenon  
 identified under study.  
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Validity 
parameter 
Definition Application to methodology (Phase 1) of the 
study 
External The generalisability The audit is based on standardised national 
validity of the findings of the outcomes that apply to all PHC clinics. Thus, the 
 study to similar audit can be applied to measuring the same 
 contexts or phenomena at similar facilities in future. 
 populations.  
Predictive The ability to 
 
validity accurately assume  
 future predictions  
 involving the  
 phenomenon under  
 study, considering  
 the study findings.  
 
Trustworthiness of the data 
 
In the semi-structured interviews, the ability of the study to produce rich qualitative 
data depends on the researcher’s ability to accurately interpret and understand both 
verbal and non-verbal information provided by research participants (Given, 2008). 
Researcher bias is possible in qualitative data, resulting in descriptions of collected 
data that are not true and influenced by the researcher. Researcher bias, including 
unconscious bias, can be built into the design of the study and/or can be evident in the 
interpretation of the results. Thus, it is essential for a study design to prove adequate 
trustworthiness with the researcher ensuring reflexivity involving self- awareness of 
perceptions and assumptions as to exclude them from study design and data analysis 
processes. This sense of objectivity is important, especially in the interpretivist,  
phenomenological and transformative nature of this study (Byrne, 2017). 
Moreover, trustworthiness denotes the quality of research, results and findings and 
encompasses a range of concepts to identify the quality of research outside of 
quantitative parameters; including transferability, credibility, confirmability and 
dependability (Given, 2008; Schwandt, 2014). 
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Table 3.2 A table with trustworthiness parameters and application thereof in 
Phase 2 of the study (Given, 2008) 
 
Trustworthiness 
parameters 
Definition Application to methodology 
(Phase 2) of the study 
Transferability The awareness of the 
scope of the study and 
the degree of 
applicability to other 
contexts. 
The question schedule was formulated to 
be applicable to other facilities within the 
sample of the study, thus it is not facility- 
specific in nature. Thus, it can applied to 
other PHC clinics in the population. 
Credibility The depth of the In order to ensure unbiased data, an 
 accurate desciption of independent reviewer was used to rule 
 the phenomenon under out bias in the stages of data analysis 
 study as described by and related findings. During the 
 collected data. transcription and interpretive stages, the 
Confirmability This involves data 
researcher aimed to accurately and 
 
collected being able to honestly convey information. The 
 
support any researcher documented all decisions 
 
interpretations, claims or made about data and interpretation to 
 
findings made in the ensure transparency of decisions made 
 
study. 
around data interpretation. 
Dependability The extent that the Although similar data may be expected in 
 findings may be certain circumstances if the study is 
 replicated using the applied within the population, as the 
 same context and study is phenomenological, the lived 
 procedure of the study. experiences of phenomena may differ 
  due to the diverse nature of qualitative 
  research. 
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Ethical Considerations 
 
Ethics can be considered the ‘rules of conduct’ by which research can be guided to 
ensure ethical veracity. The Belmont Report Commission (1979) reports that 
beneficence, respect for dignity and justice should frame a research process that is 
valid in design and adequately sampled. Ethical considerations must include; 
avoidance of harm, voluntary participation, informed consent, and anonymity and 
confidentiality (Mertens, 1998; US Department of Health: Human Services, 1979; 
Walliman, 2010). Within the transformative paradigm of the study, the ethics of 
research designs is essential in ensuring trust and respect in voicing of participants’ 
lived experiences (Mertens et al., 2013). 
 
Avoidance of Harm 
 
Avoidance of harm involves the rights of research participants being upheld and the 
avoidance of physical and psychological harm of the participants during the research 
process or as a result thereof. Avoidance of harm is closely linked to aspects of 
confidentiality, anonymity and the right to privacy of the research participant (Sim, 
2010). Within Phase 1 of the study, were conducted discreetly and away from patients 
or personnel other than dispensing personnel that were present in the medicine room 
or dispensary at the time of the audit. Interviews were conducted away from other PHC 
clinic personnel or patients in a private area to prevent intimidation or harassment by 
other personnel or staff. Furthermore, the responses were collected anonymously with 
the identities of all participants remaining strictly confidential. 
 
Voluntary Participation 
 
Voluntary participation involves research participants that understand the study and 
give consent to take part in the study. Volunteer sampling involves a purposive/non- 
random sampling approach, in order to have research participants that fit inclusion and 
exclusion criteria (Remler & Van Ryzin, 2010). Participants in this study participated 
voluntarily in the audits (Phase 1) and the semi-structured-interviews (Phase 2). All 
information pertaining to the study, including the voluntary nature thereof, was clearly 
stated on the consent form handed to the research participants before the research 
commenced, with the participants being aware that they were free to withdraw from the 
study at any stage. 
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Informed Consent 
 
As guided by the ethical considerations underpinned by the Nuremburg Code of the 
1940s and the Helsinki Declaration of 1964 (revised 2013), informed consent involves 
the informing of research participants about the purpose and intention of the study with 
particular emphasis on benefits or potential risks to the participant involved in the 
research. Furthermore, this ethical requirement ensures that each research participant 
is aware that they may withdraw their participation in the study at any given time 
without any consequence (Schwandt, 2014; US Government, 1949; Vogt & Johnson, 
2011; World Medical Association, 2013). 
Before the study commenced, research participants were informed of details of the 
voluntary nature of the research, including pertinent issues of confidentiality and 
anonymity of information provided to the researcher during the study. This was done 
through a printed written consent from, read by the participant and explained by the 
researcher for purposes of clarity. Once participants had understood and signed this 
consent form, informed consent of research participants was received. 
 
Confidentiality and Anonymity 
 
Confidentiality involves the protection and non-dissemination of information provided 
by a research participant during a study. This links to aspects of anonymity (involving 
the protection of the research participants and research sites identity) to ensure that 
participants feel comfortable to reveal necessary information to the researcher, with 
information only being revealed to a third party with consent from the participant (Mills 
et al., 2010). Upholding confidentiality and anonymity of the data provided from 
participants forms the basis of ethical data collection and respects the autonomy of 
individual research participants involved in respective case studies (Childress & 
Beauchamp, 2001; Mills et al., 2010). 
Confidentiality of data collected was ensured throughout the period of study and 
research participants were informed about confidentiality during the consent stage. 
Other than the fact that the audit took place in a medicine room or pharmacy (as part 
of Phase 1) or the capacity of the personnel (either pharmacist, pharmacist’s assistant 
or nurse), the name and details of the research participants were anonymous 
throughout the study (as part of Phase 2); and data collected was analysed in a 
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confidential manner with only the researcher, supervisor, co-supervisor and 
independent reviewer having access to collected data. 
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CHAPTER FOUR 
RESULTS AND DISCUSSION 
The study was comprised of two phases; Phase 1 involving a quantitative audit and 
Phase 2: Part A and B involving qualitative semi-structured interviews with personnel 
and patients respectively. 
Firstly, the audit results from the dispensary or medicine room at each clinic were 
analysed. Key findings are discussed, identifying the effects on quality or availability 
of delivery of pharmaceutical services at each facility. Thus, insight is given into 
objective 1.3.1 (i) of the study. 
Thereafter, the results from Phase 2: Part A and Part B will be discussed. Themes and 
sub-themes identified from qualitative data analysis of interview transcripts will be 
mentioned with regard to the effects on perceived pharmaceutical care provided at the 
PHC clinics; hence fulfilling objective 1.3.1 (ii) of the study. 
 
Phase 1: Results obtained from dispensaries and medicine room 
 
Results obtained from the audit provide an understanding of the capacity of each PHC 
clinic to provide pharmaceutical services using the GPP and IC Manual as standard 
references. The audit included a section relating to general standards applicable to all 
dispensaries or medicine rooms and, secondly, a section with standards applicable to 
the type of personnel available within each setting. As described in Table 4.1, each 
clinic either had a dispensary or medicine room. 
Table 4.1: The dispensing model and available dispensing facility at each clinic 
in the study 
 
Clinic Dispensing model Dispensing facility 
Clinic P Pharmacist-based Dispensary 
Clinic N Nurse-based Medicine room 
Clinic PA Pharmacist’s assistant-based Dispensary 
 
 
The results from audits will be discussed as indicated in Figure 4.1. Firstly, general 
standards relating to premises will be discussed with three main aspects; suitability of 
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infrastructure, control of medicines and patient interaction being discussed with related 
findings. 
 
 
 
Figure 4.1: Outline of results relating to general standards applicable to 
pharmacy premises, indicating each section and sub-section under which these 
are discussed 
General standards relating to the premises 
 
4.1.1.1 Suitability of facility 
 
i. Facility Size and Cleanliness 
 
All three clinics had a dispensary or medicine room that was orderly and tidy.  
Dispensaries in Clinic P and Clinic PA were of an adequate size to allow for maximum 
flow of personnel to promote efficiency and supervision of personnel if necessary. The 
GPP states that pharmacy premises should be designed to allow for a ‘logical flow of 
work’. This promotes communication and supervision between personnel to aid the 
prevention of dispensing errors and to ensure quality of dispensed products (South 
African Pharmacy Council, 2018). Furthermore, the premises should be tidy, clean and 
maintained to ensure safe dispensing and the reduction of the risk of cross- 
contamination of dispensed medicines. The size of the pharmacy premises should be 
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adequate in comparison to the number of prescriptions dispensed daily and allow for 
the appropriate number of dispensing personnel to work effectively and to provide 
sufficient storage space (South African Pharmacy Council, 2018). 
Notably, the medicine room in Clinic N was small and was also used as a kitchen. The 
space had been used as efficiently as possible, however the actual room size and 
space for flow of personnel was minimal due to infrastructure constraints of the clinic. 
However, considering that the space is mainly used for medicine storage and 
dispensing takes place in consultation rooms, it could be sufficient. The current 
infrastructure at this clinic (Clinic N) would not support the introduction of pharmacy 
personnel, and if pharmacy personnel were to join the clinic staff, a medicine room 
upgrade would be required in order to meet minimum standards for dispensing (South 
African Pharmacy Council, 2018). 
ii. Facility lockability and medicine security 
 
In Clinic P and Clinic PA, the dispensaries were fully lockable with restricted access - 
allowing only personnel involved in dispensing into the space. However, within Clinic 
N the medicine room also served as a kitchen, thus access to this room was not always 
restricted. The GPP states that pharmacy premises should be designed such that only 
pharmacy personnel or licensed personnel have direct access to medicines with a 
procedure being in place to ensure access to the pharmacy premises in cases of an 
emergency aligned with the Occupational Health and Safety Act 85 of 1993 (South 
Africa, 1993; South African Pharmacy Council, 2018). The open accessibility raises 
concerns around medicine control and issues of theft of medicines. When probing the 
restricted access to the medicine room (Clinic N), the operational manager of the 
facility noted: 
My biggest challenge is the control or management [of medicines]. Let me 
put it this way, for example, if you can go there now and look at my 
pharmacy - it’s not a pharmacy, it’s a kitchen at the same time. So I can’t 
say control of medication is not a challenge, because every staff member 
here at this facility will go into that kitchen to fetch water, because it’s a 
kitchen. So for me, as an operational manager, it’s so difficult to control 
medication. Operational manager (Clinic N): 1:74 
In Clinic PA, medicine security was also a concern for personnel due to poor 
maintenance of existing infrastructure. The pharmacist’s assistant was frustrated 
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about clinic maintenance as the Schedule 5 cupboard had been broken for a long time 
with no response to requests to have it fixed. This is not only illegal as schedule 5 
substances become openly accessible, but may also encourage theft of potential high 
risk medicines, able to cause addiction and self-harm. 
iii. Appearance of facility environment 
 
The GPP states that the appearance of pharmacy premises should ‘inspire confidence 
in the nature of the health care service that is provided and portray a professional 
image’ (South African Pharmacy Council, 2018). Therefore the appearance of the 
pharmacy environment should be one that promotes quality pharmaceutical services. 
All dispensing facilities audited displayed only health-related information, providing for 
a professional image. The dispensary in Clinic P was the only clinic to display 
adequate signage as stipulated by the GPP and IC Manual; including signs 
designating non-smoking and non-eating areas (Department of Health: South Africa, 
2017b; South African Pharmacy Council, 2018). This signage helps promote patient 
trust in the hygiene of the pharmacy – that medicines are being dispensed in a space 
where personnel are attempting to prevent contamination and to adhere to hygiene 
standards. 
iv. Dispensary Equipment 
 
Dispensing equipment such as counting trays, graduated plastic measures and 
dispensing containers (or packets) and labels were available for use in all clinics with 
facilities for cleaning of utensils and hand-washing (with cold water) being available. 
The GPP states that clean, functional and suitable dispensing equipment and labels 
should be available, including those required for pharmaceutical services rendered at 
each clinic (South African Pharmacy Council, 2018). A dispensing balance was only 
available in Clinic P, however due to compounding not taking place in Clinic N and 
Clinic PA there was no need for such equipment in these clinics. 
v. Availability of Standard Operating Procedures 
 
According to the GPP, SOPs are important within the dispensary to minimise the risk 
of adverse practice and to provide guidance and standardisation of the pharmacy’s 
daily processes. Within all three clinics the SOPs were adequate and up-to-date, 
however they were not all signed as noted by personnel. Notably, it is the role of the 
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responsible pharmacist to ensure that up-to-date SOPs are available within each PHC 
clinic setting. Within the study clinics, these SOPs were provided and updated by the 
district pharmacist, under whose supervision the pharmaceutical services at all three 
clinics falls. Thus, all three clinics had SOPs available to potentially guide the following: 
i.  Good housekeeping (cleaning procedures etc.). 
 
ii.  Pest (insects, rodents etc.) elimination. 
 
iii.  Receipt of stock. 
 
iv.  Effective stock rotation (FEEFO – first entry, expiry, first out). 
 
v. Disposal or removal of S1 – S6 expired, damaged and/or contaminated stock 
as required in Regulation 27 of Act 101 of 1965. 
vi.  Product types requiring special storage or handling instructions. 
 
vii.  Separation and handling of goods returned from patients. 
 
viii.  Recall of medicine. 
 
ix.  Delivery of medicines. 
 
x. Procedures to be followed regarding the handling of keys, money, etc. For a 
locum or relief pharmacist(s) (where applicable). 
xi.  Cold chain management (including procedures to be followed in the event of a 
power failure). 
xii.  Enquiry or complaint procedure. 
 
xiii.  Stock-taking. 
 
xiv. Obsolete or unusable stock. 
 
xv. Storage of medicine. 
 
xvi.  Procurement of medicine. 
 
xvii.  Handling of product complaints. 
 
xviii.  Pre-packing (including quality assurance procedures) (where applicable). 
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xix. Availability of Standard Operating Procedures 
 
4.1.1.2 Storage and control of medicines 
 
i. General medicine storage and stock rotation 
 
The GPP states that storage areas should be hygienic, have enough washable 
shelving and be adequate to avoid storing medicines on the ground. These areas 
should be sufficient in size to allow for the neat arrangement of stock, and to facilitate 
stock rotation (South African Pharmacy Council, 2018). In all three clinics, storage 
areas were tidy and orderly manner with storage of stock off the ground. All three areas 
were large enough to ensure adequate stock rotation. In Clinic N, where the medicine 
room was relatively small, there was a reported effort to ensure stock rotation despite 
the infrastructure constraints. Storage conditions should also be at a temperature 
below 25°C, with humidity control, and storage of medicines away from light. All three 
clinics complied with these storage requirements of the GPP and the IC Manual; by 
having wall-mounted thermometers and air-conditioners within storage areas with no 
obvious threat to medicine integrity. This being said, none of the clinics had a means 
of pest control within the medicine storage rooms (Department of Health: South Africa, 
2017b; South African Pharmacy Council, 2018). 
According to the GPP, stock rotation based on the “First Expiry, First Out” (FEFO) or 
“First In – First Out” principle should be followed to ensure that patients receive 
efficacious, safe medicines stored in adequate conditions (Department of Health: 
South Africa, 2017b; South African Pharmacy Council, 2018). Within all three clinics, 
no expired medicines were evident on the shelves at the time of the audit. 
ii. Thermolabile medicine control and storage 
 
In the case of thermolabile or ‘cold chain products’, handling and storage of these 
medicines needs to be controlled to prevent deterioration or damage of the medicine. 
In this case, instructions from the manufacturer should be followed during transport, 
delivery and storage, with the pharmacist or appropriate personnel being responsible 
for ensuring product integrity upon receipt. To maintain product integrity, GPP 
standards and manufacturer’s instructions should be followed during distribution, 
supply and storage of thermolabile medicines (South African Pharmacy Council, 
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2010). In all clinics, there was evidence of adequate provision for the appropriate 
receipt of thermolabile medicines. 
Storage should take place in a refrigerator or freezer with temperatures monitored 
twice daily; in all three clinics there was no firm evidence of this being done regularly 
with entries being made on recommended recording sheets. A calibrated thermometer 
aligned with WHO standards should be used for monitoring temperature and it should 
be hung on the middle shelf of the refrigerator (South African Pharmacy Council, 
2018). All three clinics had thermometers to measure the temperature within the 
refrigerator, however it was not certain that these were WHO approved and they were 
not hung from the middle shelf. A further requirement is that the inside of refrigerators 
and freezers should be clean and defrosted monthly (with documentation thereof) with 
no condensation dripping onto products; with sufficient space for stock rotation and 
orderly storage (South African Pharmacy Council, 2018). There was no documented 
evidence regarding cleaning of refrigerators, but all were clean and orderly with no 
obvious cause for concern. 
The storage refrigerator or freezer should be within the pharmacy and connected to 
an alarm or warning system in the event of a power failure, or if temperatures deviate 
from the acceptable range of 2°C-8°C (Department of Health: South Africa, 2017b; 
South African Pharmacy Council, 2018). None of the clinics had this available and 
there were no back-up generators for power supply. Staff indicated that in the event of 
a power outage they would ensure alternative arrangements are made to maintain 
product integrity. Fortunately, there is not a high load of thermolabile medicines within 
the clinic setting, thus available stock could be moved around in cold boxes to other 
facilities if required in an emergency. 
iii. Pharmaceutical waste disposal 
 
According to GPP and IC Manual, waste material should be collected in suitable closed 
containers according to an SOP (Disposal or removal of S1 – S6 expired, damaged 
and/or contaminated stock, as required in Regulation 44 of Act 101 of 1965) 
(Department of Health: South Africa, 2017b; South African Pharmacy Council, 2018). 
In all three clinics there were appropriate containers for waste disposal and records of 
the waste disposal were available, including the disposal of expired medicines. The 
GPP notes that a pharmacist should use pharmaceutical knowledge to ensure the 
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proper organisation and preparation of waste aligned to acceptable regulations (South 
African Pharmacy Council, 2018). The operational manager in Clinic N noted that the 
cluster pharmacist does support her in the process of correct pharmaceutical waste 
disposal. Furthermore, the IC Manual stipulates key aspects of general health waste 
management. Thus, any waste management within the dispensary should be aligned 
with that occurring in the greater PHC facility (Department of Health: South Africa, 
2017b). 
iv. Medicine stock management 
 
According to the GPP, it is the responsibility of the pharmacist (or in their absence, 
pharmacy personnel or a licensed prescriber) to ensure control over medicines 
purchased and received at a facility. Upon stock arrival, an appropriate member of 
staff from each clinic does ensure quantity, type, quality of stock and that medicines 
are stored in the correct manner. No medicine should be dispensed when the safety, 
efficacy or quality of that medicine is considered to possibly be compromised in 
anyway, thus these checks are important to ensure safe medicine supply to patients 
as part of the pharmaceutical service provision (South African Pharmacy Council, 
2018). 
Within all three clinics, 90% of tracer medicines were available at the time of the audit 
(according to the PHC Tracer Medicines List) and the min/max quantities were 
reportedly known for each item by the personnel responsible to assist in stock 
ordering. Although personnel in Clinic N and PA mentioned difficulties in stock 
management functions, patients did not recall a high prevalence of stock outs. Where 
stock outs did occur, personnel from both Clinic N and PA mentioned that these were 
due to difficulties attaining the medicines from the pharmaceutical depot. Dispensers 
from both Clinic N and PA explained that they could contact the pharmacist in this 
regard or communicate with other clinics, and often use their personnel vehicles to 
attain stock for patients. 
4.1.1.3 Patient Interaction 
 
i. Patient consultation 
 
According to GPP, a covered waiting area close to the dispensary should be available 
with enough comfortable seating for patients. All the clinics had a suitable patient 
67  
waiting area with enough seating close to the dispensaries (Clinic P and PA) and the 
consultation rooms (Clinic N). Within Clinic P and PA, dispensing is done in a semi- 
private area at a dispensing window. There is a separate consultation area for private 
consultations; however the frequent use of this room remains challenging due to time 
constraints. For example, at Clinic P the Pharmacist’s assistant reported: 
…we try and explain to the person and they will moan that you are taking 
time. So it’s always important to them to come and go quickly. So, unless 
you see that this patient needs it, we have the consulting room there. Then 
for example, the first time on an injection and insulin, we call the patient in 
and explain everything so that you don’t get the shout behind, you see? 
Pharmacist’s assistant 2 (Clinic P): 32:85 
Furthermore, privacy involves being able to have a discussion within the pharmacy 
setting without being interrupted or overheard by other patients within the setting 
(Andersen, Blenkinsopp, & Armstrong, 2004). As part of the dispensing process, 
providing medicine-related counselling in a private, comfortable setting promotes 
patient privacy and comfort, thus quality pharmaceutical services provision. 
ii. Use of support aids and health information 
 
According to GPP, when providing advice on medicine use, support aids such as 
package inserts, health information leaflets or computer print-outs, should be provided. 
Support aids and health information help contribute to the development of health 
literacy and promote understanding of medicines or health conditions (Colledge, Car, 
Donnelly, & Majeed, 2008). Other than package inserts in certain packaged medicines, 
no other resources to be provided with the medicine as part of the dispensing process, 
in any of the facilities. 
The availability of information resources regarding medicine use during dispensing 
would be advantageous since consultation time is short and often rushed. The use of 
information aids in enhancing health understanding, as part of health literacy 
development, can promote effectiveness of therapy; thus, may help bring down high 
costs of non-adherence and medicine misuse (Colledge et al., 2008). In addition, 
health information resources can also be used to provide medicine-related counselling 
across a language barrier. For example, Dowse and Ehlers (2004) state that the use 
of pictograms on medicine labels can positively influence medicine-related 
understanding, particularly with medicine instructions given during the dispensing 
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consultation. Due to these benefits, providing these information resources would be 
worthwhile for Clinics P, N and PA to undertake during future dispensing processes. 
iii. Patient record-keeping 
 
According to Section 22(a) of the Medicine and Related Substances Act, the record of 
a written prescription, in either private or public sector, should be held for a minimum 
of five years; together with a patient profile detailing all prescriptions dispensed to be 
kept on site (South Africa, 1965). Within all clinics, patient record-keeping was unclear, 
especially as the patient files and records are kept by clinic administration clerks. 
Whether information such as complete a patient file or dispensed prescriptions are 
kept for five years is unclear. There is not much understanding between the personnel 
and the administration clerks in this regard. 
As stated in the GPP, these patient records are crucial to establishing any previously 
dispensed medicines and patient history (South African Pharmacy Council, 2018). 
Furthermore, it can contribute to the pharmacists’ understanding of the effects of 
previous medications on patient health. Prescription records can be used to inform 
knowledge of prescription patterns, common irrational prescribing trends, the use of 
specific medicines among different patient groups or demographics and can guide 
demand for medicines aiding in preventing stock outs (Walker, 2000). Thus, these 
crucial documents being lost or incomplete at the three clinics is a barrier to providing 
complete and informed pharmaceutical services to patients. 
In addition, according to the IC Manual, dispensing processes at PHC clinics should 
be computerised as part of the District Health Information System (DHIS) (Department 
of Health: South Africa, 2017b). The GPP mentions that, if possible, dispensing 
processes and patient records should be computerised (South African Pharmacy 
Council, 2018). At all three clinics there was no computerised system for dispensing, 
with manual dispensing taking place in each clinic. This observation appears to be in 
agreement with the situation throughout the country, with Gray et al. (2016), noting 
that public sector facilities are more likely than private sector facilities to have paper- 
based dispensing and patient record systems in place. 
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Standards dependent on type of personnel present on premises 
 
Within the GPP, there are different requirements applicable to a dispensary or 
medicine room depending on whether a nurse, pharmacist’s assistant or pharmacist 
are present in each setting (South African Pharmacy Council, 2018). The results of the 
audit regarding standards dependent on the type of personnel present on the premises 
will now be discussed; namely in the order of Clinic N (nurse-based model), Clinic PA 
(pharmacist’s assistant-based model), and Clinic P (pharmacist model). 
 
 
 
Figure 4.2: Outline of the results and discussion of standards dependent on the 
type of personnel present on pharmacy premises with section and sub-sections 
under which each is discussed 
4.1.2.1 Clinic N (Nurse-based model) 
 
i. Patient consultation 
 
Within Clinic N, dispensing took place in a consulting room with medicines being 
transported to the consulting room from the medicine room daily. This is in accordance 
with requirements of the GPP, stating that the medicine room is for medicine storage 
purposes only. This ensures that medicines are stored in appropriate conditions, 
promoting the integrity and safety of available medicines (South African Pharmacy 
Council, 2018). 
ii. Dispensing license 
 
At Clinic N, the diagnosis, prescribing and dispensing of medicines for a patient 
consultation is provided by the same nurse. Research has shown that having the 
prescriber and personnel as the same person at a facility adds to the potential health 
risk of patients as the ‘double checks’ involved in prescription review (ensuring quality 
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of the process) is by-passed (Foster & McIntyre, 2012; Gray, 2010). Thus, medication 
errors, interactions or health risks may go unnoticed during the pharmaceutical service 
provision. This, in turn, may put the patient’s health at greater risk. 
In addition, a discrepancy regarding dispensing licenses was noted. According to the 
GPP, a dispensing nurse at a PHC facility needs to hold a dispensing license in terms 
of Section 22C(1) of the Medicines and Related Substances Act 101 of 1965 However 
no nurses at the time had a dispensing license, with one nurse reported having been 
on the course for a dispensing license, but has yet to complete it (South Africa, 1965). 
Crowley and Stellenberg (2015) noted that there are gaps in knowledge relating to 
how many nurses are adequately trained and licensed in terms of the Medicines and 
Related Substances Act to dispense medications. It seems the lack of clarity regarding 
the dispensing license requirements in the Medicines and Related Substances Act and  
the Nursing Act (Act 33 of 2005) have resulted in a lack of clarity of understanding about 
the dispensing license and need thereof for practicing nurses in PHC (South Africa, 
1965, 2005). There urgently needs to be more clarity in light of this noted inconsistency 
between the Medicines and Related Substances Act and the Nursing Act, such as to 
adequately equip nurses to fulfil the dispensing process in an informed and capable 
manner (Gray et al., 2016). Furthermore, Section 56(6) of the Nursing Act should not 
be used as to evade demonstrated competence, but rather as a ‘transitional 
concession’, originally arising in the context of ART roll-out within PHC settings 
(Crowley & Stellenberg, 2015; Gray, 2010; Stevens, 2008). When asking the nurse 
enrolled in the dispensing license course about the course’s relevance on her 
dispensing practice she stated: 
It will help me to improve but not the clinic as a whole, because I am not 
working alone, you see, that is the thing. But now that I know what is wrong 
and what is right, then I will do the right thing like giving the right respiratory 
treatment and all that. But I will not speak for other people, because they 
are not trained but I will buddy train them so that they must know what to 
do right. That’s going to take time for them but for me it will improve … and 
I have clarity. Nurse 1(Clinic N): 4:172 
In this excerpt, the nurse explains how the dispensing license enhances her ‘clarity’ 
regarding dispensing appropriate medicines for safe, rational use by patients. 
However, importantly she states that upon completion of the course she will be the 
only one in the clinic with this understanding. This indicates that there are varying 
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levels of dispensing training and expertise underpinning dispensing process as nurse- 
based facilities, contributing to varying quality of these services provided to patients. 
iii. Pharmacist support 
 
According to the GPP, in PHC facilities where dispensing takes place by those other 
than a pharmacist (such as nurses), a pharmacist must visit the clinic monthly, 
especially considering the absence of dispensing licenses among the nurses within 
the study (South African Pharmacy Council, 2018). However, this does not take place 
within the clinic. When asked about the availability of the pharmacist, the operational 
manager responded: 
[The pharmacist is available] by the phone, not physically. He said it was a 
challenge to come here. He’s supposed to come here once a week but he 
told me that he can’t because there’s no transport for him to come and 
visit… Operational Manager (Clinic N): 1:135 
Nurses primarily dispense medicines that are on the PHC EML and STGs; however 
the down referral system means that patients on other chronic medicines have been 
referred to the clinic for their medicines. There have been concerns about the nurses’ 
knowledge regarding these medicines. According to Ruud, Srinivas, and Toverud 
(2012), nurses’ knowledge of pharmacology is often not strong enough to safely 
promote the rational use of medicines, such as in ART treatment in similar contexts 
within PHC in the Eastern Cape province. These gaps in pharmacology and related 
principles such as pharmacodynamics and pharmacokinetics could result in medicine 
interactions and adverse drug effects that compromise the quality of pharmaceutical 
service provision (Crowley & Stellenberg, 2015; Ruud et al., 2010). Crowley and 
Stellenberg (2015) recommend that pharmacists or pharmacy personnel should be 
placed in PHC clinics to ensure an adequate standard of pharmaceutical service 
provision, including improved medicine-related knowledge and understanding. 
iv. Stock management support 
 
There is evidence of medicine ordering and supply management by the operational 
manager of the facility. She expressed the need for support with stock ordering and 
management at the facility. Stock management and dispensing of medicines was 
reportedly increasing the work load of nurses. The operational manager expressed 
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frustration in the difficulty and time-consuming nature of stock management at the 
facility: 
 
Drug management - there’s no support at all. I have to take my car to 
another clinic if something is out of stock here. I have to phone and move 
around with my own car, because I’m thinking of the patient. I have my 
duties and they are still waiting for me, but I have to provide a service 
because I am a service provider. Operational Manager (Clinic N) 
Crowley and Stellenberg (2015) state that because of nurses having this increased 
work load, nurses need to be adequately supported such that they can provide the 
best quality service for patients. 
v. Reference availability 
 
Not all current reference sources, as stipulated by the GPP, were present within the 
clinic; including latest additions of MIMs, MIMS Desk Reference or South African 
Medicines Formulary (SAMF), a comprehensive pharmacology textbook, a latest copy 
of the Medicine and Related Substances Act No. 101 of 1965, the GPP Manual and 
the latest Daily Drug Use to guide practice. The absence of such references to support 
pharmaceutical services provision may put the quality thereof at risk at the facility, 
particularly due to supposed low level of medicine-related knowledge of nurses 
underpinning dispensing processes (Ruud et al., 2012). 
4.1.2.2 Clinic PA (Pharmacist’s assistant-based model) 
 
i. Dispensing support 
 
At Clinic PA, two post-basic pharmacist’s assistants were indirectly supervised by an 
off-site pharmacist. Currently, the pharmacist’s assistants dispense medicines 
prescribed by nurses and doctors at the facility. According to the GPP, where 
pharmacist’s assistants are dispensing in a PHC facility, re-packaged or patient ready 
packs should be provided to the facility for dispensing. This is to simplify the dispensing 
process and to minimise chance of dispensing errors and risk to patient health (South 
African Pharmacy Council, 2018). At this facility, although patient ready packs were 
mostly provided, the pharmacist’s assistants did mention pre-packing from bulk size 
packs to dispense to patients. No separate pre-packing facilities that complied with the 
Medicine and Related Substances Act 101 of 1965 were evident, thus posing a 
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potential risk of contamination or dispensing errors by pharmacist’s assistants during 
pharmaceutical service provision (South Africa, 1965). 
According to the GPP, a pharmacist must be constantly available to provide support 
telephonically or by electronic means to indirectly supervised pharmacist’s assistants. 
In particular, if a patient has a noted co-morbidity (a common phenomenon with the 
high prevalence of HIV/AIDs, TB and NCDs at PHC level) this consultation should take 
place while dispensing the prescription. Pharmacist’s assistants at the facility 
telephonically contact the district pharmacist or the cluster pharmacist for advice on 
how to proceed with dispensing the prescription but noted that it is often difficult to get 
hold of a pharmacist at the time of dispensing. The pharmacist’s assistant, when asked 
about the availability of the pharmacist via the telephone, he responded, “Sometimes 
they are busy – they’re in meetings or they’re out of town. It’s very difficult” (Pharmacist’s 
assistant 2 (Clinic PA): 37:33). This is concerning as consultation with a pharmacist is 
necessary to ensure that these aspects on prescriptions are dealt with accordingly to 
promote the highest attainable standard of care for patients during the dispensing 
process. Osman (2005) and Foster and McIntyre (2012) note that pharmacist’s 
assistants in the public sector are not well accustomed to principles of pharmacology 
and pharmacotherapeutics; thus may struggle to pick up medicine complications or 
interactions on prescriptions. Furthermore, there have been concerns regarding 
medicine-related counselling involving side effects or adverse effects and the ability to 
promote rational prescribing at facility level (Foster & McIntyre, 2012; Osman, 2005). 
Ideally, in order to provide quality pharmaceutical services at a facility, a strong 
medicine knowledge should accompany dispensing for prescription monitoring and 
medicine-related counselling to promote the optimal use of medicines. 
ii. Stock management support 
 
According to GPP, the pharmacist should visit the clinic to support and monitor 
indirectly supervised pharmacist’s assistants at least once a month (South African 
Pharmacy Council, 2018). This was reportedly not carried through appropriately at the 
clinic, with irregular visits and lack of support. The pharmacist’s assistants expressed 
the need for more support, primarily in stock management, from a pharmacist. When 
asked if a pharmacist visits monthly for support, one of the pharmacist’s assistants 
mentioned: 
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No, never … Like the thing is I don’t have the power to do anything because 
I’m not a pharmacist, but now it’s been three years without a pharmacist. 
Pharmacist’s assistant 2 (Clinic PA): 37:34 
In support of this phenomenon, Osman (2005) notes that indirectly supervised 
pharmacist’s assistants within PHC settings often find supply management 
challenging due to not having a firm grasp of supply management skills (involving 
ordering or budget utilisation) needed for appropriate stock management. 
Furthermore, many indirectly supervised pharmacist’s assistants, such as those at 
Clinic PA, are short staffed and lack computerised stock management software to aid 
with stock management. In the public sector, pharmacist’s assistants need to be 
familiar with the ordering process as the depot ordering process is a challenging and 
often ‘tedious’ process (Osman, 2005). One of the pharmacist’s assistant’s views 
supported this observation: 
Now, unfortunately, you see, it’s just us at the facility and sometimes you 
run out of some medicines in an emergency and sometimes we need 
something today and we need to go take it - to go and get something from 
the depot. But you end up waiting two days. Pharmacist’s assistant 2 (Clinic 
PA): 37:21 
iii. Reference availability 
 
In a PHC clinic where dispensing takes place by indirectly supervised pharmacist’s 
assistants, the pharmacist should ensure updated protocols and SOPs to provide a 
guide to the quality provision of pharmaceutical service provision at the facility (South 
African Pharmacy Council, 2018). This was adequately done within the clinic. 
Furthermore, the GPP provides a list of information resources that should be available 
for reference at each clinic indirectly supervised at PHC level. Within the clinic, the 
latest editions of the Daily Drug Use and the SAMF (or MIMS Desk Reference) were 
not available. The unavailability of these resources to guide prescription monitoring 
and to supplement limited medicine knowledge of the pharmacist’s assistant could put 
the patient’s health at risk (Osman, 2005). 
75  
4.1.2.3 Clinic P (Pharmacist-based model) 
 
i. Dispensing process 
 
In Clinic P, the pharmacist is on-site in the dispensary providing continuous direct 
supervision of four pharmacist’s assistants within dispensary hours. The pharmacist 
also supervises other post-basic pharmacist’s assistants and registered nurses 
indirectly at other facilities within the sub-district. 
Currently, both the pharmacist’s assistants and the pharmacist on-site execute the 
dispensing process with the pharmacist available to consult with patients on request 
of the patient or if referred to by the pharmacist’s assistants. 
Any patient that has queries about the medications or they want information 
or have any further questions about the mediations, the post-basics call me 
upstairs. If they don’t understand it’s my job to communicate and tell them, 
sometimes they like to speak to someone senior to give them answers. 
Pharmacist (Clinic P): 33:4 
According to the GPP, at PHC level any prescriptions for patients with co-morbidities 
or suspected medicine interactions need to be referred to the pharmacist (South 
African Pharmacy Council, 2018). At this clinic, prescriptions for patients with co- 
morbidities are not necessarily referred to the pharmacist for dispensing. Only some 
prescriptions with medicine interactions that the personnel have not experienced 
before are referred to the pharmacist for advice. This raises concerns regarding 
potential health risks regarding many patients with co-morbidities at PHC level. The 
presence of a health professional with medicine-related knowledge to oversee the 
dispensing of complicated prescriptions, with the potential for a high incidence of drug 
interactions is necessary to promote optimal patient outcomes (Cipolle et al., 2012). 
ii. Prescription monitoring 
 
Munroe et al. (1997) suggest that the pharmacist-based model should be the ‘standard 
of care’ as it has been shown to most appropriately influence rational prescribing, thus 
has cost-saving implications and promotes healthy patient outcomes. Within Clinic P, 
the pharmacist has a relationship with the prescribers and can promote quality 
prescribing at the facility better than pharmacist’s assistants. The pharmacist’s 
assistants on-site also have a relationship with the prescribers, although they 
mentioned that their relationship can be a challenging one. The challenge may be due 
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to the limited pharmacological knowledge of the pharmacist’s assistant, and the limited 
access to reference materials, as found in the study (particularly in Clinic PA). Thus, 
pharmacist’s assistants collaborating in the prescribing process and contributing to 
positive clinical outcomes may be difficult (Osman, 2005). Upon asking the 
pharmacist’s assistants about collaboration with nurses as prescribers at the facility, 
one responded, “There is a problem with the nurses because sometimes if you ask 
clarity on something, they feel their integrity is being undermined; whereby the doctors 
are more open to that questioning” (Pharmacist’s assistant 3 – Clinic P: 40:7). In Clinic 
PA, there was a similar relationship between pharmacist’s assistants and the nurses. 
One pharmacist’s assistant mentioned, “…The nurses, they are stubborn. To us, they 
are stubborn, because sometimes, I mean they do not like it. So sometimes what we do 
is we change it ourselves, because we can’t keep on going back the whole day to 
change things” (Pharmacist’s assistant 2 – Clinic PA 37:25). This difficult relationship 
between personnel and prescriber may compromise patient safety as it has seemingly 
resulted in prescriptions being changed without proper prescriber authorisation. 
The pharmacist is better placed to collaborate with prescribers due to the professional 
nature of pharmacy education and training and due to the medicine-related knowledge 
of the pharmacist. According to the GPP, the pharmacist should have a relationship 
with other healthcare professionals ensuring a ‘therapeutic alliance’ in matters of 
pharmaceutical services provision and patient care (South African Pharmacy Council, 
2018). This alliance is further relevant in the context of pharmaceutical care and the 
pharmacists’ role therein (Walkowiak & Keene, 2004; Wiedenmayer, 2006). The GPP 
states that inter-professional relationships are necessary for the functioning of a 
pharmacist in providing adequate pharmaceutical services (South African Pharmacy 
Council, 2018). 
iii. Housekeeping functions 
 
The pharmacist on-site ensures guidelines of the STGs are adhered to and that the 
dispensary had all the necessary reference books available for adequate reference to 
inform dispensing. Furthermore, all SOPs are regularly updated with the pharmacist 
co-ordinating with the district pharmacist. This is in accordance with the GPP that 
suggests that it is the pharmacist’s role to ensure current guiding references for 
dispensing and medicine use are available (South African Pharmacy Council, 2018). 
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Adequate signage according to GPP standards was evident, including a valid SAPC 
pharmacy registration and the name of the pharmacist visible within the pharmacy 
(South African Pharmacy Council, 2018). However, nametags and designations of 
pharmacy personnel were not provided for each personnel. The GPP and the IC 
Manual both stipulate the need for all staff to wear identification tags indicating the full 
names of staff, staff designation and the emblem of the Department of Health: South 
Africa (Department of Health, 2017b; South African Pharmacy Council, 2018). 
Moreover, the right to be treated by a named health professional is also included in 
the Patient’s Rights Charter, part of the Constitution of the Republic of South Africa 
(Act No. 108 of 1996) (Department of Health: South Africa, n.d.). In this study it was 
noted that many patients were unaware of who the pharmacist and pharmacist’s 
assistants were within Clinic P, thinking that the pharmacist’s assistants were 
pharmacists or vice versa. The wearing of name tags with full name and designation 
will help to provide more clarity on roles within the pharmacy setting. 
 
Phase 2: Results obtained from semi-structured interviews 
 
Semi-structured interviews were conducted with personnel at each clinic (Phase 2: 
Part A) (n=11) and with 10 patients who had received medicines from each clinic 
(Phase 2: Part B) (n=30). Table 4.2 below states the type of personnel at each clinic 
dispensing medicines at each facility. 
Table 4.2: Type of personnel dispensing at each PHC clinic in Phase 2: Part A 
of the study 
 
Clinic Type of personnel Number at facility 
P Pharmacist 1 
 Pharmacist’s assistant 4 
N Operational manager 
(registered nurse) 
1 
Registered nurse 3 
PA Pharmacist’s assistant 2 
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During the study, the researcher aimed to ensure that patients interviewed within 
Phase 2: Part B reflected the demographics evident in the waiting rooms of the PHC 
clinics. As indicated in Table 4.3, the patients interviewed were mostly female. 
Table 4.3: Gender of patients in Phase 2: Part B of the study 
 
Gender 
Female 28 (93.3%) 
Male 2 (6.7) 
The employment status of participants is indicated in Table 4.4. A total of 56.7% of 
participants were employed, however no distinction was made between formal or 
informal employment. Of the participants, 26.6% were unemployed and 23.3% retired. 
Table 4.4: Employment status of patients in Phase 2: Part B of the study 
 
Employment Status 
Unemployed 1 (3.3%) 
Employed 17 (56.7%) 
Employed (part time) 1 (3.3%) 
Retired 7 (23.3%) 
Student (higher education) 4 (13.3%) 
 
Table 4.5 shows that 30% of participants have a primary-level education, 16.6% a 
grade 10-level education and 33% have secondary education. Interestingly, 20% of 
the participant group had or are currently enrolled in higher education (at FET college, 
technical university or university-level). This demographic shows that patients from a 
wide array of educational backgrounds utilise the PHC health system. 
Table 4.5: Highest level of education of patients in Phase 2: Part B of the study 
 
Highest level of education 
Primary 9 (30%) 
Secondary (Grade 10) 5 (16.7%) 
Secondary 10 (33.3%) 
Higher Education 6 (20%) 
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In Table 4.6, the age of patients is represented highlighting that approximately 40% of 
participants were under the age of 35 years. Participants between the ages of 35 to 
64 years old made up 43.3% of the sample and 16.6% of participants were over the  
age of 65. 
Table 4.6: Age of the patients involved in Phase 2: Phase B of the study 
 
Age (years) 
18-24  4 (13.3%) 
25-34  8 (26.7%) 
35-44  8 (26.7%) 
45-54 2 (6.7%) 
55-64 3 (10%) 
65-75 5 (16.7%) 
 
The transcripts from the semi-structured interviews involving personnel and patients 
were qualitatively coded via the process described in the methodology section (Section 
3.5.1), with the development of themes being developed from allocated qualitative 
code groups. The coding process and subsequent thematic development was 
independently reviewed and confirmed the credibility and confirmability of the coding 
process. Six main themes were identified, and these are summarised in Figure 4.3. 
 
 
Figure 4.3: Themes identified in the qualitative data analysis process 
 
Personnel 
frustrations 
Personnel-patient 
relationship 
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services 
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Clinic-related 
challenges 
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pharmaceutical 
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frustrations 
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From data analysis, three themes were identified as relevant to both patients and 
personnel. Personnel noted clinic-related challenges and frustrations involved in the 
dispensing process and patients noted personal frustrations of their own. Themes 
relevant to personnel only will be discussed first (indicated in orange in Figure 4.3), 
with the theme identified relevant to the patients discussed thereafter (indicated in 
yellow in Figure 4.3). Lastly, the three common themes (indicated in green in Figure 
4.3) will be discussed. 
 
Clinic-related challenges 
 
4.2.1.1 Patient clinic misuse 
 
The personnel, particularly in Clinic N, mentioned that patients do not use the PHC 
clinic system as intended. Firstly, patients bypass the closest clinic in their local sub- 
district to use another clinic further away due to better service provision and patient 
satisfaction at the latter clinic. This causes a services demand imbalance on particular 
clinics, resulting in increased patient load (from outside designated catchment areas) 
and increased waiting times. This also increases the potential of medicine stock outs 
as medicine demand can be unpredictable. The operational manager from Clinic N 
responsible for medicine supply management stated: 
Sometimes the pharmaceutical care doesn’t fulfil needs and we’ve got out 
of stock medication, because we’re catering for all the patients around us. 
We not only issuing medication for the people that are staying within our 
catchment area, you’re also catering for other ones … So sometimes you 
get out of stock because of that. Because you order according to your head 
count, but people will come from other areas. They will come here and then 
you have to provide a service to them. Operational Manager (Clinic N): 1:49 
This misuse of the clinic system was also evident through patient responses, who 
mentioned the use of clinics outside of their sub-district due to irregular quality of care 
provision between PHC clinics within the sub-districts and districts within the area. A 
patient from Clinic N commented, “I actually don’t come from here but there’s a big 
problem that side. So coming this side, there’s not really a problem for me because I 
get the correct medicine. I don’t have issues coming here” (Patient 9 (Clinic N): 14:1). 
Secondly, personnel were frustrated that some patients were ‘shoppers’, misusing the 
PHC clinic system by not using one clinic, but by using multiple clinics for care and 
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medicine provision. This frustrates personnel as it is difficult to have a full patient 
history, track adherence to therapy and develop patient relationships; thus making the 
provision of pharmaceutical care challenging. A nurse from Clinic N expressed her 
frustration: 
You see this morning I was in a bit of a mood, you see, because this area 
is supposed to be allocated for Kwamagxaki but we’ve got those patients 
that they call them ‘shoppers’, he or she lives in Dwesi but you’ll go past 
Dwesi Clinic and past Joe Slovo and come to our clinic. Another one is from 
Zwide. It comes past Zwide and comes to us and they end up here. So here 
in our system, he is a defaulter and this person hasn’t been coming for 3 
months now, yet he or she is taking it [medicine] elsewhere. So that’s why 
we advise and we tell them go to the nearest clinic because you don’t need 
bus fares and all that. But they want to come to this clinic. Nurse 3 (Clinic 
N): 3:116 
4.2.1.2 Poor dispensary infrastructure 
 
Not only was poor infrastructure affecting storage of stock, as highlighted in Phase 1 
of the results, but poor infrastructure was also affecting counselling areas as noted 
within Phase 2. Results from Phase 1 indicate that within Clinic PA and P, dispensing 
is done in a semi-private area at a dispensing window, while at Clinic N within a 
consultation room. These spaces that allow for patient consultation are particularly 
important in terms of pharmaceutical care provision as they may have direct effects on 
privacy and comfort affecting patient receptiveness within the care relationship (Kerr,  
2009). 
Both patients’ and personnel’ responses suggested that dispensing from a dispensing 
window, even if semi-private, was not always conducive to adequate patient 
consultation as privacy is infringed upon and patients waiting in the waiting area may 
hear the consultation or may even interrupt the consultation. Patients reportedly shout 
to interrupt a consultation if too much time is considered to be spent on a patient at 
the dispensing window. For example, a patient from Clinic PA mentioned that 
personnel and patients in consultation “get pressure from the next person saying 
‘you’re slow, come on guys, we’ve been here since 4 o’clock … we shout at them and 
put pressure on them” (Patient 5 (Clinic PA): 18:3). This resulted in patients feeling 
they had to rush through the consultation in order to avoid not being intimidated by 
other patients. 
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This interruption affects the quality of the consultation; impacting on patients tendency 
to remember instructions and medicine-related counselling. It also makes the provision 
of pharmaceutical care more difficult impossible as the situation doesn’t allow for 
adequate pharmaceutical care consultation. In cases were minor changes can be 
made, Foster and McIntyre (2011) recommends putting up screens within the waiting 
areas to ensure privacy for patient counselling while dispensing with less interference 
or view from those in the waiting area. This could be a practical solution to preventing 
consultation interruption. 
Having a private consultation room for all patients being dispensed medicines would 
be the ideal, especially for those requiring pharmaceutical care intervention. Within 
Clinic N, the dispensing process took place in the nurse’s consultation room during 
consultation, thus it was a private area away from other patients. The use of a private 
consulting area is reportedly preferred by patients due to increased privacy, which is 
important when dealing with patient health conditions with associated stigma, such as 
HIV/AIDs (Foster & McIntyre, 2011). However, within the nurse-based model, waiting 
times are reportedly longer due to longer consultation times (Foster & McIntyre, 2012). 
As previously mentioned, privacy is a key facilitating factor in the provision of 
pharmaceutical services, but also in promoting an adequate pharmaceutical care 
relationship. Thus, ensuring privacy during the pharmaceutical consultation process 
should be ensured. The GPP has noted this need by ensuring pharmacy premises 
contain a private consultation area, however, as previously mentioned, the consistent 
use of this is unknown due to time constraints (South African Pharmacy Council, 
2018). Furthermore, when considering patient demographic, privacy may become 
increasingly important. It has been noted in a similar study based in the PHC setting 
within South Africa, that demographics may determine an increased need or 
preference for privacy. For example, Sello et al. (2011) noted that the youth (often 
seeking reproductive health services) are more likely to prefer more privacy upon 
consultation. Similarly, the elderly preferred more privacy upon pharmaceutical 
consultation. This is possibly linked to more traditional aspects of many South African 
cultures where older persons may be less willing to discuss personal problems with 
those younger or unknown to them (Sello et al., 2011). Considering the demographic 
of the clinics under study including a high number of youth and patients above 50 
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years old, aspects of privacy are important to consider when applying pharmaceutical 
care in practice. 
 
Patient frustrations 
 
4.2.2.1 Waiting times 
 
In all clinics, patients were concerned about long waiting times, although many noted 
the efficiency of the dispensary was better at Clinics P and PA (where dispensaries 
are designated entities within the clinic). The waiting time at clinic administration (with 
the administration clerks) was a concern for patients and apparently fuelled 
dissatisfaction with the clinic system. This was expressed by one of the respondents 
as follows: 
The dispensary is alright. It’s that side by the clerks. They take a long time. 
Before 7 o’clock I was here - for so long just sitting. And I was sitting here 
the whole time only just to get medication. The whole time, I’m sitting there. 
Patient 2 (Clinic P): 28:5 
The IC manual, as part of Component 2: Integrated Clinical Services Management 
(ICSM), suggests that patients should not wait more than three hours while receiving 
services at the clinic, and should be notified of any delays to be expected within the 
clinic departments (Department of Health South Africa, 2017b). Furthermore, the 
average waiting time should be displayed at facility reception. If long waiting times are 
identified as a problem within the facility, ‘bottle neck areas’ should be identified and 
services streamlined accordingly to promote efficient flow of patients through the clinic 
system. In Clinic P, a pharmacist’s assistant attempts to try and reduce waiting times 
by monitoring the situation 
…we have that thing where the patient comes from the clerk they write the 
time, the sister writes the time and we see that when they come here we 
write the time and we take that to the facility manager, so they can review 
it by the patient. Pharmacist’s assistant 1 (Clinic P): 31:17 
Another pharmacist’s assistant from Clinic P expressed the need for someone such 
as a ‘queue marshal’ to assist in ensuring lesser waiting times, “the only thing you can 
do is if you have a regular queue marshal every one hour or two hours that helps… 
So they know what is happening” (Pharmacist’s assistant 4 (Clinic P): 39:12). 
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Despite attempts to improve waiting times, the long duration of patient stay at the clinic 
was still apparent to the personnel. The personnel were also aware that this is a cause 
of patient frustration. A pharmacy assistant in Clinic P claimed that patient 
dissatisfaction with waiting times and clinic maladministration was often expressed at 
the dispensary, stating: 
You know, we are like the shock absorbers. We are the last team to see the 
patient. If the patient gets angry starting from the security; if they get angry 
there, with clerks, with nurses, it ends with us. They were already fighting 
when the situation is like that. Pharmacist’s assistant (Clinic P): 31:2 
This ’fighting’ and intimidation reportedly forms a barrier to providing quality 
consultation and associated pharmaceutical care involving adequate, timely 
consultation. Patients are often rushing and unable to ask questions about their 
medicines after long hours getting through the clinic system. A patient from Clinic N 
noted: 
I think they should spend more time with the patient, because they actually 
make you like rush and you actually forget if you like, wanted to ask a 
question … because you’re just panicking to get out the door you end up 
not asking. Patient 2 (Clinic N): 5:6 
This means attempting to develop professional relationships with patients, central to 
providing pharmaceutical care may be difficult because the consultation is pressured 
and patient interest or contribution at the end of a long clinic visit is minimal. 
4.2.2.2 Patients’ needs 
 
After analysing patient responses, patient satisfaction with the dispensing process is 
a concern. Upon asking patients whether their needs were met during the dispensing 
process, many responded positively, stating that their needs were met. However, 
further probing of patients’ understanding of how to use their medicine and the 
significance of their medicine in their overall treatment of their condition, suggested 
that many were unsure or stated that they wished to know more. For example, 
according to a patient at Clinic PA, the service was “…ok, as far as I’m concerned. I 
don’t know about the others, but me I’ve never had a problem. They are good” (Patient 
9 (Clinic PA): 34:1). However, when probed about medicine understanding and 
medicine-related counselling, the same patient stated: 
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They don’t explain what the side effects are and the implications of taking 
this medicine. I really would appreciate if it was explained to me that this is 
like this and this causes this, X, Y and Z … They don’t explain the 
medication. So today they said ‘this is your medicine’ altogether, with 
normal hypertension medication and pain tablets … so I’m going to get 
home and try and figure it out… Patient 9 (Clinic PA): 34:11 
Similar findings were noted in Clinic N. A patient noted “Their services are good, it’s 
just the waiting” (Patient 10 (Clinic N): 11:1), however when asked about medicine 
understanding, the patient noted “They don’t explain here. I Google it for myself, 
because … I always want to know the pills that they give” (Patient 10 (Clinic N): 11:13). 
A patient at Clinic P also noted that the service was “good” (Patient 4 (Clinic P): 41:1), 
however when asking about how the dispensing process could be improved, she 
noted, “First, communication with us. So not just ‘do you know how to use it?’ Silence. 
‘Yes’ and that’s it … It’s not my job to ask how to use this medication” (Patient 4 (Clinic 
P): 41:13). 
These responses would suggest that the mere act of receiving a medicine at the clinic 
and the presence of no stock outs creates patient satisfaction with the service; 
however, being provided with an understanding of the relevance and optimal use of 
the medicine appears to be comparatively less important. In this regard, it seems 
patients are not familiar with having pharmaceutical care consultations with emphasis 
on their medicine-related needs. Thus, receiving this care along with a medicine is 
apparently viewed as less important than the tangible receipt of a medicine every 
month. Koster et al. (2016) similarly note that patients often believe that they have 
received complete medicine-related information regarding medicine use; however 
some information regarding specific instructions has often been left out of this 
consultation. Similarly, the information that pharmaceutical personnel believe patients 
should receive is not always the same information they consider helpful during 
medicine-related counselling (Koster et al., 2016). 
 
Personnel frustrations 
 
4.2.3.1 High workload 
 
Almost all personnel in all clinics mentioned a high workload. Nurses in Clinic N stated 
that their role in the clinics was multifaceted, often filling multiple care roles at the clinic 
due to staff shortage. Over and above this, the nurses were required to take on a 
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dispensing role and a stock management role, which leads to increased work load and 
consultation time. In addition, personnel in all clinics noted staff shortages impacting 
on the quality of services they provide, particularly in Clinic PA. Many patients noted 
that personnel were doing their best despite staff shortages and high workload. For 
example, a patient from Clinic N noted: 
 
Service delivery here is quite good and sometimes it’s that we [the patients] 
don’t want to understand. They have a lot of work and you have to put it 
into consideration that it’s a lot of patients a day … But sometimes, you will 
find that the problem is with us. The patients, you understand? We are just 
in it for ourselves … we aren’t patient enough. Patient 1 (Clinic N): 7:5 
Similarly in Clinic PA, a patient remarked: 
 
I don’t want to say that they’re aggressive sometimes, because I don’t want 
to use that word, but it’s the pressure I think that they get from us [the 
patients], because we’re sometimes impatient. Then, otherwise they do 
their best. Patient 5 (Clinic PA): 18:3 
Pharmacist’s assistants in Clinic PA expressed concerns about their high workload, 
stating that it was difficult to fulfil dispensing, pre-packing, prescription monitoring and 
stock management functions simultaneously at the facility. Pharmacist’s assistants are 
also required take on tasks outside of their scope of practice, such as cleaning the 
dispensary in order to maintain hygiene standards. (Choi, Cheung, & Pang, 2013; 
Darwish, 2000; Naledi, Barron, & Schneider, 2011; Shaver & Lacey, 2003). This high 
workload can hinder the provision of pharmaceutical care as it minimises provider 
performance and time available for the provision of care during consultation 
(Perzynski, Caron, Margolius, & Sudano, 2018). 
High work load is of particular importance due to the consequential effects on clinic 
staff. Due to this, the IC Manual states the importance of ensuring enough staff 
members according to a skills mix related to the services provided (Department of 
Health South Africa, 2017). Health care workers that face high workload and 
exhaustion often have poor job satisfaction, with facilities having difficulty in retaining 
these staff (Perzynski et al., 2018). Participants spoke about their workload in the 
following ways: 
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You know what, I like my job. But the problem is we are short staffed so we 
on our own, like today, we are short staffed, so it’s too much for us. We are 
only two here for the whole clinic. Pharmacist’s assistant 2 (Clinic PA): 37:16 
Furthermore, a nurse from Clinic N noted: 
 
In the big clinics, have you seen that there’s a nurse doing just her part, so 
obviously it’s much more nicer because even for administration for that 
person, she’s got time to prepare files and has time to maybe schedule her 
appointments. Here, you are here and there, so really you can get behind 
on things like statistics or filing … So, as much as I’m comfortable because 
I’m used to working like this, I’m sure it would be nicer if I was just dedicated 
to that particular service, you see. But you work according to our situation 
at the clinics, you can’t always have what you want the way you want it. 
Nurse 3 (Clinic N): 3:87 
Improving workload (and causative factors, such as staff shortage and high patient 
load) of PHC staff is essential to ensuring adequate human resources retention. 
Moreover, poor job satisfaction has been shown by other authors as negatively 
affecting quality of care provision, including pharmaceutical care, at PHC clinics (Choi, 
Cheung, & Pang, 2013; Darwish, 2000; Shaver & Lacey, 2003). 
4.2.3.2 Misunderstanding of indirectly supervised clinics 
 
It became evident in the study is that there seems to be a misunderstanding between 
the pharmacist’s opinion about needs of the indirectly supervised cluster clinics and 
the actual needs related to the functioning of the clinics. The pharmacist in the study 
reported that: 
You find [Clinic N]’s dispensary is practically in the kitchen, but it’s a small 
clinic. In fact, it’s not a problem, but they’re not provided with an assistant, 
because I mean really, they don’t need one - they see about three patients 
a day. Pharmacist (Clinic P): 33:38 
However, it became evident in the study that this was not true. The operational 
manager expressed concerns about the infrastructure constraints of the medicine 
room and the high patient load, especially from patients not from the catchment area 
of the clinic putting pressure on service provision. 
Furthermore, as mentioned in the results of Phase 1, the indirectly supervised clinics 
explained that clinic visits for support in pharmaceutical services provision was not 
happening once monthly and expressed the need for more support in pharmaceutical 
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services management to endure constant availability of medicines at each clinic. This 
indicates that there could be a misunderstanding regarding the stock management 
capabilities of personnel at indirectly supervised clinics. 
 
Personnel-patient relationship 
 
4.2.4.1 Poor patient attitude 
 
The personnel indicated that poor patient attitude was a problem during dispensing 
activities. A main driver of patients’ poor attitude was seemingly due to challenges at 
the clinic; mainly with poor clinic administration and long waiting times. A nurse at 
Clinic N stated: “It’s hard because if you spend enough time with one patient they are 
panicking those in the waiting areas … so you’re always rushing because they will 
panic” (Nurse (Clinic N): 2:92). Similarly in Clinic P, when asked about the relationship 
between personnel and patients a pharmacist’s assistant responded: 
Because of the load that we have here - out of ten, I would give it a 4; 
because then even when we help them when we dispensing the medication 
and give it to them, we try and explain to the person and they will moan that 
you are taking time. Pharmacist’s assistant (Clinic P): 32:85 
Patients are tired and often put pressure on personnel to rush the dispensing 
consultation due to having experienced a long waiting time. The personnel mention 
that this affects the quality of the consultation and lessens the counselling provided 
during the duration of the consultation. 
The pharmacist stated that this poor patient attitude could be due to a lack of respect 
for medicines, as they are freely provided at public sector clinics. The pharmacist at 
Clinic P when asked if the patients left equipped with knowledge on how to use their 
medicines effectively, mentioned: 
The answer to that question is no, especially if you’re not paying for the 
medication. Some of them just don’t have the respect – it’s being abused. 
You hear sinful stories that your aqueous cream and your Cortoderm® is 
widely abused and I think if a patient pays for a certain medication they 
would have more respect. Pharmacist (Clinic P): 33:35 
Personnel also suggested that patients often ‘lie’ and are untruthful about taking their 
medicines, and ‘lie’ about personal details or adherence to treatment. For example, a 
nurse from Clinic N stated: 
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But what they do, our clients, they like to lie. They will say they were staying 
in Kwamagxaki and will give you a street number and an address only to 
find out it’s a church and they are staying somewhere else. Because they 
don’t want to be chased away. So that is the challenge. Nurse 1 (Clinic N): 
4:112 
Furthermore, another nurse at Clinic N responded when asked about the biggest 
challenge to providing pharmaceutical care, “It is difficult because they are lying a lot 
of them” (Nurse 2 (Clinic N): 2:78). For example, when asked about ensuring 
adherence of patients, a pharmacist’s assistant from Clinic P noted that, “[we] ask the 
patient to go fetch the empty containers at home. Sometimes the patient, they are 
scared to come to clinic and they will make up stories that we know” (Pharmacist’s 
assistant 4 (Clinic P): 39:9). Furthermore, a nurse at Clinic N stated that adherence 
follow-up is difficult, stating, ‘sometimes we will trace the defaulters to their house, but 
… they give wrong addresses, so it is a problem tracing them (Nurse 2 (Clinic N): 
2:48). Thus, patients lying negatively affects efforts to check adherence of patients. 
Palmieri and Stern (2009) noted that patients often lie to avoid negative consequences 
or to present themselves as compliant, doing so to prevent feelings of ‘embarrassment 
or shame’. This is concerning as patients lying in the medical setting can negatively 
affect the relationship between the patient and health professional and can 
compromise the quality of care provided as a result (Palmieri & Stern, 2009). 
4.2.4.2 Personnel perception 
 
There were mixed reactions regarding the perception of personnel. The majority of 
patients stated that they felt they could ask questions regarding therapy and felt 
comfortable to do so. This comfortable relationship promotes pharmaceutical care and 
a relationship that is based on understanding and respect (Cipolle, et al, 2012). A 
patient at Clinic N stated that: 
It is not a tense situation whereby people are always upset by my way the 
nurses are so rude. But it’s not always like that. Some of them do take real 
pride in their work and they do it well. I always look forward to coming here. 
Patient 1 (Clinic N): 7:1 
A few patients contradicted this and felt there was no relationship between patient and 
personnel. When asking a patient at Clinic P about ability to ask questions during 
consultation, she stated: 
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Now I wouldn’t feel happy to ask. I don’t even feel happy to say ‘hi’, because 
they don’t look happy that I’m there to see them. That’s why I would never 
say ‘I don’t understand this one’. Like no, no. They just get cheeky. So you 
don’t understand the situation and go with the flow … we don’t have a 
relationship. It’s the reality, we don’t have a relationship. Patient 4 (Clinic 
P): 41:21 
From these mixed responses, it seems patients have different perceptions about 
personnel, noting that it is often dependent on which personnel you get at a particular 
facility. It is evident to see that some patients still feel intimidated or unable to ask 
questions or to voice opinions about their therapy choice. Negative perceptions of 
personnel are a barrier to pharmaceutical care delivery and active steps to ensuring a 
comfortable relationship between personnel and patient should be encouraged to 
facilitate quality pharmaceutical care within a facility (Cipolle et al, 2006). 
4.2.4.3 Patient understanding of patients 
 
The personnel seemed to have a reasonable understanding of their patients; such as 
the patient demographic (age, language), education level (reading ability) and patient 
preferences. Furthermore, most personnel seemed to be concerned with their patients’ 
needs and aimed to provide the best possible care that they could, given their clinic’s 
context. A pharmacists’ assistant at Clinic P commented: 
Since we are dealing with poor people, we know it is essential for us to be 
here. Because they don’t have money to go to doctors and to go to 
chemists. You know? And also, we are rendering this service, in a smart 
way, in a way that we put that principle Batho Pele in action and give them 
the information, you know, for their access. Pharmacist’s assistant 1 (Clinic 
P): 31:7 
The passion for patient care was evident through the attitude of personnel. A nurse 
from Clinic N explained, “…the only need is to ensure that the client can access the 
care that they need, and also the information … So I love my patients. I will say that 
so they are my first priority” (Nurse 1 (Clinic N): 4:67). In addition, many personnel 
expressed views indicating that they were aware of many of the circumstances that 
patients are in or struggles that they most commonly face, such as a language barrier. 
For example, a pharmacist’s assistant from Clinic PA noted: 
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Like others they will ask you, ‘please write which one is for pain’, because 
although it is written some of them cannot read and understand English so 
we must write it in Xhosa. And you just have to write it. Pharmacist’s assistant 
4 (Clinic P): 39:5 
The concern of personnel for patients’ needs is necessary to facilitate quality 
pharmaceutical care as this is based on the principle of patient-centredness and 
should take into consideration the individual patient’s context. This is also aligned to 
the guiding principles of the IC programme and PHC in general, focusing on 
community-orientated care with prioritised patient need (Department of Health, 2011; 
Department of Health South Africa, 2017b; South African Pharmacy Council, 2018). 
 
Adequate pharmaceutical services 
 
4.2.5.1 Incomplete dispensing process 
 
From both patient and personnel responses it would appear that phase 3 of the 
dispensing process (involving medicine-related counselling) was often inadequate, 
rushed or left out of dispensing. A nurse at Clinic N, described the typical dispensing 
process as follows: 
I just give medication, but at that time is not adequate, because when you 
are dispensing you tell the clients the side effects and what the treatment is 
gonna do and all of that. But when you are in a rush because there is the 
line there that you’re supposed to take care of, then you don’t have enough 
time to share information with a client and that is the problem, sometimes 
we just assume that ‘ok, you have hypertension, your treatment is you take 
one a day’ but we don’t know if the patient understands the side effects. 
Some, they are not educated, so we’re just assuming she or he will know 
because we don’t have time. Nurse 1 (Clinic N): 4:30 
A pharmacist’s assistant at Clinic P similarly stated the following, “…I’m not gonna lie, 
the times that we explain the terms and conditions of the side effects are rare … 
Sometimes it is so full there’s not enough time to explain all things, just to be honest…” 
(Pharmacist’s assistant 4 (Clinic P): 39:11). 
From a patient’s perspective, the poor provision of medicine-related counselling was 
noted. However, many also noted that they realise this due to clinic-related constraints 
and patient attitude. For example, a patient from Clinic PA stated that: 
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They don’t run through thoroughly, you know, ‘this medicine two times a day’ ‘this 
medicine is for those’, ‘this medicine is for this’. And sometimes you don’t even 
hear what they are saying because of the time, because they want to help 
someone else. Patient 5 (Clinic PA): 18:7 
Phase 3 of the dispensing process should involve information and individualised 
instructions relating to the medicine being given to the patient. This is crucial within 
the dispensing process to ensure the effective and safe use of medicines and promote 
optimal therapeutic outcomes (Sanii et al, 2016; South African Pharmacy Council, 
2018). It was also noted that patients reported differing quality of dispensing, even 
between the same type of dispensing personnel suggesting that there is no uniform 
process or standardisation regarding quality within the dispensing process. This may 
lead to differing levels of understanding of medicine use and importance. The provision 
of standardised quality pharmaceutical services is necessary to support the provision 
of pharmaceutical care. Although the three phases of dispensing are defined clearly 
within the GPP manual, the enforcement of these phases within every dispensing 
consultation is seemingly not evident. 
 
Poor pharmaceutical care 
 
4.2.6.1 Poor multidisciplinary healthcare team collaboration 
 
From the study, it became apparent that MDHT collaboration at PHC level seems to 
be at a minimum. The doctor, pharmacist and nurses do not usually collaborate on 
conducting pharmaceutical plans or to identify adequate treatment for patients. When 
asking the pharmacist about his collaboration with nurses and the doctor at the facility, 
he stated, “Yes, I always have an open door policy so I’m fine with it and that’s what 
you create” (Pharmacist (Clinic P): 33:17). Thus, it was evident that the pharmacist 
serves as a health professional at the clinic that may assist with providing medicine- 
related knowledge not only on-site, but also to indirectly supervised clinics. When 
asking about this role around medicine information provision and whether he is 
contacted for advice he responded, “Always. We have the smaller clinics now that 
have no pharmacist so they constantly call … About twice, thrice a week, if they have 
a problem” (Pharmacist (Clinic P): 33:35). According to Kerr (2009), the pharmacist is 
appropriately equipped with medicine-related information and can be consulted within 
practice settings for evidence-based, current information about medicines. 
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When probing the role of the pharmacist at the clinic in discussing care plans and 
treatment decisions about patient care, the pharmacist at Clinic P responded: 
Quite often. For example, the protocol has changed, for example, with 
treating STIs [Sexually Transmitted Infections]. You know, I need to order 
stock now, for example, do I order the one drug? But we have to move 
forward because the new protocol is implemented. Yes, they’re fine with it 
- straight into protocol and implement it. Pharmacist (Clinic P): 33:19 
 
This quote indicates that the pharmacist’s role within the MDHT at the clinic is still 
primarily viewed as a medicines provider and not particularly as a health professional 
with pharmacotherapy knowledge who can contribute to assessing and contributing to 
patient care. The pharmacist should be involved in ensuring treatment care follows 
treatment guidelines and protocols, such as the PHC STGs, however the pharmacist’s 
role should not only be limited to this. 
According to personnel within Clinic P and PA, the dispensary often received 
prescriptions with medicine errors or aspects of irrational prescribing. Prescriptions 
that do not meet legal requirements or errors made in the transcription of doctors’ 
prescriptions are also seen at the clinics. The pharmacist expressed frustration in 
relation to this, stating “I mean you get the patient files, it’s not filed properly, it’s not 
done orderly, nurses are not doing the scripts properly and they’re not writing properly 
at the end of the day it impact[s] on them” (Pharmacist (Clinic P): 33:10). The 
pharmacist’s assistants felt that communicating with prescribers at the facility, 
particularly the nurses, was often difficult when discussing prescription and medicine 
errors, for example: 
Automatically at the dispensary when we give penicillin we ask the patient 
if they are allergic to penicillin. Some patients don’t even know the word 
penicillin, so we have to explain the symptom; like vomiting. And the patient 
will say ‘no’. But other information - it is written on the file outside. The 
allergies, it is written ‘allergic to penicillin’ … but on the doctor’s side, it is 
written ‘penicillin’ … and then you call the doctor and say, ‘Hi doctor, there’s 
a Mama that says she is allergic to penicillin, but you have written it’. And 
she will be like ‘it’s not me that wrote that?’ But there’s only one doctor at 
the facility. So some of them, even the doctor, you know when you are 
wrong, you’ve done wrong. It’s like we understand. It’s busy and you try to 
rush the medicines but please - prescribe the right medicine. Pharmacist’s 
assistant 4 (Clinic P): 39:7 
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This gives insight into the challenges faced by pharmacist’s assistants within MDHT 
collaborations. Particularly, pharmacist’s assistants noted the difficulties in 
collaborating with clinic staff. For example one pharmacist’s assistant at Clinic P noted 
that, “I think the biggest challenge is the team work. It’s the team work – with the 
nurses and doctors” (Pharmacist’s assistant 1 (Clinic P): 31:10). This challenge could 
be due to factors such as the limited pharmacological knowledge and professional 
communication skills of pharmacist’s assistants. In addition, it could also be due to the 
effects of the task-shifting process itself, as it may influence social hierarchies or role 
definitions within the clinic that can cause tension and misunderstanding between 
clinic staff (Callaghan et al., 2010; Osman, 2005). 
The MDHT collaboration between PHC staff has the potential to greatly benefit the 
patient due to the multidisciplinary input potentially provided by each valuable member 
of the team (Callaghan et al., 2010). Perzynski et al., (2018) suggest that how health 
teams at PHC level work together (their workplace social capital) affects their efficiency 
in providing quality healthcare provision. If healthcare teams have stronger 
collaborative relationships and higher agreement on common goals, workplace 
problems may be solved easier and patient care may be of a higher quality standard. 
To ensure this sense of social capital between PHC staff, dynamic workplace 
relationships need to be promoted and facilitated (Perzynski et al., 2018). 
4.2.6.2 Patient non-adherence 
 
A major sub-theme emerging from personnel from all clinics involves the phenomenon 
of non-adherence to dispensed medicines. Non-adherence is of particular concern in 
the PHC setting due to the majority of regimens involving long-term chronic therapy. 
Non-adherence to these therapies may result in sub-therapeutic doses, thus 
decreasing the effectiveness of medicine therapy (Fischer et al., 2010; World Health 
Organisation, 2003). When asked about challenges experienced at the dispensary, a 
pharmacist’s assistant from Clinic P noted, “The biggest one is that they are defaulting 
- I can say maybe it’s 80% patients that are defaulting, but I don’t know why” 
(Pharmacist’s assistant 1 (Clinic P) 15:4). The pharmacist (Clinic P) also expressed 
his concern regarding high non-adherence stating, “So I would say a good 60% don’t 
respect and use it, and those that get their medication for nothing are non-compliant’ ’  
(Pharmacist (Clinic P): 33:25). Nurses also stated their frustration with non-adherent 
patients, “When we have default rates this high, what happens to your defaulters if you 
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can’t trace them? If they don’t live in this area how are we supposed to trace them?” 
(Nurse (Clinic N): 3:249). 
Adherence checks that took place within the clinic involving patients on TB and ART 
were conducted mainly by non-pharmacy staff such as nurses and CHWs. In all three 
clinics, nurses would follow up with patients not collecting and taking TB and ART 
medicines adherently and CHWs would educate ‘defaulters’. In Clinic PA, adherence 
clubs, mainly patient-led, were reported at the clinic that help foster relationships 
between patients around adherent medicine use. All these methods are challenging to 
undertake, due to patients lying about addresses and contact details, manipulation of 
pill counting (both noted previously to affect personnel-patient relationship), leaving 
medicine boxes at home and the loss of patient files and clinic documents. Thus, 
adherence has been identified as a major challenge by personnel that affects 
personnel motivation and also adversely affects patient health outcomes. 
Walkowiak and Keene (2004) stress that personnel need problem-solving abilities and 
good communication skills during medicine-related counselling. This promotes patient 
adherence to dispensed regimens of treatment. This is reflected in GPP, the 
pharmacist should ‘determine compliance with the therapy and follow-up to ensure 
that the patient’s medicine-related needs may be met’ (South African Pharmacy 
Council, 2018). Schellack (2011) mentions that the process of dispensing includes 
adherence evaluation together with patient education. The person dispensing 
medicines needs to be able to fulfil this task adequately to ensure dispensing promotes 
optimal health outcomes. Furthermore, in cases of task-shifting, dispensing should be 
shifted such that the dispensing process can be executed by personnel who can fulfi l 
these aspects of the dispensing process. Task shifting should be done, taking into 
consideration the risks involved, if tasks are not adequately executed (Armstrong et 
al., 2013). Non-adherence can be considered one of these risks; thus is a result of 
incomplete dispensing processes at PHC facilities. 
Moving forward, potential avenues for the pharmacist to be more involved in 
adherence monitoring needs to be explored. Practically, the screening of patients 
could be done to prioritise those in need of adherence counselling. Within this 
counselling ‘tailoring’ adherence advice is important. Interestingly, this overlaps with 
the individualised approach central to a pharmaceutical care philosophy, thus 
indicating that pharmaceutical care could be used to target high rates of non- 
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adherence (Cutler & Everett, 2010). There are also opportunities for pharmacists to 
play a mentorship role. For example, in a study in Lusikisiki within the Eastern Cape, 
an adherence committee was set up to support an ART programme involving 
community members, clinic committee members, adherence counsellors and clinic 
staff meeting monthly (Medecins Sans Frontiers South Africa, 2006). This concept of 
an adherence committee including a pharmacist to track adherence and provide 
medicine-related support could be crucial to solving the problem of high non- 
adherence. In addition, the pharmacist could support and mentor clinic staff or CHW 
on issues relating to adherence of chronic therapy and TB or ART management 
(Bheekie & Bradley, 2016). 
Cutler and Everett (2010) noted that although improving adherence is critical to 
improving patient health outcomes, the current system offers no support or 
motivational incentive to do so. This mirrors the opinions involving the current fee-for- 
service funding model which doesn’t motivate health professionals and personnel to 
ensure quality dispensing services and pharmaceutical care to achieve better patient 
outcomes (Cutler & Everett, 2010). Similarly, the NHI has noted that the fee-for-service 
model of funding health care provision of the dispensing of medicines may be a major 
contributing factor to expected health outcomes not being reached due to poor quality 
service provision. Moving forward, the NHI aims to restructure funding of services that 
would affect dispensing and pharmaceutical care provision in order to prioritise quality 
and efficiency (Department of Health, 2017a). 
4.2.6.3 Adverse Drug Reaction reporting 
 
As ADR monitoring is a crucial aspect in promoting high quality pharmaceutical 
services and care, the process at ADR facilities was probed within the semi-structured 
interviews with personnel at each facility (South African Pharmacy Council, 2018). The 
knowledge and importance of ADRs reporting was most apparent in Clinic P. Although 
in Clinic P personnel were cognisant of the importance of ADR reporting, the 
pharmacist remarked that he was unsure if submitting forms to SAHPRA even resulted 
in any change, indicating the need for feedback regarding these reports. He stated 
that all completed forms are sent to the district pharmacist as part of the reporting 
process, however he feels as “nothing becomes of it, you never hear anything and 
that’s the saddest part, I don’t know. Nothing happens” (Pharmacist (Clinic P): 33:44). 
Similarly, Suleman (2010) notes that South African health professionals often feel 
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unmotivated to report ADRs appropriately due to poorly disseminated data reported 
back to facilities. The provision of this feedback is crucial to ‘incentivise’ the reporting 
of ADRs through pharmacovigilance surveillance structures (Bukirwa et al., 2008). 
There was some knowledge about the process among pharmacist’s assistants in Clinic 
PA, although there was poor knowledge about ADR reporting by nurses at Clinic N. 
For example, a nurse from Clinic N responded in the following way when asked about 
the process at the clinic for ADR reporting: 
I didn’t see any [ADR reporting process], but I think there is a record that 
needs to be recorded. I won’t lie, because I didn’t see any of those. Yes,  
but they need to be recorded. But I don’t know like to the district or whatever, 
or to doctor? But they need to record and give it to whoever-in-charge. I 
think there is a book but we don’t have any, you see. Nurse 1 (Clinic N): 
4:128 
Ruud et al. (2012) noted that nurse management of ADRs may not be appropriately 
understood and established to promote the safe use of medicines. This weak 
knowledge about the importance of ADR reporting may negatively affect patient health 
outcomes and the safety of patient populations (Ruud et al., 2012). 
Pharmacovigilance is a fundamental aspect of pharmaceutical care that should be 
functional within PHC facilities. Ideally, pharmacovigilance involves both medicine- 
related information and clinical knowledge, for example, drawing relationships 
between a medicine and a reported adverse event (Suleman, 2010). The GPP states 
that the pharmacist could play a role in working with other healthcare providers and 
patients to ‘identify, manage and report adverse drug reactions and drug interactions’. 
Furthermore, pharmacists can take a role in ensuring therapeutic monitoring of high 
risk medications or combination regimens at particular facilities (Suleman, 2010). The 
pharmacist is considered the controller and advisor on safe, effective, rational and 
appropriate use of medicines. Furthermore, the Code of Conduct for Pharmacists and 
Other Persons Registered in terms of the Pharmacy Act states that a pharmacist’s 
‘prime concern’ is the wellbeing of the patient and the public, thus having a direct role 
in ADR reporting and management is an important one (South African Pharmacy 
Council, 2018). Due to this, a more defined role for the pharmacist in co-ordination and 
education on the importance of ADR reporting should be apparent, both at clinics on-
site and in other indirectly supervised clinics. 
98  
4.2.6.4 Pharmacist accessibility 
 
The understanding regarding the pharmaceutical care philosophy seems to be low 
among personnel in the study. When the pharmacist was asked about what is the most 
important role he assumes at the clinic, he responded, “To make sure they actually 
got the medicine they deserve to get. To make sure the availability is always there. 
That’s the most important” (Pharmacist (Clinic P): 33:6). When further probed about 
the pharmaceutical care aspect, he replied that his role involved, “Explaining the side 
effects of the medicine to counteract any effects that can be had or seen” Pharmacist 
(Clinic P): 33:7). This information, as part of medicine-related counselling, should be 
provided to the patient as part of Phase 3 of the dispensing process, and forms part of 
providing quality pharmaceutical services. In contrast to this pharmacist’s perception, 
pharmaceutical care is involves more individualised patient advice and assessment of 
medicine needs. Although Hepler & Strand first discussed the concept of 
pharmaceutical care as early as 1990, it seems nearly 28 years later the concept is 
misunderstood and confused with more logistical and administrative functions within 
the dispensary, such as medicine supply management. 
The pharmacist further explained the following when referring to the importance of his 
role at the clinic, “To put the answer to your question in a nutshell, to make sure there’s 
a constant flow of medication to the patient” (Pharmacist (Clinic P): 33:5). This 
correlates with the pharmacist’s remark that only a minority of his time is utilised 
interacting with patients in activities, such as dispensing. He stated, “my job description 
is, basically speaking, about 20% dispensing and the rest is stock control and 
admin[istration] work, and doing orders and checking orders” (Pharmacist (Clinic P): 
33:3). This indicates that the pharmacist views his role as involving mostly medicine 
stock management, to ensure availability and access to medicines. Although this is a 
fundamental aspect of pharmaceutical services provision, the pairing of this with 
pharmaceutical care is beneficial to patients within the PHC setting. The pharmacist 
has the medicine-related knowledge to fulfil this pharmaceutical care provider role and 
this is a missed opportunity to taking on a more patient-centred role in patient care at 
the clinic. 
Some patients even reported that they were unware that they could consult with the 
pharmacist about medicine-related therapy. Having the pharmacist interacting with 
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patients regarding their health needs is integral to the pharmaceutical care process, 
thus the availability of the pharmacist in this sense is crucial. The IC Manual states 
that patients should have access to a pharmacist, either at the facility or through 
referral, in order to have access to a comprehensive PHC health service (Department 
of Health South Africa, 2017). 
It is evident from the findings of the study that the pharmacist needs to be supported 
with regard to a high administrative load within the dispensary as this may provide a 
more conducive environment for allowing the pharmacist to take on more 
pharmaceutical care-related functions. Walkowiak and Keene (2004) note that within 
resource-constrained contexts, pharmacists are still involved mostly in supply 
management functions, as this study confirmed. To facilitate this, medicine supply 
management needs to be shifted to other pharmacy personnel, such as to the 
pharmacy assistant, such to free up the pharmacists time for cognitive and patient- 
centred roles. Boschmans, Fogarty, and Brown (2016) state that PSWC, such as the 
pharmacist’s assistant, will help facilitate this shift in the role of the pharmacist. Task- 
shifting should occur so as to allocate medicine supply management and simpler 
dispensing phases to PSWC to allow pharmacists to efficiently utilise their cognitive 
medicine knowledge (Walkowiak & Keene, 2004). This could improve efficiency of the 
utilised roles within the dispensaries as the role of the pharmacist’s assistant is one that 
is ‘functional and operational’ as opposed to more cognitive functions of the pharmacist 
within the practice setting (Kotze, 2011). 
In addition, the National Drug Policy for South Africa underscores the emerging 
‘critical’ role of the pharmacist in preventative health services, a key aspect of PHC 
provision, together with the relevance of their knowledge of rational medicine use 
(Department of Health, 1996). Thus, the underutilisation of the pharmacist in the 
strengthening of PHC services and associated care is contrary to this. For example, 
the pharmacist is well-trained in promoting pharmaceutical public health along with 
aspects of pharmaceutical care, particularly for conditions common in PHC settings 
including hypertension, hyperlipidaemia, diabetes, chronic pain and those with co- 
morbidities (Berenguer, La Casa, de la Matta, & Martin-Calero, 2004). In addition to 
chronic condition support, awareness of drug misuse, promotion of adherence, dealing 
with pharmaceutical hazard alerts or ADR reporting are areas of utilisation where the 
pharmacist’s abilities can be used to promote patient care (Walker, 2000). 
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Furthermore, there is an opportunity for the pharmacist to become more involved in 
pharmaceutical care of an increasingly older patient population, targeting aspects such 
as polypharmacy and pharmacokinetic irregularities in the PHC setting (Bheekie & 
Bradley, 2016). 
Importantly, the pharmacist’s role as the provider of pharmaceutical care offers many 
potential benefits to the facility and the greater health system. Under the concept of 
pharmaceutical care, it is ideally the responsibility of the pharmacist within a facility to 
assess medicine problems or health risks and to communicate relevant information 
with pharmaceutical authorities. For example, there is a strong correlation between 
choice of pharmacotherapy and morbidity and mortality rates, with the number of 
additional therapies and the overall costs of patients to facilities and healthcare 
systems being potentially reduced with the increase of pharmaceutical care 
(Berenguer et al., 2004; Hepler & Strand, 1990). In this way, pharmacy policy can be 
strengthened with an emphasis on cost-effective medicine utilisation; impacting the 
quality and sustainability of health care systems, including PHC re-engineering 
(Heidari, 2014; Luisetto & Sahu, 2016). 
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Summary 
 
4.3.1 Phase 1 
 
In summary, results from the Phase 1 of the study gave substantial insight into the 
quality and availability of pharmaceutical services at the three PHC clinics. Results 
from Phase 1 indicated that: 
i. All clinics were fairly suited to facilitate basic pharmaceutical services provision; 
however challenges of poor infrastructure, including small medicine room size 
and unrestricted access to medicines in Clinic N were apparent challenges. In 
addition, maintenance of existing infrastructure was a challenge causing 
frustration for personnel, as equipment was not fixed timeously when broken. 
 
ii. All facilities had necessary equipment to provide necessary services with no 
immediate concern involving medicine storage and medicine integrity. This 
being said, storage areas did not fulfil all standards applicable to GPP and the 
IC Manual and back-up generators (with constant electricity supply) for 
refrigerated medicines were not available at any of the clinics. 
 
iii. With regard to patient-oriented aspects of pharmaceutical services, 
infrastructure of dispensaries, including the use of open dispensary windows, 
threatened the privacy of the pharmaceutical consultation. Although private 
consultation rooms were available in all three clinics, these rooms are 
underutilised due to time constraints and patient load. 
 
iv. No additional information resources regarding medicine use were available to 
patients as part of the dispensing process. 
 
v. There was no clear understanding regarding patient prescription records and 
folders evident at the clinics. No computerised record keeping or dispensing took 
place at the clinics. 
 
vi. Concerns were raised over the necessity for dispensing licenses within Clinic 
N, as none of the nurses had a dispensing licenses at the time of the study. A 
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discrepancy between guiding legislature regarding this license requirement is 
seemingly due to this absence of dispensing licenses at the facility. 
 
vii. Clinic N reported a need for pharmacy personnel to assist with dispensing 
medication, together with support with regard to medicine supply management 
at the facility. 
 
viii. Concerns were raised in Clinic N over the absence of prescription monitoring 
at the facility and the dispensing of down-referral medications that do not 
appear on the PHC EML. 
 
 
ix. Within Clinic PA, pharmacist’s assistants expressed their need for more support 
from a pharmacist with regard to medicine supply management and with 
dispensing, stating that monthly support visits were not taking place and that it 
was often difficult to contact a pharmacist when in need of medicine-related 
information. 
 
 
x. Within Clinic P, where both the pharmacist and pharmacist’s assistants take part 
in dispensing activities, the pharmacist was considered better placed to act on 
prescription monitoring and collaboration with prescribers. It was noted that the 
pharmacist was crucial in ensuring prescribing at the clinic was in accordance 
to the PHC EML. 
 
Despite these facilitating and constraining factors, the medicine room and 
dispensaries fulfilled most criteria on the pharmaceutical services audit, supporting 
basic pharmaceutical services provision at the facilities. 
 
4.3.2 Phase 2 
 
In interviews to gain insight into the lived experiences of personnel and patients of 
pharmaceutical care, the following results were reported as prevalent themes: 
i. Firstly, some clinic-related challenges were identified from the responses of 
personnel. Patient clinic misuse, involving patients by-passing their local clinic, 
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together with the use of multiple clinics by a single patient were identified to 
cause significant frustration at Clinic N. This, together with the unsuitable 
infrastructure, added to the frustration of personnel at the clinics. 
 
ii. Patients reported frustration involving long waiting times, particularly at clinic 
administration, this impacted on the relationship with personnel and fostered 
substantial patient dissatisfaction with the clinic. 
 
iii. Not all patients viewed the provision of medicine-related counselling as part of 
the dispensing process as important as the receipt of the medicines, raising 
concerns over the medicine-related understanding of patients at the clinic. 
 
iv. Personnel reported a high workload at all facilities, particularly the nurses as 
they had to incorporate dispensing into the patient consultation. 
 
v. It was also evident that there was a misunderstanding between the pharmacist 
and the circumstances at indirectly supervised clinics, warranting better 
understanding in the support needs of personnel off-site. 
 
vi. There were a multitude of stressors to the personnel-patient relationship, such 
as poor patient attitude; including disinterest, lack of respect and dishonesty. 
There were also mixed reactions regarding the perception of personnel, with 
some patients feeling intimidated to ask questions due to pressures of time and 
high workload of personnel. 
 
vii. Despite the stressors to the relationship between personnel and patient, it was 
evident that personnel had a good understanding of the circumstances of their 
patients, including demographic and income level; and tried to provide a quality 
service despite clinic-related challenges and high workload. 
 
viii. Evidently, phase 3 of dispensing, including medicine-related counselling, was 
often omitted from the process, contributing to a varying quality of dispensing 
between personnel. This impacts medicine understanding and adherence to 
patient therapy. 
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ix. Patient non-adherence was noted as a challenge to care provision in all clinics, 
resulting in de-motivation and frustration of personnel. Adherence checks are 
difficult due to poor patient attitude, with opportunities for patient education 
being difficult due to time constraints and high patient load. 
 
x. The concept of pharmaceutical care was vague, being defined as more 
administrative tasks rather than patient-centred care. 
 
xi. With regard to pharmacovigilance, the pharmacist had the most knowledge 
regarding this process in the study, however expressed disappointment with 
the ADR reporting process due to lack of feedback. ADR importance in Clinic 
PA and Clinic N was vague. 
 
xii. The pharmacist’s is largely involved in administrative functions, including 
medicine supply management, with only a minority of time spent with patients, 
including dispensing. Due to this, patients felt the pharmacist was inaccessible. 
The large administrative role of the pharmacist and the ineffective task-shifting 
of these roles to PSWC is seemingly a cause. 
 
xiii. Despite the pharmacist interacting with prescribers regarding prescription 
errors and providing medicine-related knowledge, there was no real MDHT 
collaboration taking place regarding patient-related care and treatment options. 
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CHAPTER FIVE 
CONCLUSION, 
RECOMMENDATIONS AND LIMITATIONS 
 
 
Conclusion 
 
The results obtained from the study provide useful insight into the facilitating and 
constraining factors affecting the provision of pharmaceutical services and care at 
PHC level. Within the greater context of the NHI and the progressive realisation of 
access to quality health care, these factors regarding pharmaceutical services and 
care may be of concern. PHC re-engineering and associated IC initiatives, 
implemented during Phase 1 of NHI, focused on improving performance and quality of 
services of the PHC sector; however the results of the study mention considerable 
challenges to providing optimal pharmaceutical services and care to patients. Thus, 
the preparatory measures taken to improve quality of care at PHC clinics should 
continue as part of health systems strengthening activities within the second and third 
phases of the NHI. Not only will these activities improve patient care, but they are 
necessary for health facility accreditation with the OHSC norms and standards 
(Department of Health: South Africa, 2017a). 
From these results, one can gain an understanding into the current gaps within this 
provision and how this may affect the overall quality and availability of pharmaceutical 
services (objective 1.3.1 (i)) and pharmaceutical care (objective 1.3.1 (ii)) at PHC 
clinics. These insights will be discussed under the headings pharmaceutical services 
(Section 5.1.1) and pharmaceutical care (Section 5.1.2). 
 
Pharmaceutical services 
 
With regard to pharmaceutical services, it was clear that the three dispensing models 
being compared upheld most aspects of GPP and IC standards. Both dispensaries 
and medicine rooms appeared to provide sufficient space conducive to a fair standard 
of pharmaceutical services provision. However, there are concerns that the provision 
of optimal services is compromised by poor maintenance of existing facilities and 
limited infrastructure, such as inadequate medicine room security, suitability and size 
and privacy of dispensary waiting areas. These issues could adversely affect the safe 
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control and storage of medicines, resulting in theft of medicines; and threaten quality 
pharmaceutical consultation due to patient interruption and lack of privacy. 
Indirectly supervised personnel expressed a need for greater pharmacist support, 
mainly in the refining of stock ordering and management functions. In the nurse-based 
model of dispensing, where pharmacy personnel were not available, a need for PSWC 
as expressed especially because of their knowledge of the use and control of 
medicines. Pharmacy personnel were not only viewed as having the potential to better 
underpin and support pharmaceutical services provision, but it felt that their presence 
would help reduce the high workload of nurses within PHC. 
All personnel expressed the view that the dispensing process was often incomplete, 
with the third phase, involving medication education and counselling, being absent. 
This was viewed as being the consequence of a multitude of causative factors such 
as high patient load, long waiting times, patient attitude and staff shortages. The 
inclusion of clear and complete medicine-related counselling during the dispensing 
process is fundamental to the provision of pharmaceutical services as it supports the 
rational use of medicines. Furthermore, the provision of medicine-related counselling 
appeared to vary from provider to provider, irrespective of the category of healthcare 
professional, suggesting that patients may be receiving pharmaceutical services of a 
varying quality even within the same facility. This results in irregular understanding of 
rational medicine use and could even promote non-adherence to dispensed therapy. 
Thus, even though a basic standard of pharmaceutical services were available at the 
PHC clinics in the study, the quality thereof could be improved to encourage better 
medicine use and understanding among patients. The optimisation of these 
pharmaceutical services is necessary to promote the highest standard of health of 
patients accessing these services at PHC level. 
 
Pharmaceutical care 
 
It was evident that pharmaceutical care experienced at the clinics was minimal. The 
cause of this was apparently the consequence of two major factors including; clinic- 
related factors and workload of the pharmacist. 
Many clinic-related factors resulted in a constraining environment that did not support 
the process of pharmaceutical care provision to patients. These include high patient 
loads, long waiting times, staff shortages and lack of adequate private consulting 
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areas. In addition, the collaborative team approach to handling patient cases (a key 
principle of pharmaceutical care) was not common practice at the clinic, with the 
pharmacist fulfilling the role of prescription monitoring and promotion of rational 
prescribing. The pharmacist was not necessarily included when developing care plans 
for patients, making the provision of pharmaceutical care difficult. 
The role of the pharmacist within the PHC setting appears to largely be stock 
management and administrative functions, with the pharmacist having minimal patient 
interaction. The process of shifting more technical aspects of dispensing to pharmacy 
support personnel has not been effective and the pharmacist has not been freed up to 
provide the more patient-centred and cognitive aspects of patient care. This is in 
contrast to the shifting paradigm of the profession of pharmacy that is adopting greater 
patient interaction and clinical pharmacy roles. Hence, this phenomenon is concerning 
as the underutilisation of the pharmacist is a missed opportunity in optimising patient 
health outcomes and patient satisfaction within the PHC system. 
 
Limitations 
 
The study took place within three PHC clinics within a sub-district within the Nelson 
Mandela Bay Health District of which generalisability of the findings from the study may 
be dependent on facility-specific characteristics and resources available within the 
particular sub-district. Due to this, the study provides phenomenological findings that 
may contribute to the understanding of pharmaceutical services at the PHC level, but 
cannot be generalised to other PHC clinics in other areas or provinces. 
 
Recommendations 
 
The following recommendations have been proposed from the study: 
 
Future research: 
 
i. There needs to be more research into the successes and failures of task-shifting 
involving PHC clinic staff within the South African context, particularly among 
pharmacy personnel. Furthermore, aspects regarding the relationship between 
clinic and pharmacy personnel due to task-shifting needs to be studied including 
the social and professional dynamics that result from this process. 
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ii. There is potential for the optimisation of patient health outcomes by ensuring the 
highest level of social capital (collaborative relationship) between multidisciplinary 
staff at clinics. More research into how fostering this sense of social capital within 
PHC in South Africa needs to be encouraged in order to understand current 
relationships and how these can be enhanced to promote optimal patient outcomes 
and efficiency of PHC provision. 
 
iii. Much has been understood about pharmaceutical care and the need for it to be 
provided in the PHC setting; however the contextual limitations of facilities which 
may limit the ability to provide pharmaceutical care need to be taken into 
consideration. Future research needs to focus on particular challenges within 
resource-constrained settings, providing practical solutions to overcoming these so 
that the highest attainable standard of pharmaceutical care possible can be 
provided. 
 
Policy 
 
i. There needs to be future discussion over the appropriate pharmaceutical 
personnel skills mix at a PHC level. This optimal skills mix should take the following 
into consideration: 
i. the roles of each member of personnel in the provision of optimal levels of 
pharmaceutical service 
ii. the clinical and cognitive functions of the pharmacist could be utilised more 
in practice through pharmaceutical care. 
iii. the HRH crisis and contributing factors that affect the retention of staff. 
 
Practice: 
 
i. There needs to be stronger ties between pharmacists and indirectly supervised 
personnel at PHC clinics. Not only should monthly, documented visits be 
enforced, but there needs to be greater emphasis on understanding the 
capabilities of indirectly supervised personnel, with ongoing mentoring to ensure 
pharmaceutical services are performed optimally when indirectly supervised. To 
ensure this, an agreement on where and how the pharmacist can provide 
additional and on-going support can be made. 
ii.  Within the PHC MDHT, there needs to be a revised perception of the pharmacist 
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and their input in the collaboration regarding patient care. At facility level, this 
needs to be discussed within the MDHT to provide suitable mechanisms by which 
the on-site pharmacist may be utilised more, contributing more to decisions 
regarding pharmacotherapy of patients. This could provide better opportunities for 
the provision of pharmaceutical care. 
 
iii.  Where there are currently pharmacists and PSWC on-site, adjustment to task- 
shifting needs to take place in order to free-up the pharmacist for more patient- 
centred and cognitive functions. Additional training or support for PSWC in 
executing administrative tasks, such as medicine supply management, should be 
provided to facilitate this shift in patient care. 
 
Despite limitations of the study, it is evident that pharmaceutical services and care at 
PHC clinics provide opportunities for the pharmacist, and PSWC, to better contribute 
to patient health outcomes. However, moving forward requires research, policy and 
practice changes to facilitate optimisation of provision within the constrained PHC 
environment. This optimisation requires the collaboration of researchers, health 
professionals, policy-makers and patients to promote multidisciplinary and inclusive 
solutions. Such solutions should hold true to the ideals of PHC re-engineering as part 
of the NHI implementation, in order to promote equity, efficiency and quality of 
healthcare provision to South African communities. 
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APPENDICES 
 
APPENDIX A: Request for Permission for Access to Research Sites 
 
 
 
 
Department of Pharmacy 
Faculty of Health Sciences 
Nelson Mandela University 
6001 
 
 
To whom it may concern, 
 
This letter requests the permission to conduct a masters study entitled, “Delivery of 
Pharmaceutical Services and Care at Three Primary Healthcare Clinics with Different 
Dispensing Models in the Nelson Mandela Bay Health District” at three Primary Health Care 
Clinics within the Nelson Mandela Bay Health District. 
The intended study, “Delivery of Pharmaceutical Services and Care at Three Primary 
Healthcare Clinics with Different Dispensing Models in the Nelson Mandela Bay Health 
District”, aims to explore pharmacist-based, pharmacist’s assistant-based and nurse-based 
dispensing models through experiences of quality and availability of pharmaceutical services 
and care provided at three public primary health care (PHC) clinics. As South Africa moves into 
an era of National Health Insurance (NHI), the idea of PHC re-engineering is placed at the 
forefront, however the role of the pharmacist in this process remains vague and largely 
undefined. Thus, the study into these three dispensing models at the PHC level will help better 
understand the role of the pharmacist in providing quality pharmaceutical services and care 
at PHC level and within the multidisciplinary healthcare team. 
We request the identification of three PHC clinics in the Nelson Mandela Bay Health District 
that each has one of the following dispensing models: pharmacist-based, pharmacist’s 
assistant-based and nurse-based; and the permission to conduct the study, consisting of two 
phases during the period of September and October 2017. 
Phase 1 includes an audit that will be carried out, that includes aspects of the Good Pharmacy 
Practice Guidelines and the Ideal Clinic Guidelines. This audit will be carried out within the 
pharmacy dispensary or medicine room, where storage and/or dispensing takes  place. The 
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audit will be done by the researcher, with the personnel checking the audit thereafter to 
ensure accurate data collection. 
Phase 2: Part A will involve the carrying out of semi-structured recorded interviews with 
personnel at each PHC clinic that consent to take part in the study. Interviews will be 
conducted in allocated private areas at the respective PHC clinics. 
Phase 2: Part B will involve 10 patients from each PHC clinic that have received dispensed 
medication from the personnel interviewed during Part A. After giving consent to take part in 
the study, each participant will participate in semi-structured recorded interviews that will 
take place in a private area at the clinic. 
We hope that this two phase study will provide rich data and findings to better understand 
the three dispensing models under study, and to provide a better understanding of the 
pharmaceutical services and care provided at the three PHC clinics in the Nelson Mandela Bay 
Health District. 
We look forward to your permission to conduct this study. 
 
 
Kind Regards, 
 
 
 
 
 
 
Amy Bobbins (Researcher) Dr Sue Burton (Supervisor) 
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APPENDIX B: Audit: Phase 1 
 
 
 
Weighting Key for the Audit: 
1 Not Important, but Necessary to Record 
2 Low Importance 
3 Slight Importance 
4 Neutral Importance 
5 Moderate Importance 
6 Very Important 
7 Extremely Important 
 
 
 
PROVISION OF PHARMACEUTICAL SERVICES AT PRIMARY HEALTH CARE (PHC) 
LEVEL: 
 
Mark each applicable answer with an ‘X’: 
 
1. Date and Start Time: 
 
D 
 
D 
 
/ 
 
M 
 
M 
 
/ 
 
Y 
 
Y 
 
Y 
 
Y 
 
at 
 
H 
 
H: 
 
M 
 
M 
 
 
 
2. Type of Dispensing Premises: 
 
Medicine Room: 
  
Pharmacy Dispensary: 
  
 
1. GENERAL STANDARDS RELATING TO THE 
PREMESIS: 
 
Does not comply 
 
Does comply 
 
Weighting 
1.1. The pharmacy or medicine room is tidy and orderly. 0 3 5 
1.2. The pharmacy or medicine room is fully lockable, secure 
and there is controlled and restricted access (personnel only).  
0 3 5 
1.3. The necessary dispensing equipment is available and is  in 
working order, including: 
1. counting trays 
2. dispensing balance 
3. graduated, stamped glass or plastic measures 
4. dispensing containers and labels. 
 
0 3 2 
0 3 2 
0 3 2 
0 3 2 
1.4. Thermolabile medicines are kept in accordance with cold- 
chain management, including: 
1. a refrigerator (between 2 and 80C) recorded twice daily 
2. thermometer hung from middle shelf of refrigerator 
3. a warning system if refrigeration has failed 
4. refrigerator cleaned and defrosted once a month 
5. refrigerator only stores pharmaceuticals (no food, etc.) 
 
0 3 6 
0 3 6 
0 3 6 
0 3 6 
0 3 6 
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6. freezers are available for polio and measles vaccines 
with ice packs (if applicable) 
7. evidence of stock control within the refrigerator 
(vaccines and medicines) 
8. when thermolabile medicines are supplied to patients,  
efforts are made by the personnel to maintain the cold 
chain when given to the patient or care-giver 
9. when thermolabile medicines are delivered by 
suppliers, they are temperature monitored from 
dispatch point to delivery point with proof thereof 
provided. 
0 3 6 
0 3 6 
0 3 6 
0 3 6 
1.5. Medicines stored in the dispensary or medicine room are 
protected from: 
1. excessive light 
2. extremes in temperature (kept below 250 C by an air- 
conditioning system) and have at least one wall- 
mounted thermometer 
3. sources of damp and excessive humidity 
4. pest infestations (i.e. there is evidence of pest control). 
 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
1.6. There are no expired medicines on the shelves. 0 3 3 
1.7. Expired medicines are disposed of in the correct manner 
(according to SOP). 
0 3 3 
1.8. Stock that arrives is checked for quality, quantity, type,  
storage requirements and expiry dates. 
0 3 3 
1.9. Stock is received in a secure and undercover area. 0 3 3 
1.10. There are suitable facilities where equipment and 
utensils can be washed and adequate hand-washing facilities. 
0 3 5 
1.11. Storage areas in the pharmacy or medicine room are 
large enough for adequate stock rotation, kept in a tidy 
condition and have stock orderly arranged off the floor. 
0 3 3 
1.12. The size of the dispensary or medicine room has enough 
space to allow for maximum flow, efficiency and supervision of 
personnel. 
0 3 5 
1.13. There is adequate, suitable waste disposal and record of 
waste disposal available. 
0 3 2 
1.14. There is a waiting area for patients that is near the 
dispensing area, undercover and provides enough comfortable 
seating. 
0 3 5 
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1.15. The easily accessible area for counselling and the 
provision of information regarding the safe use of medicines is: 
1. semi-private at the point of dispensing 
2. a private area 
3. a consultation area. 
 
0 3 5 
0 3 5 
0 3 5 
1.16. 90% of tracer medicines are available (According to the 
PHC Tracer Medicines List). 
0 3 6 
1.17. A re-order stock level (with min/max quantities) is 
determined for each item on the provincial/district formulary 
(e.g. the PHC Essential Medicines List (EML) and the PHC 
Tracer Medicines List). 
0 3 3 
1.18. There is a back-up electricity supply to ensure the 
uninterrupted supply of electricity. 
0 3 6 
1.19. A computerised programme is used for dispensing. 0 3 7 
1.20. The record of the prescription is kept for five years. 0 3 7 
1.21. A patient profile detailing all prescriptions dispensed to 
the patient is kept for five years after the last entry on site.  
0 3 7 
1.22. The dispensing area only displays materials directly 
linked to health. 
0 3 5 
1.23. The dispensing area is designated as a non-smoking 
area. 
0 3 5 
1.24. The dispensing area is designated as a non-eating area. 0 3 5 
1.25. When providing advice on medicine use, support aids 
(such as health information leaflets, package inserts or 
computer print-outs) are provided to patients or care-givers. 
0 3 5 
1.26. Standard Operating Procedures (SOPs) relevant to the 
practice of pharmacy are available in the dispensary. 
Including: 
1.  good housekeeping (cleaning procedures etc.). 
2.  pest (insects, rodents etc.) elimination. 
3.  receipt of stock. 
4.  effective stock rotation (FEEFO – First entry, expiry, first out). 
5.  disposal or removal of S1 – S6 expired, damaged and/or 
contaminated stock as required in Regulation 27 of Act 101 of 
1965. 
6.  product types requiring special storage or handling instructions. 
7.  separation and handling of goods returned from  patients. 
8.  recall of medicine. 
9.  delivery of medicines. 
0 
 
 
None 
available 
1 
 
 
< 10 
available 
2 
 
 
> 10 
available 
3 
 
 
All 
available 
3 
129  
10.  procedures to be followed regarding the handling of keys, 
money, etc. for a locum or relief pharmacist(s) (where 
applicable). 
11.  cold chain management (including procedures to be followed in 
the event of a power failure). 
12.  enquiry or complaint procedure. 
13.  stock-taking. 
14.  obsolete or unusable stock. 
15.  storage of medicine. 
16.  procurement of medicine. 
17.  handling of product complaints. 
18.  pre-packing (including quality assurance procedures) (where 
applicable). 
19.  reporting of adverse drug reactions. 
     
2. WHERE THE NURSE IS THE PERSONNEL OF MEDICINES (WITH A MEDICINE ROOM): 
2.1. Dispensing takes place in the consultation room with 
medicines being transported to the consultation room(s) daily.  
0 3 3 
2.2. There is evidence of adequate drug ordering and supply 
management records kept in the clinic by the nurse in charge 
of dispensing. 
0 3 3 
2.3. The diagnosis, prescribing and dispensing is done by the 
same nurse in the facility. 
Yes No 
2.4. The nurse dispensing at this facility is the holder of a 
licence contemplated in section 22C (1) (a dispensing license).  
Yes No 
2.5. At this facility only medicines that are on the PHC EML 
are dispensed by the nurse (refer to PHC EML). 
0 3 6 
2.6. At this facility only medicines in accordance with STGs are 
dispensed. 
0 3 6 
2.7. There are reference sources available to the dispensing 
nurse, including: 
1. EML/STGs 
2. latest edition of MIMs 
3. latest edition of MIMS Desk Reference (MDR) or 
South African Medicines Formulary (SAMF) 
4. a comprehensive textbook on pharmacology 
5. a medical dictionary 
6. the latest copy of the medicines and related 
substances act 101 of 1965 as amended 
7. the Good Pharmacy Practice (GPP) Manual 
 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
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8. the latest edition of Daily Drug Use (or another drug 
interactions source). 
0 3 3 
3. WHERE THE PHARMACIST’S ASSISTANT (POST-BASIC) IS THE PERSONNEL OF MEDICINES (WITH A 
DISPENSARY): 
3.1. The pharmacist visits and documents visits to the clinic to 
monitor supervise and support personnel at least once a 
month. 
0 3 5 
3.2. The pharmacist involved in the indirect supervision of the 
pharmacist’s assistant(s) provides updated protocols and SOPs 
describing the responsibilities of the pharmacist’s assistant. 
0 3 5 
3.3. Re-packaged or patient-ready packs are provided to this 
facility for dispensing to patients. 
0 3 5 
3.4. Compounding takes place at this pharmacy, according to 
provided SOPs. 
Yes No 
3.5. If a patient has a co-morbidity, consultation with a 
pharmacist electronically or via telephone takes place while 
the prescription is being dispensed. 
0 3 5 
3.6. The size of the dispensary is sufficient for the volume of 
prescriptions dispensed. 
0 3 5 
3.7. There are reference sources available in the pharmacy, 
including: 
1. EDL/STGs 
2. the GPP Manual 
3. the latest edition of Daily Drug use (or another drug 
interactions source) 
4. the latest edition of the SAMF or MDR 
5. there is access to a telephone or other means of 
communication to another institution (district or sub- 
district) or another pharmacy for further information if 
required. 
 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
3.8. Separate facilities that comply with GMP standards are 
available for pre-packing and compounding in accordance with 
the Medicines and Related Substances Act 101 of 1965 (if 
applicable). 
0 3 3 
4. WHERE THE PHARMACIST IS THE MAIN PERSONNEL OF MEDICINES (WITH A DISPENSARY): 
4.1. The pharmacist has 24 hour access to the pharmacy. 0 3 5 
4.2. The pharmacist ensures that protocols guiding the 
prescribing of medicines at the facility are carried through (i.e.  
are in communication with rational prescribing at the facility). 
0 3 5 
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4.3. The pharmacist takes part in PTC activities within the 
municipal, regional or district level. 
Yes No 
4.4. The pharmacist ensures that SOPs at the pharmacy are 
regularly updated with national and provincial guidelines. 
0 3 5 
4.5. The pharmacist ensures that the reference information 
materials are updated in the pharmacy. 
0 3 3 
4.6. There are reference sources available in the pharmacy, 
including: 
1. EDL/STGs 
2. the GPP Manual 
3. the latest edition of Daily Drug use (or another drug 
interactions source) 
4. the latest edition of the SAMF or MDR 
5. there is access to a telephone or other means of 
communication to another institution (district or sub- 
district) or another pharmacy for further information if 
required. 
 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
0 3 3 
4.7. The pharmacist is available to consult with patients, when 
requested. 
0 3 6 
4.9. The pharmacist is involved in drug supply management at  
the PHC facility. 
Yes No 
4.10. Prescriptions for patients with co-morbidities or 
suspected drug interactions are given to the pharmacist to 
dispense. 
Yes No 
4.11. The pharmacist has a relationship with the prescribers at 
the facility to ensure the prescribing of the correct medication 
and doses for patients. 
Yes No 
4.12. Compounding takes place at this pharmacy according to 
provided SOPs. 
Yes No 
4.13. Separate facilities that comply with GMP standards are 
available for pre-packing and compounding in accordance with 
the Medicines Act (if applicable). 
0 3 3 
4.14. The size of the dispensary is sufficient for the volume of 
prescriptions dispensed. 
0 3 5 
4.15. The name of the pharmacist on duty is visible in or 
outside the pharmacy. 
0 3 3 
4.16. The pharmacist (and PSWC if applicable) on duty is/are 
wearing (a) nametag indicating his/her name and designation. 
0 3 3 
4.17. The pharmacy is under the continuous direct supervision 
of the pharmacist. 
0 3 3 
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4.18. A valid original certificate is available indicating the 
recording of the pharmacy by the Registrar of the South 
African Pharmacy Council. 
0 3 7 
4.19. Who does the actual picking of medicines prior to 
dispensing? 
Pharmacist PSWC 
4.20. Who gives the medicine to be dispensed to the patient or 
care-giver? 
Pharmacist PSWC 
4.21. Every prescription is checked and signed by a 
pharmacist before being dispensed to a patient or care-giver. 
0 3 7 
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APPENDIX C: Participant Consent Form 
 
 
 
 
Department of Pharmacy 
Faculty of Health Sciences 
Nelson Mandela University 
6001 
Cell: 
Email: 
 
 
 
 
Date: 
 
Contact person: 
 
INFORMED CONSENT FORM 
 
I, ………………………………………………………, identity number…………………., 
confirm that I have been requested and hereby willing to participate in the interviews 
that will be part of a study, entitled: “Delivery of Pharmaceutical Services and Care at 
Three Primary Healthcare Clinics with Different Dispensing Models in the Nelson 
Mandela Bay Health District.”, conducted by Amy Bobbins (primary researcher) of the 
Department of Pharmacy, Faculty of Health Sciences at the Nelson Mandela 
University. 
The following aspects of the study have been explained to me, the participant: 
 
The primary aim of this study is to explore pharmacist-based, pharmacist-assistant 
based and nurse-based staffing models through experiences of quality and availability 
of pharmaceutical services and care provided at three public PHC clinics in the Nelson 
Mandela Bay District. 
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In participating in this study, I will be involved in an in-depth interview with the 
researcher. It will be digitally recorded and field notes may be taken by the researcher 
during the interview. 
I have a choice to participate in the interview, as it is voluntary and I have the right to 
willingly withdraw from the study at any time. 
My confidentiality will be ensured, no names or other identification attributes will be 
published. 
I may be invited to view the transcripts, analysis, interpretations, and descriptions 
obtained from the interview; so as to validate the accuracy and transparency of the 
transcripts, field notes and interpretations of the researcher. 
I have the freedom to suggest the removal of information that may lead to the exposure 
of my identity. 
It is hoped that I will enjoy participating in this research. 
Participation in the study will not result in any cost due to me. 
I, hereby voluntarily consent to participate in this study. 
Signed and confirmed at ……………………………………… on the 
………………............2017. 
 
 
 
(Interviewee) 
 
 
 
 
(Witness) 
 
 
 
(Principal investigator) 
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APPENDIX D: Interview Schedule for Personnel: Phase 2: Part A 
 
Section A: 
Demographic Information: 
1. PHC Clinic: 
PHC Clinic:  
Clinic P  
Clinic N  
Clinic PA  
 
 
2. Designation of Dispensing Staff member: 
 
 
Designation at PHC Clinic:  
Pharmacist  
Pharmacist’s assistant (Basic)  
Pharmacist’s assistant 
(Post- basic) 
 
Registered Nurse  
 
 
Section B: 
Interview Schedule: 
 
 
 
1. Can you please tell me about your role as a provider of medicines to patients at this  clinic? 
 
2. How do you feel about that role? 
 
After these questions the researcher will be led by the experiences and feelings of the 
healthcare professional – or may use any of the following questions to explore the issue in 
more depth. 
 
 
3. What role do you see medicines playing in the overall treatment of the patient? 
 
 
4. How do you think that the pharmaceutical care provided at this PHC clinic fulfils  patient 
expectations and needs? 
 
 
5. What do you believe is your biggest challenge to providing adequate pharmaceutical care to 
patients in the PHC setting? 
 
 
6. How do feel about your ability to provide the required medicine-related information to a 
patient? 
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7. How would you go about communicating with prescribers regarding an identified prescription 
problem, such as a medicine interaction? 
 
 
8. Can you describe your experiences of working together with prescribers at his clinic  in 
working out a plan of action or treatment plan for a patient? 
 
 
9. Can you describe any experiences had discussing a treatment plan with a patient for their 
prescribed treatment? How often does this happen? 
 
 
10. How do you feel about discussing suitable follow-up communication or visits with a patients 
regarding their medicine therapy? How often does this happen? 
 
 
11. How do you think that dispensing in this clinic ensures that patients understand the side 
effects and possible adverse effects that may arise from their dispensed regimen? 
 
 
12. How do you think that your current dispensing process motivates the patient to use their 
medicines rationally and safely? 
 
 
13. What is currently done at the PHC clinic to ensure the adherence of patients to their 
prescribed medications? 
 
 
14. What is the usual procedure when an adverse reaction to a medicine is noted or reported to 
the PHC clinic? 
 
 
15. How you think more time and effort could be invested in a better interpersonal professional 
relationship between the personnel and patient? 
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APPENDIX E: Interview Schedule for Patients Phase 2: Part B 
 
Section A: 
Demographic Information: 
1. PHC Clinic: 
PHC Clinic:  
Clinic P  
Clinic N  
Clinic PA  
 
2. Biographical Information: 
 
Age :  
Gender:  
Employment Status:  
Highest Level of 
Education: 
 
 
Section B: 
Proposed Interview Schedule: 
 
1. What has your experience been like as a receiver of medicine and care from this PHC clinic? 
 
 
After this question the researcher will be led by the experiences and feelings of the 
participant – or may use any of the following questions to explore the issue in more 
depth. 
 
 
2. How do you feel about the service you received while getting your medicines at this PHC 
Clinic and did it fulfil your needs as a patient? 
 
 
3. When you are given your medicines, what does the person dispensing them do to ensure that 
you understand how to take your medicines correctly? 
 
 
4. What do you think could be done by the personnel to ensure that you understand how to use 
your medications better? 
 
 
5. Do you understand what you are being treated for and how the medicine given to you will help 
you? 
 
6. How do you feel about the amount of time that the personnel spent with you giving you 
information and counselling you about using your medication properly? 
 
 
7. How comfortable do you feel to ask the person that gave you your medication any questions 
or for advice? 
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8. How do you think you could have a better relationship with your personnel? 
 
 
9. Would you like the personnel to follow-up with you while you are using your medicines, and 
how would you like this to be done? 
 
 
10. How do you think that the personnel including you in making a plan for taking your medicines 
will help you understand and control your health better? 
